Ares Commercial Real Estate (ACRE) 10-K 15 Feb 23 2022 FY Annual report Financial data

COVER PAGE

COVER PAGE - USD ($)	12 Months Ended
	Dec. 31, 2022	Feb. 14, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-35517
Entity Registrant Name	ARES COMMERCIAL REAL ESTATE CORPORATION
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	45-3148087
Entity Address, Address Line One	245 Park Avenue
Entity Address, Address Line Two	42nd Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10167
City Area Code	212
Local Phone Number	750-7300
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	ACRE
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 624,555,623
Entity Common Stock, Shares Outstanding		54,606,826
Documents Incorporated by Reference	Portions of the registrant’s Proxy Statement for its 2023 Annual Meeting of Stockholders to be filed not later than 120 days after the end of the fiscal year covered by this annual report on Form 10-K are incorporated by reference into Part III of this Form 10-K.
Entity Central Index Key	0001529377
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2022
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP
Auditor Location	Los Angeles, California

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 141,278	$ 50,615
Loans held for investment ($887,662 and $974,424 related to consolidated VIEs, respectively)	2,264,008	2,414,383
Current expected credit loss reserve	(65,969)	(23,939)
Loans held for investment, net of current expected credit loss reserve	2,198,039	2,390,444
Real estate owned held for sale, net	0	36,602
Investment in available-for-sale debt securities, at fair value	27,936	0
Other assets ($2,980 and $2,592 of interest receivable related to consolidated VIEs, respectively; $129,495 and $128,589 of other receivables related to consolidated VIEs, respectively)	155,749	154,177
Total assets	2,523,002	2,631,838
LIABILITIES
Secured funding agreements	705,231	840,047
Notes payable	104,460	50,358
Secured term loan	149,200	149,016
Collateralized loan obligation securitization debt (consolidated VIEs)	777,675	861,188
Secured borrowings	0	22,589
Due to affiliate	5,580	4,156
Dividends payable	19,347	16,674
Other liabilities ($1,913 and $570 of interest payable related to consolidated VIEs, respectively)	13,969	9,182
Total liabilities	1,775,462	1,953,210
Commitments and contingencies (Note 9)
STOCKHOLDERS' EQUITY
Common stock, par value $0.01 per share, 450,000,000 shares authorized at December 31, 2022 and 2021 and 54,443,983 and 47,144,058 shares issued and outstanding at December 31, 2022 and 2021, respectively	537	465
Additional paid-in capital	812,788	703,950
Accumulated other comprehensive income	7,541	2,844
Accumulated earnings (deficit)	(73,326)	(28,631)
Total stockholders' equity	747,540	678,628
Total liabilities and stockholders' equity	$ 2,523,002	$ 2,631,838

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Loans held for investment	$ 2,264,008	$ 2,414,383
Other assets	155,749	154,177
Other liabilities	$ 13,969	$ 9,182
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	450,000,000	450,000,000
Common stock shares issued (in shares)	54,443,983	47,144,058
Common stock, shares outstanding (in shares)	54,443,983	47,144,058
Variable Interest Entity, Primary Beneficiary
Loans held for investment	$ 887,662,000	$ 974,424,000
Interest receivable	2,980,000	2,592,000
Other assets	129,495,000	128,589,000
Other liabilities	$ 1,913,000	$ 570,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue:
Interest income	$ 170,171	$ 133,631	$ 121,052
Interest expense	(65,994)	(50,080)	(51,949)
Net interest margin	104,177	83,551	69,103
Revenue from real estate owned	2,672	18,518	13,593
Total revenue	106,849	102,069	82,696
Expenses:
Management and incentive fees to affiliate	14,898	12,136	8,159
Professional fees	3,350	2,436	2,640
General and administrative expenses	6,394	4,741	3,732
General and administrative expenses reimbursed to affiliate	3,777	3,016	3,653
Expenses from real estate owned	4,309	18,548	18,127
Total expenses	32,728	40,877	36,311
Provision for current expected credit losses	46,061	10	20,185
Realized losses on loans sold	0	0	4,008
Gain on sale of real estate owned	2,197	0	0
Income before income taxes	30,257	61,182	22,192
Income tax expense, including excise tax	472	722	352
Net income attributable to common stockholders	$ 29,785	$ 60,460	$ 21,840
Earnings per common share:
Basic earnings per common share (in dollars per share)	$ 0.58	$ 1.43	$ 0.66
Diluted earnings per common share (in dollars per share)	$ 0.57	$ 1.42	$ 0.66
Weighted average number of common shares outstanding:
Basic weighted average shares of common stock outstanding (in shares)	51,679,744	42,399,613	32,977,462
Diluted weighted average shares of common stock outstanding (in shares)	52,126,256	42,681,505	33,196,508

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income attributable to common stockholders	$ 29,785	$ 60,460	$ 21,840
Other comprehensive income:
Realized and unrealized gains (losses) on derivative financial instruments	4,642	2,844	0
Unrealized gains (losses) on available-for-sale debt securities	55	0	0
Comprehensive income	$ 34,482	$ 63,304	$ 21,840

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Impact of adoption of CECL	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Earnings (Deficit)	Accumulated Earnings (Deficit) Impact of adoption of CECL
Beginning balance (in shares) at Dec. 31, 2019			28,865,610,000
Beginning balance at Dec. 31, 2019	$ 426,339	$ (5,051)	$ 283	$ 423,619	$ 0	$ 2,437	$ (5,051)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)			4,600,000,000
Sale of common stock	73,232		$ 46	73,186
Offering costs	(341)			(341)
Stock-based compensation (in shares)			(23,278,000)
Stock‑based compensation	1,339			1,339
Net income	21,840					21,840
Dividends declared	(44,343)					(44,343)
Ending balance (in shares) at Dec. 31, 2020			33,442,332,000
Ending balance at Dec. 31, 2020	473,015		$ 329	497,803	0	(25,117)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)			13,637,237,000
Sale of common stock	204,779		$ 136	204,643
Offering costs	(436)			(436)
Stock-based compensation (in shares)			64,489,000
Stock‑based compensation	1,940			1,940
Other comprehensive income	2,844				2,844
Net income	60,460					60,460
Dividends declared	$ (63,974)					(63,974)
Ending balance (in shares) at Dec. 31, 2021	47,144,058		47,144,058,000
Ending balance at Dec. 31, 2021	$ 678,628		$ 465	703,950	2,844	(28,631)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)			7,190,369,000
Sale of common stock	106,267		$ 72	106,195
Offering costs	(233)			(233)
Stock-based compensation (in shares)			109,556,000
Stock‑based compensation	2,876			2,876
Other comprehensive income	4,697				4,697
Net income	29,785					29,785
Dividends declared	$ (74,480)					(74,480)
Ending balance (in shares) at Dec. 31, 2022	54,443,983		54,443,983,000
Ending balance at Dec. 31, 2022	$ 747,540		$ 537	$ 812,788	$ 7,541	$ (73,326)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net income	$ 29,785	$ 60,460	$ 21,840
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of deferred financing costs	7,096	9,895	6,434
Accretion of discounts, deferred loan origination fees and costs	(10,347)	(8,433)	(7,430)
Stock-based compensation	2,876	1,940	1,339
Depreciation of real estate owned	0	825	892
Provision for current expected credit losses	46,061	10	20,185
Realized losses on loans sold	0	0	4,008
Amortization of derivative financial instruments	(1,029)	0	0
Gain on sale of real estate owned	(2,197)	0	0
Changes in operating assets and liabilities:
Other assets	(17,674)	(18,545)	(15,344)
Due to affiliate	1,424	1,006	389
Other liabilities	1,162	1,192	(551)
Net cash provided by (used in) operating activities	57,157	48,350	31,762
Investing activities:
Issuance of and fundings on loans held for investment	(652,720)	(1,241,996)	(524,166)
Principal repayment of loans held for investment	824,940	534,973	341,450
Proceeds from sale of loans held for sale	0	0	96,597
Receipt of origination fees	8,513	7,632	4,526
Purchases of capitalized additions to real estate owned	0	(144)	(274)
Proceeds from sale of real estate owned	38,227	0	0
Purchases of available-for-sale debt securities	(27,872)	0	0
Amounts received (paid) under derivative financial instruments	2,085	(150)	0
Net cash provided by (used in) investing activities	193,173	(699,685)	(81,867)
Financing activities:
Proceeds from notes payable	105,000	15,869	6,967
Repayments of notes payable	(51,110)	(27,880)	0
Payment of secured funding costs	(4,467)	(13,066)	(5,065)
Proceeds from issuance of debt of consolidated VIEs	0	540,471	0
Repayments of debt of consolidated VIEs	(85,856)	(121,246)	0
Dividends paid	(71,807)	(58,424)	(42,765)
Proceeds from sale of common stock	106,267	204,779	73,232
Payment of offering costs	(163)	(324)	(301)
Net cash provided by (used in) financing activities	(159,667)	627,174	119,246
Change in cash and cash equivalents	90,663	(24,161)	69,141
Cash and cash equivalents, beginning of period	50,615	74,776	5,635
Cash and cash equivalents, end of period	141,278	50,615	74,776
Supplemental Information:
Interest paid during the period	57,819	40,126	46,137
Income taxes paid during the period	250	1,406	399
Supplemental disclosure of noncash investing and financing activities:
Dividends declared, but not yet paid	19,347	16,674	11,124
Other receivables related to consolidated VIEs	129,495	128,589	6,410
Secured funding agreements
Financing activities:
Proceeds from secured funding agreements	267,192	970,036	473,493
Repayments of secured funding agreements	(402,008)	(885,541)	(446,530)
Secured term loan
Financing activities:
Proceeds from secured funding agreements	0	90,000	0
Repayments of secured funding agreements	0	(50,000)	0
Secured bowowings
Financing activities:
Proceeds from secured funding agreements	0	0	60,215
Repayments of secured funding agreements	$ (22,715)	$ (37,500)	$ 0

ORGANIZATION

ORGANIZATION	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	ORGANIZATION Ares Commercial Real Estate Corporation (together with its consolidated subsidiaries, the “Company” or “ACRE”) is a specialty finance company primarily engaged in originating and investing in commercial real estate loans and related investments. Through Ares Commercial Real Estate Management LLC (“ACREM” or the Company’s “Manager”), a Securities and Exchange Commission (“SEC”) registered investment adviser and a subsidiary of Ares Management Corporation (NYSE: ARES) (“Ares Management” or “Ares”), a publicly traded, leading global alternative investment manager, it has investment professionals strategically located across the United States and Europe who directly source new loan opportunities for the Company with owners, operators and sponsors of commercial real estate (“CRE”) properties. The Company was formed and commenced operations in late 2011. The Company is a Maryland corporation and completed its initial public offering (the “IPO”) in May 2012. The Company is externally managed by its Manager, pursuant to the terms of a management agreement (the “Management Agreement”). The Company operates as one operating segment and is primarily focused on directly originating and managing a diversified portfolio of CRE debt-related investments for the Company’s own account. The Company’s target investments include senior mortgage loans, subordinated debt, preferred equity, mezzanine loans and other CRE investments, including commercial mortgage backed securities. These investments are generally held for investment and are secured, directly or indirectly, by office, multifamily, retail, industrial, lodging, self storage, student housing, residential, and other commercial real estate properties, or by ownership interests therein. The Company has elected and qualified to be taxed as a real estate investment trust (“REIT”) for United States federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2012. The Company generally will not be subject to United States federal income taxes on its REIT taxable income as long as it annually distributes all of its REIT taxable income prior to the deduction for dividends paid to stockholders and complies with various other requirements as a REIT.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated. Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Global macroeconomic conditions, including heightened inflation, changes to fiscal and monetary policy, higher interest rates, currency fluctuations, labor shortages and challenges in the supply chain, have the potential to negatively impact the Company and its borrowers. These current macroeconomic conditions may continue or aggravate and could cause the United States economy or other global economies to experience an economic slowdown or recession. We anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States or other major global economy. The Company believes the estimates and assumptions underlying its consolidated financial statements are reasonable and supportable based on the information available as of December 31, 2022, however, uncertainty over the global economy and the Company’s business, makes any estimates and assumptions as of December 31, 2022 inherently less certain than they would be absent the current and potential impacts of current macroeconomic conditions. Actual results could differ from those estimates. Variable Interest Entities The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation , defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE. To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE. To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company. For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements. The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change. See Note 16 included in these consolidated financial statements for further discussion of the Company’s VIEs. Cash and Cash Equivalents Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short‑term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and statements of cash flows. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, loans held for investment, available-for-sale debt securities and interest receivable. The Company places its cash and cash equivalents with financial institutions and, at times, cash held may exceed the Federal Deposit Insurance Corporation insured limit. The Company has exposure to credit risk on its loans held for investment and available-for-sale debt securities. The Company and the Company’s Manager seek to manage credit risk by performing due diligence prior to origination or acquisition and through the use of non‑recourse financing, when and where available and appropriate. Loans Held for Investment The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized loan fees and origination costs (the “carrying value”). Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors. Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection. Loan balances that are deemed to be uncollectible are written off as a realized loss and are deducted from the current expected credit loss reserve. The write-offs are recorded in the period in which the loan balance is deemed uncollectible based on management’s judgment. Current Expected Credit Losses Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, requires the Company to reflect current expected credit losses (“CECL”) on both the outstanding balances and unfunded commitments on loans held for investment and requires consideration of a broad range of historical experience adjusted for current conditions and reasonable and supportable forecast information to inform credit loss estimates (the “CECL Reserve”). ASU No. 2016-13 was effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. ASU No. 2016-13 was adopted by the Company on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of January 1, 2020. Subsequent period increases and decreases to expected credit losses impact earnings and are recorded within provision for current expected credit losses in the Company’s consolidated statements of operations. The CECL Reserve related to outstanding balances on loans held for investment required under ASU No. 2016-13 is a valuation account that is deducted from the amortized cost basis of the Company’s loans held for investment in the Company’s consolidated balance sheets. The CECL Reserve related to unfunded commitments on loans held for investment is recorded within other liabilities in the Company's consolidated balance sheets. See Note 4 included in these consolidated financial statements for CECL related disclosures. Real Estate Owned Real estate assets are carried at their estimated fair value at acquisition and are presented net of accumulated depreciation and impairment charges. The Company allocates the purchase price of acquired real estate assets based on the fair value of the acquired land, building, furniture, fixtures and equipment. Real estate assets are depreciated using the straight-line method over estimated useful lives of up to 40 years for buildings and improvements and up to 15 years for furniture, fixtures and equipment. Renovations and/or replacements that improve or extend the life of the real estate asset are capitalized and depreciated over their estimated useful lives. The cost of ordinary repairs and maintenance are expensed as incurred. Real estate assets are evaluated for indicators of impairment on a quarterly basis. Factors that the Company may consider in its impairment analysis include, among others: (1) significant underperformance relative to historical or anticipated operating results; (2) significant negative industry or economic trends; (3) costs necessary to extend the life or improve the real estate asset; (4) significant increase in competition; and (5) ability to hold and dispose of the real estate asset in the ordinary course of business. A real estate asset is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate asset over the estimated remaining holding period is less than the carrying amount of such real estate asset. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate asset. An impairment charge is recorded equal to the excess of the carrying value of the real estate asset over the fair value. When determining the fair value of a real estate asset, the Company makes certain assumptions including, but not limited to, consideration of projected operating cash flows, comparable selling prices and projected cash flows from the eventual disposition of the real estate asset based upon the Company’s estimate of a capitalization rate and discount rate. The Company reviews its real estate assets, from time to time, in order to determine whether to sell such assets. Real estate assets are classified as held for sale when the Company commits to a plan to sell the asset, when the asset is being actively marketed for sale at a reasonable price and the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year. Real estate assets that are held for sale are carried at the lower of the asset’s carrying amount or its fair value less costs to sell. Available-for-Sale Debt Securities The Company acquires debt securities that are collateralized by mortgages on CRE properties primarily for short-term cash management and investment purposes. On the acquisition date, the Company designates investments in CRE debt securities as available-for-sale. Investments in CRE debt securities that are classified as available-for-sale are carried at fair value. Unrealized holding gains and losses for available-for-sale debt securities are recorded each period in other comprehensive income (“OCI”). The Company uses a specific identification method when determining the cost of a debt security sold and the amount of unrealized gain or loss reclassified from accumulated other comprehensive income (loss) into earnings. Available-for-sale debt securities that are in an unrealized loss position are evaluated on a quarterly basis to determine whether declines in the fair value below the amortized cost basis qualify as other than temporary impairment (“OTTI”). The OTTI assessment is performed at the individual security level. In assessing whether the entire amortized cost basis of each security will be recovered, the Company will compare the present value of cash flows expected to be collected from the security with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the entire amortized cost basis of the security will not be recovered and an OTTI shall be considered to have occurred. Available-for-sale debt securities are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the debt security is placed on non-accrual status. Interest payments received on non-accrual securities may be recognized as income or applied to principal depending upon management’s judgment regarding collectability of the debt security. Non-accrual debt securities are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. Debt Issuance Costs Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on the (i) Secured Funding Agreements (each individually defined in Note 6 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable, the Secured Term Loan (each defined in Note 6 included in these consolidated financial statements) and secured borrowings (described in Note 7 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability in the Company’s consolidated balance sheets. Amortization of debt issuance costs for the note payable on the hotel property that was recognized as real estate owned in the Company’s consolidated balance sheets (see Note 6 included in these consolidated financial statements for additional information on the note payable) is included within expenses from real estate owned in the Company’s consolidated statements of operations. Derivative Financial Instruments Derivative financial instruments are classified as either other assets (gain positions) or other liabilities (loss positions) in the Company’s consolidated balance sheets at fair value. These amounts may be offset to the extent that there is a legal right to offset and if elected by management. On the date the Company enters into a derivative contract, the Company designates each contract as a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability, or cash flow hedge, or as a derivative instrument not to be designated as a hedging derivative, or non-designated hedge. For all derivatives other than those designated as non-designated hedges, the Company formally documents the hedge relationships and designation at the contract’s inception. This documentation includes the identification of the hedging instruments and the hedged items, its risk management objectives, strategy for undertaking the hedge transaction and an evaluation of the effectiveness of its hedged transaction. The Company performs a formal assessment on a quarterly basis on whether the derivative designated in each hedging relationship is expected to be, and has been, highly effective in offsetting changes in the value or cash flows of the hedged items. Changes in the fair value of derivative contracts are recorded each period in either current earnings or OCI, depending on whether the derivative is designated as part of a hedge transaction and, if so, the type of hedge transaction. For derivatives that are designated as cash flow hedges, the effective portion of the unrealized gains or losses on these contracts is recorded in OCI. If it is determined that a derivative is not highly effective at hedging the designated exposure, hedge accounting is discontinued and the changes in fair value of the instrument are included in current earnings prospectively. The Company does not enter into derivatives for trading or speculative purposes. Revenue Recognition Interest income is accrued based on the outstanding principal amount and the contractual terms of each loan or debt security. For loans held for investment, the origination fees, contractual exit fees and direct loan origination costs are also recognized in interest income over the initial loan term as a yield adjustment using the effective interest method. For available-for-sale debt securities, premiums or discounts are amortized or accreted into interest income as a yield adjustment using the effective interest method. Revenue from real estate owned represents revenue associated with the operations of a hotel property classified as real estate owned that was sold in March 2022. Revenue from the operation of the hotel property was recognized when guestrooms were occupied, services had been rendered or fees had been earned. Revenues were recorded net of any discounts and sales and other taxes collected from customers. Revenues consisted of room sales, food and beverage sales and other hotel revenues. Net Interest Margin and Interest Expense Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans and debt securities as compared to its use of debt leverage. The Company includes interest income from its loans and debt securities and interest expense related to its Secured Funding Agreements, Notes Payable, securitization debt, the Secured Term Loan (each individually defined in Note 6 included in these consolidated financial statements) and secured borrowings (described in Note 7 included in these consolidated financial statements) in net interest margin. For the years ended December 31, 2022, 2021 and 2020, interest expense is comprised of the following ($ in thousands): For the years ended December 31, 2022 2021 2020 Secured funding agreements $ 33,602 $ 16,403 $ 28,003 Notes payable (1) 3,410 2,275 1,317 Securitization debt 29,341 20,104 12,384 Secured term loan 7,028 4,353 7,114 Secured borrowings 845 6,145 3,131 Other (2) (8,232) 800 — Interest expense $ 65,994 $ 50,080 $ 51,949 ____________________________ (1) Excludes interest expense on the $28.3 million note payable, which was secured by a hotel property that was recognized as real estate owned in the Company’s consolidated balance sheets (see Note 6 included in these consolidated financial statements for additional information on the note payable). Interest expense on the $28.3 million note payable is included within expenses from real estate owned in the Company’s consolidated statements of operations. (2) Represents the net interest expense recognized from the Company’s derivative financial instruments upon periodic settlement. Income Taxes The Company has elected and qualified for taxation as a REIT commencing with its taxable year ended December 31, 2012. As a result of the Company’s REIT qualification and its distribution policy, the Company does not generally pay United States federal corporate level income taxes. Many of the REIT requirements, however, are highly technical and complex. To continue to qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement that the Company distributes annually to its stockholders at least 90% of the Company’s REIT taxable income prior to the deduction for dividends paid. To the extent that the Company distributes less than 100% of its REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), the Company will pay tax at regular corporate rates on that undistributed portion. Furthermore, if the Company distributes less than the sum of 1) 85% of its ordinary income for the calendar year, 2) 95% of its capital gain net income for the calendar year, and 3) any undistributed shortfall from its prior calendar year (the “Required Distribution”) to its stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then it is required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if the Company elects to retain any of its net capital gain for any tax year, it must notify its stockholders and pay tax at regular corporate rates on the retained net capital gain. The stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If it is determined that the Company’s estimated current year taxable income will be in excess of estimated dividend distributions (including capital gain dividend) for the current year from such income, the Company accrues excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations. Excise tax expense is included in the line item income tax expense, including excise tax in the consolidated statements of operations included in this annual report on Form 10-K. The Company formed a wholly-owned subsidiary, ACRC Lender W TRS LLC (“ACRC W TRS”), in December 2013 in order to issue and hold certain loans intended for sale. The Company also formed a wholly-owned subsidiary, ACRC 2017-FL3 TRS LLC (“FL3 TRS”), in March 2017 in order to hold a portion of the CLO Securitizations (as defined below), including the portion that generates excess inclusion income. Additionally, the Company also formed a wholly-owned subsidiary, ACRC WM Tenant LLC (“ACRC WM”), in March 2019 in order to lease the hotel property classified as real estate owned, which was acquired on March 8, 2019. Entity classification elections to be taxed as a corporation and taxable REIT subsidiary (“TRS”) elections were made with respect to ACRC W TRS, FL3 TRS and ACRC WM. A TRS is an entity taxed as a corporation that has not elected to be taxed as a REIT, in which a REIT directly or indirectly holds equity, and that has made a joint election with such REIT to be treated as a TRS. A TRS generally may engage in any business, including investing in assets and engaging in activities that could not be held or conducted directly by the Company without jeopardizing its qualification as a REIT. A TRS is subject to applicable United States federal, state and local income tax on its taxable income. In addition, as a REIT, the Company also may be subject to a 100% excise tax on certain transactions between it and its TRS that are not conducted on an arm’s-length basis. For financial reporting purposes, a provision for current and deferred taxes has been established for the portion of the Company’s GAAP consolidated earnings recognized by ACRC W TRS, FL3 TRS and ACRC WM. The income tax provision is included in the line item income tax expense, including excise tax in the consolidated statements of operations included in this annual report on Form 10-K. FASB ASC Topic 740, Income Taxes (“ASC 740”), prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has analyzed its various federal and state filing positions and believes that its income tax filing positions and deductions are well documented and supported. As of December 31, 2022 and 2021, based on the Company’s evaluation, there is no reserve for any uncertain income tax positions. ACRC W TRS, FL3 TRS and ACRC WM recognize interest and penalties, if any, related to unrecognized tax benefits within income tax expense in the consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the consolidated balance sheets. Comprehensive Income Comprehensive income consists of net income and OCI that are excluded from net income. Stock-Based Compensation The Company recognizes the cost of stock‑based compensation, which is included within general and administrative expenses in the Company’s consolidated statements of operations. The fair value of the time vested restricted stock or restricted stock units (“RSUs”) granted is recorded to expense on a straight‑line basis over the vesting period for the award, with an offsetting increase in stockholders’ equity. For grants to directors and officers and employees of the Manager, the fair value is determined based upon the market price of the stock on the grant date. Earnings per Share The Company calculates basic earnings (loss) per share by dividing net income (loss) allocable to common stockholders for the period by the weighted average shares of common stock outstanding for that period after consideration of the earnings (loss) allocated to the Company’s restricted stock, which are participating securities as defined in GAAP. Diluted earnings (loss) per share takes into effect any dilutive instruments, such as restricted stock, RSUs and convertible debt, except when doing so would be anti‑dilutive. See Note 11 included in these consolidated financial statements for the earnings per share calculations. Recent Accounting Pronouncements In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848), to clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. ASU No. 2020-04 and ASU No. 2021-01 are effective for all entities and may be adopted retrospectively as of any date from the beginning of any interim period that includes or is subsequent to March 12, 2020. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848) to defer the sunset date of Topic 848 from December 31, 2022 to December 31, 2024. The Company elected to adopt the new guidance and, for the modifications that have occurred to date, the adoption of the guidance has not had a material impact on the Company’s consolidated financial statements. In March 2022, the FASB issued ASU 2022-02, Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures

LOANS HELD FOR INVESTMENT

LOANS HELD FOR INVESTMENT	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
LOANS HELD FOR INVESTMENT	LOANS HELD FOR INVESTMENTAs of December 31, 2022, the Company’s portfolio included 60 loans held for investment, excluding 150 loans that were repaid, sold or converted to real estate owned since inception. The aggregate originated commitment under these loans at closing was approximately $2.6 billion and outstanding principal was $2.3 billion as of December 31, 2022. During the year ended December 31, 2022, the Company funded approximately $676.9 million of outstanding principal and received repayments of $823.2 million of outstanding principal as described in more detail in the tables below. As of December 31, 2022, 90.2% of the Company’s loans have LIBOR or Secured Overnight Financing Rate (“SOFR”) floors, with a weighted average floor of 0.95%, calculated based on loans with LIBOR or SOFR floors. References to LIBOR or “L” are to 30-day LIBOR and references to SOFR or “S” are to 30-day SOFR (unless otherwise specifically stated). The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of December 31, 2022 and 2021 ($ in thousands): As of December 31, 2022 Carrying Amount (1) Outstanding Principal (1) Weighted Average Unleveraged Effective Yield Weighted Average Remaining Life (Years) Senior mortgage loans $ 2,225,725 $ 2,243,818 8.4 % (2) 8.8 % (3) 1.3 Subordinated debt and preferred equity investments 38,283 39,003 14.0 % (2) 14.0 % (3) 2.8 Total loans held for investment portfolio $ 2,264,008 $ 2,282,821 8.5 % (2) 8.9 % (3) 1.4 As of December 31, 2021 Carrying Amount (1) Outstanding Principal (1) Weighted Average Unleveraged Effective Yield Weighted Average Remaining Life (Years) Senior mortgage loans $ 2,397,655 $ 2,411,718 5.3 % (2) 5.4 % (3) 1.5 Subordinated debt and preferred equity investments 16,728 17,394 13.7 % (2) 13.7 % (3) 4.0 Total loans held for investment portfolio $ 2,414,383 $ 2,429,112 5.4 % (2) 5.5 % (3) 1.6 ______________________________ (1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. (2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of December 31, 2022 and 2021 as weighted by the outstanding principal balance of each loan. (3) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all interest accruing loans held by the Company as of December 31, 2022 and 2021 as weighted by the total outstanding principal balance of each interest accruing loan (excludes loans on non-accrual status as of December 31, 2022 and 2021). A more detailed listing of the Company’s loans held for investment portfolio based on information available as of December 31, 2022 is as follows ($ in millions, except percentages): Loan Type Location Outstanding Principal (1) Carrying Amount (1) Interest Rate Unleveraged Effective Yield (2) Maturity Date (3) Payment Terms (4) Senior Mortgage Loans: Office IL $151.5 $151.4 L+3.60% 8.3% Mar 2023 I/O Multifamily NY 130.6 129.3 S+3.90% 8.7% Jun 2025 I/O Office Diversified 118.0 117.7 S+3.75% 8.5% Jan 2024 (5) I/O Multifamily TX 100.0 99.2 S+3.50% 8.2% Jul 2025 I/O Industrial IL 98.2 97.8 L+4.55% 9.4% May 2024 I/O Mixed-use FL 84.0 84.0 L+4.25% 8.6% Feb 2023 I/O Office AZ 77.4 76.8 L+3.50% 8.3% Oct 2024 I/O Mixed-use NY 75.0 74.6 L+3.65% 8.4% Jul 2024 I/O Residential Condominium FL 72.5 72.3 L+5.25% 10.2% Jul 2023 I/O Residential Condominium NY 72.2 71.7 S+8.95% 15.3% Oct 2023 (6) I/O Office NC 69.1 69.0 L+4.25% 9.0% Mar 2023 (7) P/I (8) Office NY 68.2 67.6 L+3.85% 8.6% Aug 2025 I/O Multifamily TX 67.9 67.4 L+2.85% 7.6% Dec 2024 I/O Multifamily/Office SC 67.0 66.8 L+2.90% 7.6% Nov 2024 I/O Office NC 66.5 66.0 S+3.65% 8.5% Aug 2024 I/O Office IL 56.9 55.0 S+3.95% —% Jun 2023 (9) I/O Office IL 56.0 55.5 S+4.25% 9.1% Jan 2025 I/O Office GA 48.7 48.6 S+3.15% 7.8% Dec 2023 (10) I/O Hotel CA 40.0 40.0 L+4.12% 9.0% Jan 2023 I/O Hotel CA 39.5 39.1 S+4.20% 9.0% Mar 2025 I/O Mixed-use CA 37.9 37.9 L+4.10% 9.1% Mar 2023 I/O Mixed-use TX 35.3 35.2 S+3.85% (11) 8.5% Sep 2024 (11) I/O Hotel IL 35.0 29.8 S+4.00% —% (12) May 2024 (12) I/O Student Housing CA 34.5 34.5 S+3.95% 8.3% Jul 2023 (13) I/O Hotel NY 34.0 33.5 S+4.40% 9.2% Mar 2026 I/O Office CA 33.2 33.1 L+3.35% 8.5% Mar 2023 (14) I/O Multifamily CA 31.7 31.5 L+2.90% 7.6% Dec 2025 I/O Office IL 30.2 30.2 L+3.80% 8.8% Jan 2023 I/O Multifamily PA 29.3 29.3 S+4.00% (15) 8.6% Dec 2023 (15) I/O Industrial FL 25.5 25.4 L+2.90% 7.6% Dec 2025 I/O Industrial CO 24.5 24.5 (16) 12.2% Feb 2023 I/O Office MA 23.7 23.0 S+3.75% 9.6% Apr 2025 I/O Industrial NJ 23.3 23.1 L+3.75% 8.9% May 2024 I/O Multifamily WA 23.1 23.0 L+2.90% 7.5% Nov 2025 I/O Office CA 22.8 22.8 S+3.50% 8.1% Nov 2023 I/O Multifamily TX 22.2 22.1 L+2.50% 7.3% Oct 2024 I/O Industrial CA 19.6 19.6 L+3.75% 8.7% Mar 2023 I/O Student Housing AL 19.5 19.4 L+3.85% 8.6% May 2024 I/O Multifamily WA 18.8 18.7 L+3.00% 7.8% Mar 2023 I/O Self Storage PA 17.9 17.7 L+2.90% 7.6% Dec 2025 I/O Self Storage NJ 17.6 17.3 S+2.90% 8.0% Apr 2025 I/O Residential CA 14.3 14.3 13.00% —% (17) May 2021 (17) I/O Self Storage WA 11.5 11.3 S+2.90% 8.0% Mar 2025 I/O Industrial TX 10.4 10.3 L+5.25% 10.0% Dec 2024 I/O Industrial FL 9.5 9.4 L+4.75% 10.7% Nov 2024 I/O Self Storage MA 8.5 8.5 L+2.90% 7.5% Dec 2024 I/O Industrial PA 8.0 8.0 L+5.50% 10.3% Sep 2024 I/O Self Storage TX 8.0 8.0 L+2.90% 7.5% Aug 2024 I/O Self Storage MA 7.7 7.7 L+2.90% 7.5% Nov 2024 I/O Industrial PA 7.0 6.9 L+5.90% 10.7% Nov 2024 I/O Industrial TN 6.7 6.6 L+5.50% 10.3% Nov 2024 I/O Self Storage MA 6.5 6.5 L+2.90% 7.5% Oct 2024 I/O Self Storage MO 6.5 6.5 L+3.00% 7.5% Dec 2023 I/O Self Storage NJ 5.9 5.9 L+2.90% 7.7% Jul 2024 I/O Self Storage IL 5.6 5.6 L+3.00% 7.7% Dec 2023 I/O Industrial FL 4.7 4.6 S+5.75% 10.5% Mar 2025 I/O Self Storage TX 2.9 2.9 L+2.90% 7.4% Sep 2024 I/O Industrial GA 1.3 1.3 L+5.25% 10.0% Sep 2024 I/O Subordinated Debt and Preferred Multifamily SC 20.6 20.4 S+9.53% 14.3% Sep 2025 I/O Office NJ 18.4 17.9 12.00% 13.6% Jan 2026 I/O Total/Weighted Average $2,282.8 $2,264.0 8.5% _________________________ (1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 14 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected. (2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR or SOFR as of December 31, 2022 or the LIBOR or SOFR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of December 31, 2022 as weighted by the outstanding principal balance of each loan. (3) Certain loans are subject to contractual extension options that generally vary between one and two 12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications. (4) I/O = interest only, P/I = principal and interest. (5) In December 2022, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior diversified loan to January 2024. (6) This senior mortgage loan refinanced the previously existing $53.3 million senior mortgage loan that was held by the Company. The senior New York loan is currently in default due to the failure of the borrower to reach certain construction milestones. (7) In March 2022, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior North Carolina loan to March 2023. (8) In April 2022, amortization began on the senior North Carolina loan, which had an outstanding principal balance of $69.1 million as of December 31, 2022. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms. (9) Loan was on non-accrual status as of December 31, 2022 and the Unleveraged Effective Yield is not applicable. In May 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, amend the interest rate from L + 3.95% to S + 3.95% and extend the maturity date on the senior Illinois loan from June 2022 to June 2023. For the year ended December 31, 2022, the Company received $3.5 million of interest payments in cash on the senior Illinois loan that was recognized either as interest income or as a reduction to the carrying value of the loan and the borrower is current on all contractual interest payments. (10) In October 2022, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Georgia loan to December 2023. (11) In September 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, amend the interest rate from L + 3.75% to S + 3.85% and extend the maturity date on the senior Texas loan from September 2022 to September 2024. (12) Loan was on non-accrual status as of December 31, 2022 and the Unleveraged Effective Yield is not applicable. In March 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, amend the interest rate from L + 4.40% to S + 4.00% and extend the maturity date on the senior Illinois loan from May 2022 to May 2024. For the year ended December 31, 2022, the Company received $1.8 million of interest payments in cash on the senior Illinois loan that was recognized either as interest income or as a reduction to the carrying value of the loan and the borrower is current on all contractual interest payments. However, the senior Illinois loan is currently in default due to the failure of the borrower to make certain contractual reserve deposits by the May 2022 due date. (13) In May 2022, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior California loan to July 2023. (14) In November 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the senior California loan from November 2022 to March 2023. (15) In December 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, amend the interest rate from L + 3.00% to S + 4.00% and extend the maturity date on the senior Pennsylvania loan from December 2022 to December 2023. (16) At origination, the Colorado loan was structured as a senior loan and in January 2022, the Company also originated the mezzanine loan. The senior loan, which had an outstanding principal balance of $20.8 million as of December 31, 2022, accrues interest at a per annum rate of L + 6.75% and the mezzanine loan, which had an outstanding principal balance of $3.8 million as of December 31, 2022, accrues interest at a per annum rate of S + 8.50%. (17) Loan was on non-accrual status as of December 31, 2022 and the Unleveraged Effective Yield is not applicable. As of December 31, 2022, the senior California loan, which is collateralized by a residential property, is in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the May 2021 maturity date. As of December 31, 2022, the Company has elected to assign a specific CECL reserve on the senior California loan. See Note 4 included in these consolidated financial statements for more information. See Note 17 included in these consolidated financial statements for a subsequent event related to the senior California loan. The Company has made, and may continue to make, modifications to loans, including loans that are in default. Loan terms that may be modified include interest rates, required prepayments, asset release prices, maturity dates, covenants, principal amounts and other loan terms. The terms and conditions of each modification vary based on individual circumstances and will be determined on a case by case basis. The Company’s Manager monitors and evaluates each of the Company’s loans held for investment and is maintaining regular communications with borrowers and sponsors regarding the potential impacts of current macroeconomic conditions on the Company’s loans. For the years ended December 31, 2022 and 2021, the activity in the Company’s loan portfolio was as follows ($ in thousands): Balance at December 31, 2020 $ 1,815,219 Initial funding 1,166,100 Origination fees and discounts, net of costs (12,192) Additional funding 93,973 Amortizing payments (2,586) Loan payoffs (654,564) Origination fee and discount accretion 8,433 Balance at December 31, 2021 $ 2,414,383 Initial funding 578,652 Origination fees and discounts, net of costs (9,577) Additional funding 96,057 Amortizing payments (4,333) Loan payoffs (821,513) Origination fee and discount accretion 10,339 Balance at December 31, 2022 $ 2,264,008 Except as described in the table above listing the Company’s loans held for investment portfolio, as of December 31, 2022, all loans held for investment were paying in accordance with their contractual terms. As of December 31, 2022, the Company had three loans held for investment on non-accrual status with a carrying value of $99.1 million. As of December 31, 2021, the Company had two loans held for investment on non-accrual status with a carrying value of $45.0 million.

CURRENT EXPECTED CREDIT LOSSES

CURRENT EXPECTED CREDIT LOSSES	12 Months Ended
	Dec. 31, 2022
Credit Loss [Abstract]
CURRENT EXPECTED CREDIT LOSSES	CURRENT EXPECTED CREDIT LOSSES The Company estimates its CECL Reserve primarily using a probability-weighted model that considers the likelihood of default and expected loss given default for each individual loan. Calculation of the CECL Reserve requires loan specific data, which includes capital senior to the Company when the Company is the subordinate lender, changes in net operating income, debt service coverage ratio, loan-to-value, occupancy, property type and geographic location. Estimating the CECL Reserve also requires significant judgment with respect to various factors, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect the risk characteristics of the Company’s floating rate loan portfolio and (iv) the Company’s current and future view of the macroeconomic environment. The Company may consider loan-specific qualitative factors on certain loans to estimate its CECL Reserve. In order to estimate the future expected loan losses relevant to the Company’s portfolio, the Company utilizes historical market loan loss data licensed from a third party data service. The third party’s loan database includes historical loss data for commercial mortgage- backed securities, or CMBS, issued dating back to 1998, which the Company believes is a reasonably comparable and available data set to its type of loans. The Company utilized macroeconomic data that reflects a current recession given current macroeconomic conditions; however, the financial impact on the Company of current circumstances is highly uncertain. For periods beyond the reasonable and supportable forecast period, the Company reverts back to historical loss data. Management's current estimate of expected credit losses as of December 31, 2022 increased compared to the current estimate of expected credit losses as of December 31, 2021 primarily due to changes to the loan portfolio, including new loan production, and the impact of the current macroeconomic environment on certain assets, including rising inflation, and rapidly rising interest rates, partially offset by shorter average remaining loan term and loan repayments during the year ended December 31, 2022. The CECL Reserve takes into consideration the assumed impact of macroeconomic conditions on CRE properties and is not specific to any loan losses or impairments on the Company’s loans held for investment, unless the Company determines that a specific reserve is warranted for a select asset. As of December 31, 2022, the Company’s CECL Reserve for its loans held for investment portfolio is $71.3 million or 284 basis points of the Company’s total loans held for investment commitment balance of $2.5 billion and is bifurcated between the CECL reserve (contra-asset) related to outstanding balances on loans held for investment of $66.0 million and a liability for unfunded commitments of $5.3 million. The liability was based on the unfunded portion of the loan commitment over the full contractual period over which the Company is exposed to credit risk through a current obligation to extend credit. Management considered the likelihood that funding will occur, and if funded, the expected credit loss on the funded portion. During the year ended December 31, 2022, the senior mortgage loan on a residential property located in California with a principal balance of $14.3 million was downgraded to a risk rating of “5.” As such, as of December 31, 2022, this loan was assessed individually and the Company has elected to assign a specific CECL reserve of $5.6 million on the loan based on the Company’s estimate of proceeds available from the anticipated sale of the collateral property less the estimated cost to sell the property. This specific CECL reserve is included in the Company's total CECL reserve. Current Expected Credit Loss Reserve for Funded Loan Commitments Activity related to the CECL Reserve for outstanding balances on the Company’s loans held for investment as of and for the years ended December 31, 2022 and 2021 was as follows ($ in thousands): Balance at December 31, 2020 (1) $ 23,604 Provision for current expected credit losses 335 Write-offs — Recoveries — Balance at December 31, 2021 (1) $ 23,939 Provision for current expected credit losses 42,030 Write-offs — Recoveries — Balance at December 31, 2022 (1) $ 65,969 __________________________ (1) The CECL Reserve related to outstanding balances on loans held for investment is recorded within current expected credit loss reserve in the Company's consolidated balance sheets. Current Expected Credit Loss Reserve for Unfunded Loan Commitments Activity related to the CECL Reserve for unfunded commitments on the Company’s loans held for investment as of and for the years ended December 31, 2022 and 2021 was as follows ($ in thousands): Balance at December 31, 2020 (1) $ 1,633 Provision for current expected credit losses (325) Write-offs — Recoveries — Balance at December 31, 2021 (1) $ 1,308 Provision for current expected credit losses 4,031 Write-offs — Recoveries — Balance at December 31, 2022 (1) $ 5,339 __________________________ (1) The CECL Reserve related to unfunded commitments on loans held for investment is recorded within other liabilities in the Company's consolidated balance sheets. The Company continuously evaluates the credit quality of each loan by assessing the risk factors of each loan and assigning a risk rating based on a variety of factors. Risk factors include property type, geographic and local market dynamics, physical condition, leasing and tenant profile, projected cash flow, loan structure and exit plan, loan-to-value ratio, debt service coverage ratio, project sponsorship, and other factors deemed necessary. Based on a 5-point scale, the Company’s loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows: Ratings Definition 1 Very Low Risk 2 Low Risk 3 Medium Risk 4 High Risk/Potential for Loss: Asset performance is trailing underwritten expectations. Loan at risk of impairment without material improvement to performance 5 Impaired/Loss Likely: A loan that has a significantly increased probability of default and principal loss The risk ratings are primarily based on historical data as well as taking into account future economic conditions. As of December 31, 2022, the carrying value, excluding the CECL Reserve, of the Company’s loans held for investment within each risk rating by year of origination is as follows ($ in thousands): 2022 2021 2020 2019 2018 Prior Total Risk rating: 1 $ 13,536 $ 27,684 $ — $ — $ — $ — $ 41,220 2 34,706 323,544 — — 22,802 34,460 415,512 3 442,153 461,706 136,456 256,359 29,280 40,000 1,365,954 4 71,709 — 189,348 63,289 84,807 17,845 426,998 5 — — — — 14,324 — 14,324 Total $ 562,104 $ 812,934 $ 325,804 $ 319,648 $ 151,213 $ 92,305 $ 2,264,008 Accrued Interest Receivable The Company elected not to measure a CECL Reserve on accrued interest receivable due to the Company’s policy of writing off uncollectible accrued interest receivable balances in a timely manner. As of December 31, 2022 and 2021, interest receivable of $14.0 million and $17.1 million, respectively, is included within other assets in the Company's consolidated balance sheets and is excluded from the carrying value of loans held for investment. If the Company were to have uncollectible accrued interest receivable, it generally would reverse accrued and unpaid interest against interest income and no longer accrue for these amounts.

REAL ESTATE OWNED

REAL ESTATE OWNED	12 Months Ended
	Dec. 31, 2022
Real Estate Owned [Abstract]
REAL ESTATE OWNED	REAL ESTATE OWNED On March 8, 2019, the Company acquired legal title to a hotel property located in New York through a deed in lieu of foreclosure. Prior to March 8, 2019, the hotel property collateralized a $38.6 million senior mortgage loan held by the Company that was in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the December 2018 maturity date. In conjunction with the deed in lieu of foreclosure, the Company derecognized the $38.6 million senior mortgage loan and recognized the hotel property as real estate owned. As of the date of the deed in lieu of foreclosure, the Company did not expect to complete a sale of the hotel property within the next twelve months and thus, the hotel property was considered held for use, and was carried at its estimated fair value at acquisition and was presented net of accumulated depreciation and impairment charges. The Company did not recognize any gain or loss on the derecognition of the senior mortgage loan as the fair value of the hotel property of $36.9 million and the net assets held at the hotel property of $1.7 million at acquisition approximated the $38.6 million carrying value of the senior mortgage loan. On November 8, 2021, the Company entered into a Purchase and Sale Agreement to sell the hotel property to a third party for $40.0 million and the sale closed on March 1, 2022. As such, as of December 31, 2021, the hotel property was classified as real estate owned held for sale in the Company’s consolidated balance sheet. For the three months ended March 31, 2022, the Company recognized a $2.2 million gain on the sale of the hotel property as the net carrying value of the hotel property as of the March 1, 2022 sale date was lower than the net sales proceeds received by the Company. The gain on the sale of the hotel property is included within gain on sale of real estate owned in the Company’s consolidated statements of operations. As of December 31, 2021, the assets and liabilities of the hotel property are included within other assets and other liabilities, respectively, in the Company’s consolidated balance sheets and include items such as cash, restricted cash, trade receivables and payables and advance deposits. In connection with the sale of the hotel property, the Company provided a senior mortgage loan to the buyer of the hotel property. The initial advance funded under such loan was $30.7 million, with up to another $25.0 million of additional loan proceeds to be available for future advances to cover a portion of the anticipated property renovation plan costs, provided certain conditions are satisfied. At closing, the buyer contributed $12.9 million of equity into the purchase. Additionally, the buyer is required to fund an additional $8.7 million of equity associated with the anticipated property renovation plan costs. The following table summarizes the Company’s real estate owned as of December 31, 2021 ($ in thousands): Land $ 10,200 Buildings and improvements 24,281 Furniture, fixtures and equipment 4,506 38,987 Less: Accumulated depreciation (2,385) Real estate owned, net $ 36,602 For the year ended December 31, 2022, the Company did not incur depreciation expense. For the year ended December 31, 2021, the Company incurred depreciation expense of $825 thousand. Depreciation expense is included within expenses from real estate owned in the Company’s consolidated statements of operations.

DEBT

DEBT	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
DEBT	DEBT Financing Agreements The Company borrows funds, as applicable in a given period, under the Wells Fargo Facility, the Citibank Facility, the CNB Facility, the MetLife Facility and the Morgan Stanley Facility (individually defined below and collectively, the “Secured Funding Agreements”), Notes Payable (as defined below) and the Secured Term Loan (as defined below). The Company refers to the Secured Funding Agreements, Notes Payable and the Secured Term Loan as the “Financing Agreements.” The outstanding balance of the Financing Agreements in the table below are presented gross of debt issuance costs. As of December 31, 2022 and 2021, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands): As of December 31, 2022 2021 Outstanding Balance Total Outstanding Balance Total Secured Funding Agreements: Wells Fargo Facility $ 270,798 $ 450,000 (1) $ 399,528 $ 450,000 (1) Citibank Facility 236,240 325,000 192,970 325,000 CNB Facility — 75,000 — 75,000 MetLife Facility — 180,000 20,648 180,000 Morgan Stanley Facility 198,193 250,000 226,901 250,000 Subtotal $ 705,231 $ 1,280,000 $ 840,047 $ 1,280,000 Notes Payable $ 105,000 $ 105,000 $ 51,110 $ 51,755 Secured Term Loan $ 150,000 $ 150,000 $ 150,000 $ 150,000 Total $ 960,231 $ 1,535,000 $ 1,041,157 $ 1,481,755 ______________________________ (1) The maximum commitment for the Wells Fargo Facility (as defined below) may be increased to up to $500.0 million at the Company’s option, subject to the satisfaction of certain conditions, including payment of an upsize fee. Some of the Company’s Financing Agreements are collateralized by (i) assignments of specific loans, preferred equity or a pool of loans held for investment or loans held for sale owned by the Company, (ii) interests in the subordinated portion of the Company’s securitization debt, or (iii) interests in wholly-owned entity subsidiaries that hold the Company’s loans held for investment. The Company is the borrower or guarantor under each of the Financing Agreements. Generally, the Company partially offsets interest rate risk by matching the interest index of loans held for investment with the Secured Funding Agreements used to fund them. The Company’s Financing Agreements contain various affirmative and negative covenants, including negative pledges, and provisions regarding events of default that are normal and customary for similar financing arrangements. Wells Fargo Facility The Company is party to a master repurchase funding facility with Wells Fargo Bank, National Association (“Wells Fargo”) (the “Wells Fargo Facility”), which allows the Company to borrow up to $450.0 million. The maximum commitment may be increased to up to $500.0 million at the Company’s option, subject to the satisfaction of certain conditions, including payment of an upsize fee. Under the Wells Fargo Facility, the Company is permitted to sell, and later repurchase, certain qualifying senior commercial mortgage loans, A-Notes, pari-passu participations in commercial mortgage loans and mezzanine loans under certain circumstances, subject to available collateral approved by Wells Fargo in its sole discretion. In December 2022, the Company amended the Wells Fargo Facility to, among other things, (1) extend the funding period of the Wells Fargo Facility to December 15, 2025, (2) extend the initial maturity date of the Wells Fargo Facility to December 15, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the Wells Fargo Facility to December 14, 2027 and (3) modify the interest rate on advances under the Wells Fargo Facility from a per annum rate equal to the sum of one-month LIBOR or SOFR plus a pricing margin range of 1.50% to 2.75%, subject to certain exceptions, to a per annum rate equal to the sum of one-month LIBOR or SOFR plus a pricing margin range of 1.50% to 3.75%, subject to certain exceptions. In December 2020, the Company amended the Wells Fargo Facility to, among other things, eliminate the non-utilization fee on the Wells Fargo Facility. Prior to the amendment, the Company incurred a non-utilization fee of 25 basis points per annum on the average daily available balance of the Wells Fargo Facility to the extent less than 75% of the Wells Fargo Facility was utilized. For the years ended December 31, 2022 and 2021, the Company did not incur a non-utilization fee. For the year ended December 31, 2020, the Company incurred a non-utilization fee of $19 thousand. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. The Wells Fargo Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments in excess of the minimum amount necessary to continue to qualify as a REIT and avoid the payment of income and excise taxes, (d) maintenance of adequate capital, (e) limitations on change of control, (f) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (g) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (h) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity), (i) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (j) maintaining a tangible net worth of at least the sum of (1) approximately $135.5 million, plus (2) 80% of the net proceeds raised in all future equity issuances by the Company and (k) if certain specific debt yield, loan to value or other credit based tests are not met with respect to assets on the Wells Fargo Facility, the Company may be required to repay certain amounts under the Wells Fargo Facility. As of December 31, 2022, the Company was in compliance with all financial covenants of the Wells Fargo Facility. Citibank Facility The Company is party to a $325.0 million master repurchase facility with Citibank, N.A. (“Citibank”) (the “Citibank Facility”). Under the Citibank Facility, the Company is permitted to sell and later repurchase certain qualifying senior commercial mortgage loans and A-Notes approved by Citibank in its sole discretion. In January 2022, the Company amended the Citibank Facility to, among other things, extend the initial maturity date and funding availability period to January 13, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option assuming no existing defaults under the Citibank Facility and applicable extension fees being paid, which, if both were exercised, would extend the maturity date of the Citibank Facility to January 13, 2027. Advances under the Citibank Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR or SOFR plus an indicative pricing margin range of 1.50% to 2.10%, subject to certain exceptions. Prior to the January 2022 amendment, the Company incurred a non-utilization fee of 25 basis points per annum on the average daily available balance of the Citibank Facility to the extent less than 75% of the Citibank Facility was utilized. Subsequent to the January 2022 amendment, the Company incurs a non-utilization fee of 25 basis points per annum on the average daily positive difference between the maximum advances approved by Citibank and the actual advances outstanding on the Citibank Facility. For the years ended December 31, 2022, 2021 and 2020, the Company incurred a non-utilization fee of $11 thousand, $598 thousand and $516 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. The Citibank Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) maintaining tangible net worth of at least the sum of (1) 80% of the Company’s tangible net worth as of September 30, 2013, plus (2) 80% of the total net capital raised in all future equity issuances by the Company, (b) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity), (c) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (d) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (e) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00 and (f) if certain specific debt yield and loan to value tests are not met with respect to assets on the Citibank Facility, the Company may be required to repay certain amounts under the Citibank Facility. The Citibank Facility also prohibits the Company from amending the management agreement with its Manager in a material respect without the prior consent of the lender. As of December 31, 2022, the Company was in compliance with all financial covenants of the Citibank Facility. CNB Facility The Company is party to a $75.0 million secured revolving funding facility with City National Bank (the “CNB Facility”). The Company is permitted to borrow funds under the CNB Facility to finance investments and for other working capital and general corporate needs. In March 2022, the Company exercised a 12-month extension option on the CNB Facility to extend the maturity date to March 10, 2023. Since November 12, 2021, advances under the CNB Facility accrue interest at a per annum rate equal to the sum of, at the Company’s option, either (a) SOFR (with a 0.35% floor) plus 2.65% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or Daily Simple SOFR plus 1.00%) plus 1.00%; provided that in no event shall the interest rate be less than 2.65%. Prior to November 12, 2021, the interest rate on advances was a per annum rate equal to the sum of, at the Company’s option, either (a) LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 2.65% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.00%. Unless at least 75% of the CNB Facility is used on average, unused commitments under the CNB Facility accrue non-utilization fees at the rate of 0.375% per annum. For the years ended December 31, 2022, 2021 and 2020, the Company incurred a non-utilization fee of $284 thousand, $146 thousand and $38 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. The CNB Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar financing facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default, (d) limitations on dispositions of assets, (e) maintenance of minimum total asset value by the borrower under the CNB Facility and its subsidiaries and (f) prohibitions of certain change of control events. The agreements governing the CNB Facility also impose certain covenants on the Company, including the following: (i) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (ii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2013, plus 80% of the net cash proceeds raised in equity issuances by the Company after March 12, 2014, (iii) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period of at least 1.25 to 1.00, (iv) limitations on mergers, consolidations, transfers of assets and similar transactions and (v) maintaining its status as a REIT. As of December 31, 2022, the Company was in compliance with all financial covenants of the CNB Facility. MetLife Facility The Company is party to a $180.0 million revolving master repurchase facility with Metropolitan Life Insurance Company (“MetLife”) (the “MetLife Facility”), pursuant to which the Company may sell, and later repurchase, commercial mortgage loans meeting defined eligibility criteria which are approved by MetLife in its sole discretion. In July 2022, the Company exercised a 12-month extension option on the MetLife Facility to extend the initial maturity date to August 13, 2023, subject to one 12-month extension, which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if exercised, would extend the maturity date of the MetLife Facility to August 13, 2024. Advances under the MetLife Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR or SOFR plus a spread of 2.50%, subject to certain exceptions. For a period of nine months subsequent to August 2020, the non-utilization fee of 25 basis points per annum on the average daily available balance of the MetLife Facility, which is owed if less than 65% of the MetLife Facility is utilized, was waived. For the years ended December 31, 2022, 2021 and 2020, the Company incurred non-utilization fee of $247 thousand, $162 thousand and $7 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. The MetLife Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default and (d) limitations on dispositions of assets. The agreements governing the MetLife Facility also impose certain covenants on the Company, including the following: (i) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (ii) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (iii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2013, plus 80% of the net cash proceeds raised in equity issuances by the Company after August 13, 2014, (iv) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period of at least 1.25 to 1.00, and (v) if certain specific debt yield, loan to value or other credit based tests are not met with respect to assets on the MetLife Facility, the Company may be required to repay certain amounts under the MetLife Facility. As of December 31, 2022, the Company was in compliance with all financial covenants of the MetLife Facility. Morgan Stanley Facility The Company is party to a $250.0 million master repurchase and securities contract with Morgan Stanley Bank, N.A. (“Morgan Stanley”) (the “Morgan Stanley Facility”). Under the Morgan Stanley Facility, the Company is permitted to sell, and later repurchase, certain qualifying commercial mortgage loans collateralized by retail, office, mixed-use, multifamily, industrial, hospitality, student housing or self-storage properties. Morgan Stanley may approve the mortgage loans that are subject to the Morgan Stanley Facility in its sole discretion. In December 2022, the Company exercised a 12-month extension option on the Morgan Stanley Facility to extend the initial maturity date to January 16, 2024, subject to one 12-month extension, which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if exercised, would extend the maturity date of the Morgan Stanley Facility to January 16, 2025. On March 21, 2022, ACRC Lender MS LLC, a subsidiary of the Company and Morgan Stanley entered into the Second Amendment to Master Repurchase and Securities Contract to modify the interest rate provisions in the Morgan Stanley Facility such that financings under the Morgan Stanley Facility in connection with loans pledged to the Morgan Stanley Facility after December 31, 2021 will utilize SOFR. Advances under the Morgan Stanley Facility generally accrue interest at a per annum rate equal to the sum of one-month LIBOR or SOFR plus a spread ranging from 1.75% to 2.25%, determined by Morgan Stanley, depending upon the mortgage loan sold to Morgan Stanley in the applicable transaction. The Morgan Stanley Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) maintaining tangible net worth of at least the sum of (1) 80% of the Company’s tangible net worth as of September 30, 2013, plus (2) 80% of the total net capital raised in all future equity issuances by the Company, (b) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity), (c) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (d) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00 and (e) if certain specific debt yield and loan to value tests are not met with respect to assets on the Morgan Stanley Facility, the Company may be required to repay certain amounts under the Morgan Stanley Facility. The Morgan Stanley Facility also prohibits the Company from amending the management agreement with its Manager in a material respect without the prior consent of the lender. As of December 31, 2022, the Company was in compliance with all financial covenants of the Morgan Stanley Facility. Notes Payable Certain of the Company’s subsidiaries were party to two separate non-recourse note agreements with the lenders referred to therein, consisting of (1) a $28.3 million note that was closed in June 2019, which was secured by a hotel property located in New York that was recognized as real estate owned in the Company’s consolidated balance sheets and (2) a $23.5 million note that was closed in November 2019, which was secured by a $34.6 million senior mortgage loan held by the Company on a multifamily property located in South Carolina. The $28.3 million note was repaid in full in conjunction with the sale of the hotel property that was recognized as real estate owned on March 1, 2022. See Note 5 for further details. The maturity date of the $28.3 million note was June 10, 2024, subject to one 6-month extension, which if exercised would have extended the maturity date to December 10, 2024. The loan was subject to prepayment at any time. Advances under the $28.3 million note accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 3.00%. In June 2022, the Company repaid the $23.5 million note in full. The initial maturity date of the $23.5 million note was September 5, 2022, subject to two 12-month extensions, which if exercised would have extended the maturity date to September 5, 2024. Advances under the $23.5 million note accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 3.75%. In July 2022, ACRC Lender CO LLC, a wholly owned subsidiary of the Company entered into a Credit and Security Agreement with Capital One, National Association, as administrative agent and collateral agent, and the lender referred to therein. The Credit and Security Agreement provides for a $105.0 million recourse note (together with the two non-recourse note agreements discussed above, the “Notes Payable”). The $105.0 million note is secured by a $133.0 million senior mortgage loan held by the Company on a multifamily property located in New York and is fully and unconditionally guaranteed by the Company pursuant to a Guaranty of Recourse Obligation. The initial maturity date of the $105.0 million note is July 28, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date to July 28, 2027. The $105.0 million note accrues interest at a per annum rate equal to the sum of one-month SOFR plus a spread of 2.00%. As of December 31, 2022, the total outstanding principal balance of the note was $105.0 million. The $105.0 million note contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, including the following: (a) maintaining tangible net worth of at least the sum of (1) 80% of the Company’s tangible net worth as of June 30, 2022, plus (2) 80% of the total net capital raised in all future equity issuances by the Company and (b) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity). As of December 31, 2022, the Company was in compliance with all financial covenants of the $105.0 million note. Secured Term Loan The Company and certain of its subsidiaries are party to a $150.0 million Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”). In November 2021, the Company amended the Secured Term Loan to, among other things, (1) increase the commitment amount to $150.0 million, which was fully drawn on the closing date of the amendment, net of an original issue discount equal to 0.50% of the commitment amount, (2) extend the maturity date of the Secured Term Loan to November 12, 2026 and (3) update the interest rate on advances under the Secured Term Loan to the following fixed rates: (i) 4.50% per annum until May 12, 2025, (ii) after May 12, 2025 through November 12, 2025, the interest rate increases 0.125% every three months and (iii) after November 12, 2025 through November 12, 2026, the interest rate increases 0.250% every three months. Prior to the November 2021 amendment, advances under the Secured Term Loan accrued interest at a per annum rate equal to the sum of, at the Company’s option, one, two, three or six-month LIBOR plus a spread of 5.00%. During the 12-month extension period beginning December 22, 2020, the spread on advances under the Secured Term Loan increased every three months by 0.125%, 0.375% and 0.750% per annum, respectively, beginning after the third-month of the extension period. As of December 31, 2022, the total outstanding principal balance of the Secured Term Loan was $150.0 million. The total original issue discount on the Secured Term Loan represents a discount to the debt cost to be amortized into interest expense using the effective interest method over the term of the Secured Term Loan. For the year ended December 31, 2022, the estimated per annum effective interest rate of the Secured Term Loan, which is equal to the fixed interest rate plus the accretion of the original issue discount and associated costs, was 4.6%. For the years ended December 31, 2021 and 2020, the estimated per annum effective interest rate of the Secured Term Loan, which was equal to LIBOR plus the spread plus the accretion of the original issue discount and associated costs, was 5.2% and 6.4%, respectively. The Company's obligations under the Secured Term Loan are guaranteed by certain subsidiaries of the Company. Certain subsidiaries of the Company entered into a Pledge and Security Agreement with the collateral agent under the Secured Term Loan, pursuant to which the obligations of the Company and the subsidiary guarantors under the Secured Term Loan are each secured by equity interests in certain of the Company's indirect subsidiaries and other assets. In addition, the Company and certain of its subsidiaries entered into a Negative Pledge Agreement with the collateral agent under the Secured Term Loan, which prohibits pledging or otherwise encumbering, subject to permitted encumbrances, certain of the assets which were not subject to the Pledge and Security Agreement. The Secured Term Loan contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar financing agreements, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default, (d) limitations on dispositions of assets and (e) prohibitions of certain change of control events. The agreements governing the Secured Term Loan also impose certain covenants on the Company, including the following: (i) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.10 to 1.00, (ii) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (iii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2021, plus 80% of the net cash proceeds raised in subsequent equity issuances by the Company, (iv) maintaining an asset coverage ratio greater than 115%, (v) maintaining an unencumbered asset ratio greater than 125%, (vi) limitations on mergers, consolidations, transfers of assets and similar transactions, (vii) maintaining its status as a REIT and (viii) maintaining at least 65% of loans held for investment as senior commercial real estate loans, as measured by the average daily outstanding principal balance of all loans held for investment during a fiscal quarter and as adjusted for non-controlling interests. As of December 31, 2022, the Company was in compliance with all financial covenants of the Secured Term Loan. Financing Agreements Maturities At December 31, 2022, approximate principal maturities of the Company’s Financing Agreements are as follows ($ in thousands): Wells Fargo Citibank CNB Facility MetLife Facility Morgan Stanley Facility Notes Payable Secured Term Loan Total 2023 $ — $ — $ — $ — $ — $ — $ — $ — 2024 — — — — 198,193 — — 198,193 2025 270,798 236,240 — — 105,000 — 612,038 2026 — — — — 150,000 150,000 2027 — — — — — — — — Thereafter — — — — — — — — $ 270,798 $ 236,240 $ — $ — $ 198,193 $ 105,000 $ 150,000 $ 960,231 A subsidiary of the Company was party to a secured borrowing arrangement related to a transferred loan that was closed in February 2020. In April 2019, the Company originated a $30.5 million loan on an office property located in North Carolina, which was bifurcated between a $24.4 million senior mortgage loan and a $6.1 million mezzanine loan. In February 2020, the Company transferred its interest in the $24.4 million senior mortgage loan to a third party and retained the $6.1 million mezzanine loan. The Company evaluated whether the transfer of the $24.4 million senior mortgage loan met the criteria in FASB ASC Topic 860, Transfers and Servicing , for treatment as a sale – legal isolation, ability of transferee to pledge or exchange the transferred assets without constraint and transfer of effective control – and determined that the transfer did not qualify as a sale and thus, was treated as a financing transaction. As such, the Company did not derecognize the $24.4 million senior mortgage loan asset and recorded a secured borrowing liability in the Company’s consolidated balance sheets. The initial maturity date of the $24.4 million secured borrowing was May 5, 2023, subject to one 12-month extension, which may have been exercised at the transferee’s option, which, if exercised, would have extended the maturity date to May 5, 2024. Advances under the $24.4 million secured borrowing accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.50%. In July 2022, the $30.5 million loan was fully repaid and thus, the $24.4 million secured borrowing liability was derecognized.

SECURED BORROWINGS

SECURED BORROWINGS	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
SECURED BORROWINGS	DEBT Financing Agreements The Company borrows funds, as applicable in a given period, under the Wells Fargo Facility, the Citibank Facility, the CNB Facility, the MetLife Facility and the Morgan Stanley Facility (individually defined below and collectively, the “Secured Funding Agreements”), Notes Payable (as defined below) and the Secured Term Loan (as defined below). The Company refers to the Secured Funding Agreements, Notes Payable and the Secured Term Loan as the “Financing Agreements.” The outstanding balance of the Financing Agreements in the table below are presented gross of debt issuance costs. As of December 31, 2022 and 2021, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands): As of December 31, 2022 2021 Outstanding Balance Total Outstanding Balance Total Secured Funding Agreements: Wells Fargo Facility $ 270,798 $ 450,000 (1) $ 399,528 $ 450,000 (1) Citibank Facility 236,240 325,000 192,970 325,000 CNB Facility — 75,000 — 75,000 MetLife Facility — 180,000 20,648 180,000 Morgan Stanley Facility 198,193 250,000 226,901 250,000 Subtotal $ 705,231 $ 1,280,000 $ 840,047 $ 1,280,000 Notes Payable $ 105,000 $ 105,000 $ 51,110 $ 51,755 Secured Term Loan $ 150,000 $ 150,000 $ 150,000 $ 150,000 Total $ 960,231 $ 1,535,000 $ 1,041,157 $ 1,481,755 ______________________________ (1) The maximum commitment for the Wells Fargo Facility (as defined below) may be increased to up to $500.0 million at the Company’s option, subject to the satisfaction of certain conditions, including payment of an upsize fee. Some of the Company’s Financing Agreements are collateralized by (i) assignments of specific loans, preferred equity or a pool of loans held for investment or loans held for sale owned by the Company, (ii) interests in the subordinated portion of the Company’s securitization debt, or (iii) interests in wholly-owned entity subsidiaries that hold the Company’s loans held for investment. The Company is the borrower or guarantor under each of the Financing Agreements. Generally, the Company partially offsets interest rate risk by matching the interest index of loans held for investment with the Secured Funding Agreements used to fund them. The Company’s Financing Agreements contain various affirmative and negative covenants, including negative pledges, and provisions regarding events of default that are normal and customary for similar financing arrangements. Wells Fargo Facility The Company is party to a master repurchase funding facility with Wells Fargo Bank, National Association (“Wells Fargo”) (the “Wells Fargo Facility”), which allows the Company to borrow up to $450.0 million. The maximum commitment may be increased to up to $500.0 million at the Company’s option, subject to the satisfaction of certain conditions, including payment of an upsize fee. Under the Wells Fargo Facility, the Company is permitted to sell, and later repurchase, certain qualifying senior commercial mortgage loans, A-Notes, pari-passu participations in commercial mortgage loans and mezzanine loans under certain circumstances, subject to available collateral approved by Wells Fargo in its sole discretion. In December 2022, the Company amended the Wells Fargo Facility to, among other things, (1) extend the funding period of the Wells Fargo Facility to December 15, 2025, (2) extend the initial maturity date of the Wells Fargo Facility to December 15, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the Wells Fargo Facility to December 14, 2027 and (3) modify the interest rate on advances under the Wells Fargo Facility from a per annum rate equal to the sum of one-month LIBOR or SOFR plus a pricing margin range of 1.50% to 2.75%, subject to certain exceptions, to a per annum rate equal to the sum of one-month LIBOR or SOFR plus a pricing margin range of 1.50% to 3.75%, subject to certain exceptions. In December 2020, the Company amended the Wells Fargo Facility to, among other things, eliminate the non-utilization fee on the Wells Fargo Facility. Prior to the amendment, the Company incurred a non-utilization fee of 25 basis points per annum on the average daily available balance of the Wells Fargo Facility to the extent less than 75% of the Wells Fargo Facility was utilized. For the years ended December 31, 2022 and 2021, the Company did not incur a non-utilization fee. For the year ended December 31, 2020, the Company incurred a non-utilization fee of $19 thousand. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. The Wells Fargo Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments in excess of the minimum amount necessary to continue to qualify as a REIT and avoid the payment of income and excise taxes, (d) maintenance of adequate capital, (e) limitations on change of control, (f) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (g) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (h) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity), (i) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (j) maintaining a tangible net worth of at least the sum of (1) approximately $135.5 million, plus (2) 80% of the net proceeds raised in all future equity issuances by the Company and (k) if certain specific debt yield, loan to value or other credit based tests are not met with respect to assets on the Wells Fargo Facility, the Company may be required to repay certain amounts under the Wells Fargo Facility. As of December 31, 2022, the Company was in compliance with all financial covenants of the Wells Fargo Facility. Citibank Facility The Company is party to a $325.0 million master repurchase facility with Citibank, N.A. (“Citibank”) (the “Citibank Facility”). Under the Citibank Facility, the Company is permitted to sell and later repurchase certain qualifying senior commercial mortgage loans and A-Notes approved by Citibank in its sole discretion. In January 2022, the Company amended the Citibank Facility to, among other things, extend the initial maturity date and funding availability period to January 13, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option assuming no existing defaults under the Citibank Facility and applicable extension fees being paid, which, if both were exercised, would extend the maturity date of the Citibank Facility to January 13, 2027. Advances under the Citibank Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR or SOFR plus an indicative pricing margin range of 1.50% to 2.10%, subject to certain exceptions. Prior to the January 2022 amendment, the Company incurred a non-utilization fee of 25 basis points per annum on the average daily available balance of the Citibank Facility to the extent less than 75% of the Citibank Facility was utilized. Subsequent to the January 2022 amendment, the Company incurs a non-utilization fee of 25 basis points per annum on the average daily positive difference between the maximum advances approved by Citibank and the actual advances outstanding on the Citibank Facility. For the years ended December 31, 2022, 2021 and 2020, the Company incurred a non-utilization fee of $11 thousand, $598 thousand and $516 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. The Citibank Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) maintaining tangible net worth of at least the sum of (1) 80% of the Company’s tangible net worth as of September 30, 2013, plus (2) 80% of the total net capital raised in all future equity issuances by the Company, (b) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity), (c) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (d) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (e) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00 and (f) if certain specific debt yield and loan to value tests are not met with respect to assets on the Citibank Facility, the Company may be required to repay certain amounts under the Citibank Facility. The Citibank Facility also prohibits the Company from amending the management agreement with its Manager in a material respect without the prior consent of the lender. As of December 31, 2022, the Company was in compliance with all financial covenants of the Citibank Facility. CNB Facility The Company is party to a $75.0 million secured revolving funding facility with City National Bank (the “CNB Facility”). The Company is permitted to borrow funds under the CNB Facility to finance investments and for other working capital and general corporate needs. In March 2022, the Company exercised a 12-month extension option on the CNB Facility to extend the maturity date to March 10, 2023. Since November 12, 2021, advances under the CNB Facility accrue interest at a per annum rate equal to the sum of, at the Company’s option, either (a) SOFR (with a 0.35% floor) plus 2.65% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or Daily Simple SOFR plus 1.00%) plus 1.00%; provided that in no event shall the interest rate be less than 2.65%. Prior to November 12, 2021, the interest rate on advances was a per annum rate equal to the sum of, at the Company’s option, either (a) LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 2.65% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.00%. Unless at least 75% of the CNB Facility is used on average, unused commitments under the CNB Facility accrue non-utilization fees at the rate of 0.375% per annum. For the years ended December 31, 2022, 2021 and 2020, the Company incurred a non-utilization fee of $284 thousand, $146 thousand and $38 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. The CNB Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar financing facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default, (d) limitations on dispositions of assets, (e) maintenance of minimum total asset value by the borrower under the CNB Facility and its subsidiaries and (f) prohibitions of certain change of control events. The agreements governing the CNB Facility also impose certain covenants on the Company, including the following: (i) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (ii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2013, plus 80% of the net cash proceeds raised in equity issuances by the Company after March 12, 2014, (iii) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period of at least 1.25 to 1.00, (iv) limitations on mergers, consolidations, transfers of assets and similar transactions and (v) maintaining its status as a REIT. As of December 31, 2022, the Company was in compliance with all financial covenants of the CNB Facility. MetLife Facility The Company is party to a $180.0 million revolving master repurchase facility with Metropolitan Life Insurance Company (“MetLife”) (the “MetLife Facility”), pursuant to which the Company may sell, and later repurchase, commercial mortgage loans meeting defined eligibility criteria which are approved by MetLife in its sole discretion. In July 2022, the Company exercised a 12-month extension option on the MetLife Facility to extend the initial maturity date to August 13, 2023, subject to one 12-month extension, which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if exercised, would extend the maturity date of the MetLife Facility to August 13, 2024. Advances under the MetLife Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR or SOFR plus a spread of 2.50%, subject to certain exceptions. For a period of nine months subsequent to August 2020, the non-utilization fee of 25 basis points per annum on the average daily available balance of the MetLife Facility, which is owed if less than 65% of the MetLife Facility is utilized, was waived. For the years ended December 31, 2022, 2021 and 2020, the Company incurred non-utilization fee of $247 thousand, $162 thousand and $7 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. The MetLife Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default and (d) limitations on dispositions of assets. The agreements governing the MetLife Facility also impose certain covenants on the Company, including the following: (i) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (ii) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (iii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2013, plus 80% of the net cash proceeds raised in equity issuances by the Company after August 13, 2014, (iv) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period of at least 1.25 to 1.00, and (v) if certain specific debt yield, loan to value or other credit based tests are not met with respect to assets on the MetLife Facility, the Company may be required to repay certain amounts under the MetLife Facility. As of December 31, 2022, the Company was in compliance with all financial covenants of the MetLife Facility. Morgan Stanley Facility The Company is party to a $250.0 million master repurchase and securities contract with Morgan Stanley Bank, N.A. (“Morgan Stanley”) (the “Morgan Stanley Facility”). Under the Morgan Stanley Facility, the Company is permitted to sell, and later repurchase, certain qualifying commercial mortgage loans collateralized by retail, office, mixed-use, multifamily, industrial, hospitality, student housing or self-storage properties. Morgan Stanley may approve the mortgage loans that are subject to the Morgan Stanley Facility in its sole discretion. In December 2022, the Company exercised a 12-month extension option on the Morgan Stanley Facility to extend the initial maturity date to January 16, 2024, subject to one 12-month extension, which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if exercised, would extend the maturity date of the Morgan Stanley Facility to January 16, 2025. On March 21, 2022, ACRC Lender MS LLC, a subsidiary of the Company and Morgan Stanley entered into the Second Amendment to Master Repurchase and Securities Contract to modify the interest rate provisions in the Morgan Stanley Facility such that financings under the Morgan Stanley Facility in connection with loans pledged to the Morgan Stanley Facility after December 31, 2021 will utilize SOFR. Advances under the Morgan Stanley Facility generally accrue interest at a per annum rate equal to the sum of one-month LIBOR or SOFR plus a spread ranging from 1.75% to 2.25%, determined by Morgan Stanley, depending upon the mortgage loan sold to Morgan Stanley in the applicable transaction. The Morgan Stanley Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) maintaining tangible net worth of at least the sum of (1) 80% of the Company’s tangible net worth as of September 30, 2013, plus (2) 80% of the total net capital raised in all future equity issuances by the Company, (b) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity), (c) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (d) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00 and (e) if certain specific debt yield and loan to value tests are not met with respect to assets on the Morgan Stanley Facility, the Company may be required to repay certain amounts under the Morgan Stanley Facility. The Morgan Stanley Facility also prohibits the Company from amending the management agreement with its Manager in a material respect without the prior consent of the lender. As of December 31, 2022, the Company was in compliance with all financial covenants of the Morgan Stanley Facility. Notes Payable Certain of the Company’s subsidiaries were party to two separate non-recourse note agreements with the lenders referred to therein, consisting of (1) a $28.3 million note that was closed in June 2019, which was secured by a hotel property located in New York that was recognized as real estate owned in the Company’s consolidated balance sheets and (2) a $23.5 million note that was closed in November 2019, which was secured by a $34.6 million senior mortgage loan held by the Company on a multifamily property located in South Carolina. The $28.3 million note was repaid in full in conjunction with the sale of the hotel property that was recognized as real estate owned on March 1, 2022. See Note 5 for further details. The maturity date of the $28.3 million note was June 10, 2024, subject to one 6-month extension, which if exercised would have extended the maturity date to December 10, 2024. The loan was subject to prepayment at any time. Advances under the $28.3 million note accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 3.00%. In June 2022, the Company repaid the $23.5 million note in full. The initial maturity date of the $23.5 million note was September 5, 2022, subject to two 12-month extensions, which if exercised would have extended the maturity date to September 5, 2024. Advances under the $23.5 million note accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 3.75%. In July 2022, ACRC Lender CO LLC, a wholly owned subsidiary of the Company entered into a Credit and Security Agreement with Capital One, National Association, as administrative agent and collateral agent, and the lender referred to therein. The Credit and Security Agreement provides for a $105.0 million recourse note (together with the two non-recourse note agreements discussed above, the “Notes Payable”). The $105.0 million note is secured by a $133.0 million senior mortgage loan held by the Company on a multifamily property located in New York and is fully and unconditionally guaranteed by the Company pursuant to a Guaranty of Recourse Obligation. The initial maturity date of the $105.0 million note is July 28, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date to July 28, 2027. The $105.0 million note accrues interest at a per annum rate equal to the sum of one-month SOFR plus a spread of 2.00%. As of December 31, 2022, the total outstanding principal balance of the note was $105.0 million. The $105.0 million note contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, including the following: (a) maintaining tangible net worth of at least the sum of (1) 80% of the Company’s tangible net worth as of June 30, 2022, plus (2) 80% of the total net capital raised in all future equity issuances by the Company and (b) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity). As of December 31, 2022, the Company was in compliance with all financial covenants of the $105.0 million note. Secured Term Loan The Company and certain of its subsidiaries are party to a $150.0 million Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”). In November 2021, the Company amended the Secured Term Loan to, among other things, (1) increase the commitment amount to $150.0 million, which was fully drawn on the closing date of the amendment, net of an original issue discount equal to 0.50% of the commitment amount, (2) extend the maturity date of the Secured Term Loan to November 12, 2026 and (3) update the interest rate on advances under the Secured Term Loan to the following fixed rates: (i) 4.50% per annum until May 12, 2025, (ii) after May 12, 2025 through November 12, 2025, the interest rate increases 0.125% every three months and (iii) after November 12, 2025 through November 12, 2026, the interest rate increases 0.250% every three months. Prior to the November 2021 amendment, advances under the Secured Term Loan accrued interest at a per annum rate equal to the sum of, at the Company’s option, one, two, three or six-month LIBOR plus a spread of 5.00%. During the 12-month extension period beginning December 22, 2020, the spread on advances under the Secured Term Loan increased every three months by 0.125%, 0.375% and 0.750% per annum, respectively, beginning after the third-month of the extension period. As of December 31, 2022, the total outstanding principal balance of the Secured Term Loan was $150.0 million. The total original issue discount on the Secured Term Loan represents a discount to the debt cost to be amortized into interest expense using the effective interest method over the term of the Secured Term Loan. For the year ended December 31, 2022, the estimated per annum effective interest rate of the Secured Term Loan, which is equal to the fixed interest rate plus the accretion of the original issue discount and associated costs, was 4.6%. For the years ended December 31, 2021 and 2020, the estimated per annum effective interest rate of the Secured Term Loan, which was equal to LIBOR plus the spread plus the accretion of the original issue discount and associated costs, was 5.2% and 6.4%, respectively. The Company's obligations under the Secured Term Loan are guaranteed by certain subsidiaries of the Company. Certain subsidiaries of the Company entered into a Pledge and Security Agreement with the collateral agent under the Secured Term Loan, pursuant to which the obligations of the Company and the subsidiary guarantors under the Secured Term Loan are each secured by equity interests in certain of the Company's indirect subsidiaries and other assets. In addition, the Company and certain of its subsidiaries entered into a Negative Pledge Agreement with the collateral agent under the Secured Term Loan, which prohibits pledging or otherwise encumbering, subject to permitted encumbrances, certain of the assets which were not subject to the Pledge and Security Agreement. The Secured Term Loan contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar financing agreements, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default, (d) limitations on dispositions of assets and (e) prohibitions of certain change of control events. The agreements governing the Secured Term Loan also impose certain covenants on the Company, including the following: (i) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.10 to 1.00, (ii) maintaining a ratio of total debt to tangible net worth of not more than 4.50 to 1.00, (iii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2021, plus 80% of the net cash proceeds raised in subsequent equity issuances by the Company, (iv) maintaining an asset coverage ratio greater than 115%, (v) maintaining an unencumbered asset ratio greater than 125%, (vi) limitations on mergers, consolidations, transfers of assets and similar transactions, (vii) maintaining its status as a REIT and (viii) maintaining at least 65% of loans held for investment as senior commercial real estate loans, as measured by the average daily outstanding principal balance of all loans held for investment during a fiscal quarter and as adjusted for non-controlling interests. As of December 31, 2022, the Company was in compliance with all financial covenants of the Secured Term Loan. Financing Agreements Maturities At December 31, 2022, approximate principal maturities of the Company’s Financing Agreements are as follows ($ in thousands): Wells Fargo Citibank CNB Facility MetLife Facility Morgan Stanley Facility Notes Payable Secured Term Loan Total 2023 $ — $ — $ — $ — $ — $ — $ — $ — 2024 — — — — 198,193 — — 198,193 2025 270,798 236,240 — — 105,000 — 612,038 2026 — — — — 150,000 150,000 2027 — — — — — — — — Thereafter — — — — — — — — $ 270,798 $ 236,240 $ — $ — $ 198,193 $ 105,000 $ 150,000 $ 960,231 A subsidiary of the Company was party to a secured borrowing arrangement related to a transferred loan that was closed in February 2020. In April 2019, the Company originated a $30.5 million loan on an office property located in North Carolina, which was bifurcated between a $24.4 million senior mortgage loan and a $6.1 million mezzanine loan. In February 2020, the Company transferred its interest in the $24.4 million senior mortgage loan to a third party and retained the $6.1 million mezzanine loan. The Company evaluated whether the transfer of the $24.4 million senior mortgage loan met the criteria in FASB ASC Topic 860, Transfers and Servicing , for treatment as a sale – legal isolation, ability of transferee to pledge or exchange the transferred assets without constraint and transfer of effective control – and determined that the transfer did not qualify as a sale and thus, was treated as a financing transaction. As such, the Company did not derecognize the $24.4 million senior mortgage loan asset and recorded a secured borrowing liability in the Company’s consolidated balance sheets. The initial maturity date of the $24.4 million secured borrowing was May 5, 2023, subject to one 12-month extension, which may have been exercised at the transferee’s option, which, if exercised, would have extended the maturity date to May 5, 2024. Advances under the $24.4 million secured borrowing accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.50%. In July 2022, the $30.5 million loan was fully repaid and thus, the $24.4 million secured borrowing liability was derecognized.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS	DERIVATIVE FINANCIAL INSTRUMENTS The Company uses derivative financial instruments, which includes interest rate swaps and interest rate caps, on certain borrowing transactions to manage its net exposure to interest rate changes and to reduce its overall cost of borrowing. These derivatives may or may not qualify as cash flow hedges under the hedge accounting requirements of FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”). Derivatives not designated as cash flow hedges are not speculative and are used to manage our exposure to interest rate movements. See Note 2 included in these consolidated financial statements for additional discussion of the accounting for designated and non-designated hedges. The use of derivative financial instruments involves certain risks, including the risk that the counterparties to these contractual arrangements do not perform as agreed. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties that have appropriate credit ratings and are major financial institutions with which the Company and its affiliates may also have other financial relationships. The following tables detail our outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk as of December 31, 2022 and 2021 (notional amount in thousands): As of December 31, 2022 December 31, 2021 Interest Rate Derivatives Number of Instruments Notional Amount Rate (1) Index Weighted Average Maturity (Years) Number of Instruments Notional Amount Rate (1) Index Weighted Average Maturity (Years) Interest rate swaps 1 $410,000 0.2075% LIBOR (2) 0.4 1 $700,000 0.2075% LIBOR (2) 1.0 Interest rate caps 0 (3) $— — — — 1 $220,000 0.5000% LIBOR 1.0 _______________________________ (1) Represents fixed rate for interest rate swaps and strike rate for interest rate caps. (2) Subject to a 0.00% floor. (3) In March 2022, the Company re-calibrated its net exposure to interest rate changes by terminating its interest rate cap derivative, which had a notional amount of $170.0 million on the termination date and a strike rate of 0.50%. For the year ended December 31, 2022, the Company recognized a $2.0 million realized gain within OCI in conjunction with the termination of the interest rate cap. In accordance with ASC 815, the realized gain will be recognized within current earnings over the remaining original term of the interest rate cap derivative as it was designated as an effective hedge. For the year ended December 31, 2022, the Company recognized a realized gain of $1.0 million through a reduction in interest expense, on the termination of the interest rate cap within current earnings. The following table summarizes the fair value of our derivative financial instruments ($ in thousands): Fair Value of Derivatives in an Asset Position (1) as of Fair Value of Derivatives in a Liability Position (2) as of December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Derivatives designated as hedging instruments: Interest rate derivatives $ 6,565 $ 2,979 $ — $ — ____________________________ (1) Included in other assets in the Company’s consolidated balance sheets. (2) Included in other liabilities in the Company’s consolidated balance sheets.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES As of December 31, 2022, there were no contingencies recorded on the Company’s consolidated balance sheets as a result of such conditions, however, if global market conditions worsen, it could adversely affect the Company’s business, financial condition and results of operations. As of December 31, 2022 and 2021, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands): As of December 31, 2022 2021 Total commitments $ 2,510,308 $ 2,662,853 Less: funded commitments (2,282,821) (2,429,112) Total unfunded commitments $ 227,487 $ 233,741

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY At the Market Stock Offering Program On November 22, 2019, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”), pursuant to which the Company offered and sold, from time to time, shares of the Company’s common stock, governing as “at the market offering” program having an aggregate offering price of up to $100.0 million. During the year ended December 31, 2022, the Company sold an aggregate of 190,369 shares of the Company’s common stock under the Equity Distribution Agreement at an average price of $15.33 per share. The sales generated net proceeds of approximately $2.9 million. During the year ended December 31, 2021, the Company sold an aggregate of 137,237 shares of the Company’s common stock under the Equity Distribution Agreement at an average price of $15.68 per share. The sales generated net proceeds of approximately $2.1 million. The “at the market offering” program is currently unavailable. Stock Repurchase Program On July 26, 2022, the Company’s Board of Directors approved a stock repurchase program of up to $50.0 million, which is expected to be in effect until July 26, 2023, or until the approved dollar amount has been used to repurchase shares (the “Repurchase Program”). Pursuant to the Repurchase Program, the Company may repurchase shares of its common stock in amounts, at prices and at such times as it deems appropriate, subject to market conditions and other considerations, including all applicable legal requirements. Repurchases may include purchases on the open market or privately negotiated transactions, under Rule 10b5-1 trading plans, under accelerated share repurchase programs, in tender offers and otherwise. The Repurchase Program does not obligate the Company to acquire any particular amount of shares of its common stock and may be modified or suspended at any time at its discretion. The Company did not conduct any repurchases under the Repurchase Program during the year ended December 31, 2022. Equity Offerings On May 20, 2022, the Company closed the public offering of an aggregate of 7,000,000 shares of the Company’s common stock, generating net proceeds of approximately $103.2 million, after deducting transaction expenses. Equity Incentive Plan On April 23, 2012, the Company adopted an equity incentive plan, which was amended and restated in June 2018 (as further amended, the “Amended and Restated 2012 Equity Incentive Plan”). In February 2022, the Company’s board of directors authorized, and in May 2022, the Company’s stockholders approved, the first amendment to the Amended and Restated 2012 Equity Incentive Plan, which among other things, increased the total number of shares of common stock the Company may grant thereunder to 2,490,000 shares. Pursuant to the Amended and Restated 2012 Equity Incentive Plan, as amended by the first amendment, the Company may grant awards consisting of restricted shares of the Company’s common stock, restricted stock units (“RSUs”) and/or other equity-based awards to the Company’s outside directors, employees of the Manager, officers, ACREM and other eligible awardees under the plan. Any restricted shares of the Company’s common stock and RSUs will be accounted for under FASB ASC Topic 718, Compensation—Stock Compensation , resulting in stock-based compensation expense equal to the grant date fair value of the underlying restricted shares of common stock or RSUs. Restricted stock and RSU grants generally vest ratably over a one The following tables summarize the (i) non-vested shares of restricted stock and RSUs and (ii) vesting schedule of shares of restricted stock and RSUs for the Company’s directors and officers and employees of the Manager as of December 31, 2022: Schedule of Non-Vested Share and Share Equivalents Restricted Stock Grants—Directors Restricted Stock Grants—Officers and Employees of the Manager RSUs—Officers and Employees of the Manager Total Balance at December 31, 2021 16,640 25,373 497,161 539,174 Granted 24,780 — 434,150 458,930 Vested (25,283) (25,373) (84,776) (135,432) Forfeited — — (14,063) (14,063) Balance at December 31, 2022 16,137 — 832,472 848,609 Future Anticipated Vesting Schedule Restricted Stock Grants—Directors Restricted Stock Grants—Officers and Employees of the Manager RSUs—Officers and Employees of the Manager Total 2023 14,052 — 168,274 182,326 2024 1,668 — 285,405 287,073 2025 417 — 234,097 234,514 2026 — — 144,696 144,696 2027 — — — — Total 16,137 — 832,472 848,609 The following table summarizes the restricted stock and RSU compensation expense included within general and administrative expenses in the Company’s consolidated statements of operations, the total fair value of shares vested and the weighted average grant date fair value of the restricted stock and RSUs granted to the Company’s directors and officers and employees of the Manager for the years ended December 31, 2022, 2021 and 2020 ($ in thousands): For the years ended December 31, 2022 2021 2020 Restricted Stock and RSU Grants Restricted Stock and RSU Grants Restricted Stock and RSU Grants Directors Officers and Employees of the Manager Total Directors Officers and Employees of the Manager Total Directors Officers and Employees of the Manager Total Compensation expense $ 399 $ 2,477 $ 2,876 $ 329 $ 1,611 $ 1,940 $ 319 $ 1,020 $ 1,339 Total fair value of shares vested (1) 338 1,623 1,961 460 1,009 1,469 315 849 1,164 Weighted average grant date fair value 390 4,654 5,044 403 4,255 4,658 292 2,898 3,190 ___________________________ (1) Based on the closing price of the Company’s common stock on the NYSE on each vesting date. As of December 31, 2022, 2021 and 2020, the total compensation cost related to non-vested awards not yet recognized totaled $8.0 million, $6.0 million and $3.7 million, respectively, and the weighted average period over which the non-vested awards are expected to be recognized is 2.3 years.

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE The following information sets forth the computations of basic and diluted earnings per common share for the years ended December 31, 2022, 2021 and 2020 ($ in thousands, except share and per share data): For the years ended December 31, 2022 2021 2020 Net income attributable to common stockholders $ 29,785 $ 60,460 $ 21,840 Divided by: Basic weighted average shares of common stock outstanding: 51,679,744 42,399,613 32,977,462 Weighted average non-vested restricted stock and RSUs 446,512 281,892 219,046 Diluted weighted average shares of common stock outstanding: 52,126,256 42,681,505 33,196,508 Basic earnings per common share $ 0.58 $ 1.43 $ 0.66 Diluted earnings per common share $ 0.57 $ 1.42 $ 0.66

INCOME TAX

INCOME TAX	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAX	INCOME TAX The Company wholly owns ACRC Lender W TRS LLC, which is a taxable REIT subsidiary (“TRS”) formed to issue and hold certain loans intended for sale. The Company also wholly owns ACRC 2017-FL3 TRS LLC, which is a TRS formed to hold a portion of the FL3 CLO Securitization and FL4 CLO Securitization (as defined below), including the portion that generates excess inclusion income. Additionally, the Company wholly owns ACRC WM Tenant LLC, which is a TRS formed to lease from an affiliate the hotel property classified as real estate owned acquired on March 8, 2019. ACRC WM Tenant LLC engaged a third-party hotel management company to operate the hotel under a management contract prior to the sale of the hotel on March 1, 2022. The income tax provision for the Company and the TRSs consisted of the following for the years ended December 31, 2022, 2021 and 2020 ($ in thousands): For the years ended December 31, 2022 2021 2020 Current $ 42 $ 450 $ 82 Deferred — — (99) Excise tax 430 272 369 Total income tax expense, including excise tax $ 472 $ 722 $ 352 For the years ended December 31, 2022, 2021 and 2020, the Company incurred an expense of $430 thousand, $272 thousand and $369 thousand, respectively, for U.S. federal excise tax. Excise tax represents a 4% tax on the sum of a portion of the Company’s ordinary income and net capital gains not distributed during the calendar year (including any distribution declared in the fourth quarter and paid following January) plus any prior year shortfall. If it is determined that an excise tax liability exists for the current tax year, the Company will accrue excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations. The TRSs recognize interest and penalties related to unrecognized tax benefits within income tax expense in the Company’s consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the Company’s consolidated balance sheets. As of December 31, 2022, tax years 2019 through 2022 remain subject to examination by taxing authorities. The Company does not have any unrecognized tax benefits and the Company does not expect that to change in the next 12 months.

FAIR VALUE

FAIR VALUE	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE The Company follows FASB ASC Topic 820-10, Fair Value Measurement (“ASC 820-10”), which expands the application of fair value accounting. ASC 820-10 defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosure requirements for fair value measurements. ASC 820-10 determines fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. ASC 820-10 specifies a hierarchy of valuation techniques based on the inputs used in measuring fair value. In accordance with ASC 820-10, the inputs used to measure fair value are summarized in the three broad levels listed below: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others. • Level 3—Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used. GAAP requires disclosure of fair value information about financial and nonfinancial assets and liabilities, whether or not recognized in the financial statements, for which it is practical to estimate the value. In cases where quoted market prices are not available, fair values are based upon the application of discount rates to estimated future cash flows using market yields, or other valuation methodologies. Any changes to the valuation methodology will be reviewed by the Company’s management to ensure the changes are appropriate. The methods used may produce a fair value calculation that is not indicative of net realizable value or reflective of future fair values. Furthermore, while the Company anticipates that the valuation methods are appropriate and consistent with other market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial and nonfinancial assets and liabilities could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may fall within periods of market dislocation, during which price transparency may be reduced. Recurring Fair Value Measurements Derivative Financial Instruments The Company is required to record derivative financial instruments at fair value on a recurring basis in accordance with GAAP. The fair value of interest rate derivatives was estimated using a third-party specialist, based on contractual cash flows and observable inputs comprising credit spreads. Available-for-Sale Debt Securities The Company designates investments in CRE debt securities as available-for-sale on the acquisition date of such CRE debt securities. The Company is required to record investments in available-for-sale debt securities at fair value on a recurring basis in accordance with GAAP. During the year ended December 31, 2022, the Company acquired three CRE debt securities for an aggregate purchase price of $27.9 million, which consisted of floating rate, investment grade rated debt securities that had a weighted average coupon of SOFR plus 2.47%. The Company’s available-for-sale debt securities have a contractual maturity greater than 10 years from the purchase date. As of December 31, 2022, the Company had three CRE debt security investments designated as available-for-sale debt securities. As of December 31, 2021, the Company had no CRE debt security investments. The following table summarizes the Company’s investments in available-for-sale debt securities as of December 31, 2022 ($ in thousands): Face Amount Amortized Cost Unamortized Discount Unrealized Gain (Loss), Net Available-for-sale debt securities $ 28,000 $ 27,881 $ 119 $ 55 The fair value of available-for-sale debt securities was estimated using third-party broker quotes, which provide valuation estimates based upon contractual cash flows, observable inputs comprising credit spreads and market liquidity. The following tables summarize the financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 and 2021 ($ in thousands): As of December 31, 2022 Level 1 Level 2 Level 3 Total Financial assets: Interest rate derivatives $ — $ 6,565 $ — $ 6,565 Available-for-sale debt securities $ — $ 27,936 $ — $ 27,936 Financial liabilities: Interest rate derivatives $ — $ — $ — $ — As of December 31, 2021 Level 1 Level 2 Level 3 Total Financial assets: Interest rate derivatives $ — $ 2,979 $ — $ 2,979 Financial liabilities: Interest rate derivatives $ — $ — $ — $ — As of December 31, 2022 and 2021, the Company did not have any nonfinancial assets or liabilities required to be recorded at fair value on a recurring basis. Nonrecurring Fair Value Measurements The Company was required to record real estate owned, a nonfinancial asset, at fair value on a nonrecurring basis in accordance with GAAP. Real estate owned consisted of a hotel property that was acquired by the Company on March 8, 2019 through a deed in lieu of foreclosure. See Note 5 included in these consolidated financial statements for more information on real estate owned. Real estate owned was recorded at fair value at acquisition using Level 3 inputs and is evaluated for indicators of impairment on a quarterly basis. Real estate owned was considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate owned over the estimated remaining holding period is less than the carrying amount of such real estate owned. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate owned. An impairment charge is recorded equal to the excess of the carrying value of the real estate owned over the fair value. The fair value of the hotel property at acquisition was estimated using a third-party appraisal, which utilized standard industry valuation techniques such as the income and market approach. When determining the fair value of a hotel, certain assumptions are made including, but not limited to: (1) projected operating cash flows, including factors such as booking pace, growth rates, occupancy, daily room rates, hotel specific operating costs and future capital expenditures; and (2) projected cash flows from the eventual disposition of the hotel based upon the Company’s estimation of a hotel specific capitalization rate, hotel specific discount rates and comparable selling prices in the market. As of December 31, 2022, the Company did not have any financial assets or liabilities or nonfinancial assets or liabilities required to be recorded at fair value on a nonrecurring basis. As of December 31, 2021, the Company did not have any financial assets or liabilities or nonfinancial liabilities required to be recorded at fair value on a nonrecurring basis. Financial Assets and Liabilities Not Measured at Fair Value As of December 31, 2022 and 2021, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands): As of December 31, 2022 2021 Level in Fair Value Hierarchy Carrying Value Fair Carrying Value Fair Financial assets: Loans held for investment 3 $ 2,264,008 $ 2,233,319 $ 2,414,383 $ 2,408,463 Financial liabilities: Secured funding agreements 2 $ 705,231 $ 705,231 $ 840,047 $ 840,047 Notes payable 3 104,460 103,635 50,358 51,110 Secured term loan 3 149,200 137,571 149,016 150,000 Collateralized loan obligation securitization debt (consolidated VIEs) 3 777,675 749,242 861,188 863,403 Secured borrowings 3 — — 22,589 22,715 The carrying values of cash and cash equivalents, restricted cash, interest receivable, due to affiliate liability and accrued expenses, which are all categorized as Level 2 within the fair value hierarchy, approximate their fair values due to their short-term nature. Loans held for investment are recorded at cost, net of unamortized loan fees and origination costs. To determine the fair value of the collateral, the Company may employ different approaches depending on the type of collateral. The Company determined the fair value of loans held for investment based on a discounted cash flow methodology, taking into consideration various factors including capitalization rates, discount rates, leasing, occupancy rates, availability and cost of financing, exit plan, sponsorship, actions of other lenders, and comparable selling prices in the market. The Secured Funding Agreements are recorded at outstanding principal, which is the Company’s best estimate of the fair value. The Company determined the fair value of the Notes Payable, Secured Term Loan, collateralized loan obligation (“CLO”) securitization debt and Secured Borrowings based on a discounted cash flow methodology, taking into consideration various factors including discount rates, actions of other lenders and comparable market quotes and recent trades for similar products.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Management Agreement The Company is party to an Amended and Restated Management Agreement under which ACREM, subject to the supervision and oversight of the Company’s board of directors, is responsible for, among other duties, (a) performing all of the Company’s day-to-day functions, (b) determining the Company’s investment strategy and guidelines in conjunction with the Company’s board of directors, (c) sourcing, analyzing and executing investments, asset sales and financing, and (d) performing portfolio management duties. In addition, ACREM has an Investment Committee that oversees compliance with the Company’s investment strategy and guidelines, loans held for investment portfolio holdings and financing strategy. In exchange for its services, ACREM is entitled to receive a base management fee, an incentive fee and expense reimbursements. In addition, ACREM and its personnel may receive grants of equity-based awards pursuant to the Company’s Amended and Restated 2012 Equity Incentive Plan and a termination fee, if applicable. The base management fee is equal to 1.5% of the Company’s stockholders’ equity per annum, which is calculated and payable quarterly in arrears in cash. For purposes of calculating the base management fee, stockholders’ equity means: (a) the sum of (i) the net proceeds from all issuances of the Company’s equity securities since inception (allocated on a pro-rata daily basis for such issuances during the fiscal quarter of any such issuance), plus (ii) the Company’s retained earnings at the end of the most recently completed fiscal quarter determined in accordance with GAAP (without taking into account any non-cash equity compensation expense incurred in current or prior periods); less (b) (x) any amount that the Company has paid to repurchase the Company’s common stock since inception, (y) any unrealized gains and losses and other non-cash items that have impacted stockholders’ equity as reported in the Company’s consolidated financial statements prepared in accordance with GAAP, and (z) one-time events pursuant to changes in GAAP, and certain non-cash items not otherwise described above, in each case after discussions between ACREM and the Company’s independent directors and approval by a majority of the Company’s independent directors. As a result, the Company’s stockholders’ equity, for purposes of calculating the management fee, could be greater or less than the amount of stockholders’ equity shown in the Company’s consolidated financial statements. The incentive fee is an amount, not less than zero, equal to the difference between: (a) the product of (i) 20% and (ii) the difference between (A) the Company’s Core Earnings (as defined below) for the previous 12-month period, and (B) the product of (1) the weighted average of the issue price per share of the Company’s common stock of all of the Company’s public offerings of common stock multiplied by the weighted average number of all shares of common stock outstanding including any restricted shares of the Company’s common stock, RSUs, or any shares of the Company’s common stock not yet issued, but underlying other awards granted under the Company’s Amended and Restated 2012 Equity Incentive Plan (see Note 10 included in these consolidated financial statements) in the previous 12-month period, and (2) 8%; and (b) the sum of any incentive fees earned by ACREM with respect to the first three fiscal quarters of such previous 12-month period; provided, however, that no incentive fee is payable with respect to any fiscal quarter unless cumulative Core Earnings for the 12 most recently completed fiscal quarters is greater than zero. “Core Earnings” is defined in the Management Agreement as GAAP net income (loss) computed in accordance with GAAP, excluding non-cash equity compensation expense, the incentive fee, depreciation and amortization (to the extent that any of the Company’s target investments are structured as debt and the Company forecloses on any properties underlying such debt), any unrealized gains, losses or other non-cash items recorded in net income (loss) for the period, regardless of whether such items are included in other comprehensive income or loss, or in net income (loss), and one-time events pursuant to changes in GAAP and certain non-cash charges after discussions between ACREM and the Company’s independent directors and after approval by a majority of the Company’s independent directors. On April 25, 2022, the Company and ACREM entered into an amendment to the Management Agreement to (a) exclude $2.4 million of net income associated with the sale of the real estate owned property for the three months ended March 31, 2022 and to (b) include $2.0 million of net income associated with the Company’s gain on the termination of its interest rate cap derivative for the three months ended March 31, 2022, in each case, with respect to Core Earnings for the three months ended March 31, 2022. Core Earnings is defined in the Management Agreement and is used to calculate the incentive fees the Company pays to ACREM. For the years ended December 31, 2022, 2021 and 2020, the Company incurred incentive fees of $3.4 million, $2.8 million and $0.8 million, respectively. The Company reimburses ACREM at cost for operating expenses that ACREM incurs on the Company’s behalf, including expenses relating to legal, financial, accounting, servicing, due diligence and other services, expenses in connection with the origination and financing of the Company’s investments, communications with the Company’s stockholders, information technology systems, software and data services used for the Company, travel, complying with legal and regulatory requirements, taxes, insurance maintained for the benefit of the Company as well as all other expenses actually incurred by ACREM that are reasonably necessary for the performance by ACREM of its duties and functions under the Management Agreement. Ares Management, from time to time, incurs fees, costs and expenses on behalf of more than one investment vehicle. To the extent such fees, costs and expenses are incurred for the account or benefit of more than one fund, each such investment vehicle, including the Company, will typically bear an allocable portion of any such fees, costs and expenses in proportion to the size of its investment in the activity or entity to which such expense relates (subject to the terms of each fund’s governing documents) or in such other manner as Ares Management considers fair and equitable under the circumstances, such as the relative fund size or capital available to be invested by such investment vehicles. Where an investment vehicle’s governing documents do not permit the payment of a particular expense, Ares Management will generally pay such investment vehicle’s allocable portion of such expense. In addition, the Company is responsible for its proportionate share of certain fees and expenses, including due diligence costs, as determined by ACREM and Ares Management, including legal, accounting and financial advisor fees and related costs, incurred in connection with evaluating and consummating investment opportunities, regardless of whether such transactions are ultimately consummated by the parties thereto. The Company will not reimburse ACREM for the salaries and other compensation of its personnel, except for the allocable share of the salaries and other compensation of the Company’s (a) Chief Financial Officer, based on the percentage of his time spent on the Company’s affairs and (b) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of ACREM or its affiliates who spend all or a portion of their time managing the Company’s affairs based on the percentage of their time spent on the Company’s affairs. The Company is also required to pay its pro-rata portion of rent, telephone, utilities, office furniture, equipment, machinery and other office, internal and overhead expenses of ACREM and its affiliates that are required for the Company’s operations. Certain of the Company’s subsidiaries, along with the Company’s lenders under certain of the Company’s Secured Funding Agreements, as well as under the CLO transaction have entered into various servicing agreements with ACREM’s subsidiary servicer, Ares Commercial Real Estate Servicer LLC (“ACRES”). The Company’s Manager will specially service, as needed, certain of the Company’s investments. Effective May 1, 2012, ACRES agreed that no servicing fees pursuant to these servicing agreements would be charged to the Company or its subsidiaries by ACRES or the Manager for so long as the Management Agreement remains in effect, but that ACRES will continue to receive reimbursement for overhead related to servicing and operational activities pursuant to the terms of the Management Agreement. The term of the Management Agreement ends on April 25, 2023, with automatic one-year renewal terms thereafter. Except under limited circumstances, upon a termination of the Management Agreement, the Company will pay ACREM a termination fee equal to three times the average annual base management fee and incentive fee received by ACREM during the 24-month period immediately preceding the most recently completed fiscal quarter prior to the date of termination, each as described above. The following table summarizes the related party costs incurred by the Company for the years ended December 31, 2022, 2021 and 2020 and amounts payable to the Company’s Manager as of December 31, 2022 and 2021 ($ in thousands): Incurred Payable For the years ended December 31, As of December 31, 2022 2021 2020 2022 2021 Affiliate Payments Management fees $ 11,456 $ 9,384 $ 7,323 $ 3,026 $ 2,613 Incentive fees 3,442 2,752 836 1,264 830 General and administrative expenses 3,777 3,016 3,653 1,232 703 Direct costs(1) 165 9 100 58 10 Total $ 18,840 $ 15,161 $ 11,912 $ 5,580 $ 4,156 _______________________________ (1) For the years ended December 31, 2022, 2021 and 2020, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations. Investments in Loans From time to time, the Company may co-invest with other investment vehicles managed by Ares Management or its affiliates, including the Manager, and their portfolio companies, including by means of splitting investments, participating in investments or other means of syndication of investments. For such co-investments, the Company expects to act as the administrative agent for the holders of such investments provided that the Company maintains a majority of the aggregate investment. No fees will be received by the Company for performing such service. The Company will be responsible for its pro-rata share of costs and expenses for such co-investments, including due diligence costs for transactions which fail to close. The Company’s investment in such co-investments are made on a pari-passu basis with the other Ares managed investment vehicles and the Company is not obligated to provide, nor has it provided, any financial support to the other Ares managed investment vehicles. As such, the Company’s risk is limited to the carrying value of its investment and the Company recognizes only the carrying value of its investment in its consolidated balance sheets. As of December 31, 2022 and 2021, the total outstanding principal balance for co-investments held by the Company was $213.7 million and $158.3 million, respectively. Loan Purchases From Affiliate An affiliate of the Company’s Manager maintains a $200.0 million real estate debt warehouse investment vehicle (the “Ares Warehouse Vehicle”) that holds Ares Management originated commercial real estate loans, which are made available to purchase by other investment vehicles, including the Company and other Ares Management managed investment vehicles. From time to time, the Company may purchase loans from the Ares Warehouse Vehicle. The Company’s Manager will approve the purchase of such loans only on terms, including the consideration to be paid, that are determined by the Company’s Manager in good faith to be appropriate for the Company once the Company has sufficient liquidity. The Company is not obligated to purchase any loans originated by the Ares Warehouse Vehicle. In addition, from time to time, the Company may purchase loans, including participations in loans, from other Ares Management managed investment vehicles. Loans purchased by the Company from the Ares Warehouse Vehicle or other Ares Management managed investment vehicles are purchased at fair value as determined by an independent third-party valuation expert and are subject to approval by a majority of the Company’s independent directors. No loans were purchased by the Company from the Ares Warehouse Vehicle for the year ended December 31, 2022.

DIVIDENDS AND DISTRIBUTIONS

DIVIDENDS AND DISTRIBUTIONS	12 Months Ended
	Dec. 31, 2022
DIVIDENDS AND DISTRIBUTIONS
DIVIDENDS AND DISTRIBUTIONS	DIVIDENDS AND DISTRIBUTIONS The following table summarizes the Company’s dividends declared during the years ended December 31, 2022, 2021 and 2020 ($ in thousands, except per share data): Date Declared Record Date Payment Date Per Share Amount Total Amount November 2, 2022 December 30, 2022 January 18, 2023 $ 0.35 (1) $ 19,347 July 29, 2022 September 30, 2022 October 17, 2022 0.35 (1) 19,196 May 3, 2022 June 30, 2022 July 15, 2022 0.35 (1) 19,198 February 15, 2022 March 31, 2022 April 14, 2022 0.35 (1) 16,740 Total cash dividends declared for the year ended December 31, 2022 $ 1.40 $ 74,481 November 3, 2021 December 31, 2021 January 19, 2022 $ 0.35 (1) $ 16,674 July 30, 2021 September 30, 2021 October 15, 2021 0.35 (1) 16,524 May 4, 2021 June 30, 2021 July 15, 2021 0.35 (1) 16,528 February 17, 2021 March 31, 2021 April 15, 2021 0.35 (1) 14,248 Total cash dividends declared for the year ended December 31, 2021 $ 1.40 $ 63,974 December 15, 2020 December 30, 2020 January 15, 2021 $ 0.33 $ 11,124 September 16, 2020 September 30, 2020 October 15, 2020 0.33 11,072 June 19, 2020 June 30, 2020 July 15, 2020 0.33 11,072 February 20, 2020 March 31, 2020 April 15, 2020 0.33 11,057 Total cash dividends declared for the year ended December 31, 2020 $ 1.32 $ 44,325

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
VARIABLE INTEREST ENTITIES	VARIABLE INTEREST ENTITIES Consolidated VIEs As discussed in Note 2, the Company evaluates all of its investments and other interests in entities for consolidation, including its investments in the CLO Securitizations (as defined below), which are considered to be variable interests in VIEs. CLO Securitizations On January 11, 2019, ACRE Commercial Mortgage 2017-FL3 Ltd. (the “FL3 Issuer”) and ACRE Commercial Mortgage 2017-FL3 LLC (the “FL3 Co-Issuer”), both wholly-owned indirect subsidiaries of the Company, entered into an Amended and Restated Indenture (the “FL3 Amended Indenture”) with Wells Fargo Bank, National Association, as advancing agent and note administrator, and Wilmington Trust, National Association, as trustee, which governs the approximately $504.1 million principal balance of secured floating rate notes (the “FL3 Notes”) issued by the FL3 Issuer and $52.9 million of preferred equity in the FL3 Issuer (the “FL3 CLO Securitization”). The FL3 Amended Indenture amends and restates, and replaces in its entirety, the indenture for the CLO securitization issued in March 2017, which governed the issuance of approximately $308.8 million principal balance of secured floating rate notes and $32.4 million of preferred equity in the FL3 Issuer. As of December 31, 2022, the FL3 Notes were collateralized by interests in a pool of 16 mortgage assets having a total principal balance of $429.4 million (the “FL3 Mortgage Assets”) that were closed by a wholly-owned subsidiary of the Company and approximately $127.6 million of receivables related to repayments of outstanding principal on previous mortgage assets. As of December 31, 2021, the FL3 Notes were collateralized by interests in a pool of 16 mortgage assets having a total principal balance of approximately $451.6 million that were closed by a wholly-owned subsidiary of the Company and approximately $105.4 million of receivables related to repayments of outstanding principal on previous mortgage assets. On April 13, 2021, the FL3 Issuer and the FL3 Co-Issuer entered into a First Supplement to Amended and Restated Indenture (the “2021 Amended Indenture”) with Wells Fargo Bank, National Association, as advancing agent and note administrator, and Wilmington Trust, National Association, as trustee, which governs the FL3 CLO Securitization. The purpose of the 2021 Amended Indenture was to, among other things, extend the reinvestment period to March 31, 2024. During the reinvestment period, the Company may direct the FL3 Issuer to acquire additional mortgage assets meeting applicable reinvestment criteria using the principal repayments from the FL3 Mortgage Assets, subject to the satisfaction of certain conditions, including receipt of a Rating Agency Confirmation and investor approval of the new mortgage assets. The contribution of the FL3 Mortgage Assets to the Issuer is governed by a Mortgage Asset Purchase Agreement between the Seller and the FL3 Issuer, and acknowledged by the Company solely for purposes of confirming its status as a REIT, in which the Seller made certain customary representations, warranties and covenants. In connection with the securitization, the FL3 Issuer and FL3 Co-Issuer offered and issued the following classes of Notes: Class A, Class A-S, Class B, Class C and Class D Notes (collectively, the “FL3 Offered Notes”) to a third party. The Company retained (through one of its wholly-owned subsidiaries) approximately $58.5 million of the FL3 Notes and all of the $52.9 million of preferred equity in the FL3 Issuer, which totaled $111.4 million. The Company, as the holder of the subordinated FL3 Notes and all of the preferred equity in the FL3 Issuer, has the obligation to absorb losses of the CLO, since the Company has a first loss position in the capital structure of the CLO. On January 28, 2021, ACRE Commercial Mortgage 2021-FL4 Ltd. (the “FL4 Issuer”) and ACRE Commercial Mortgage 2021-FL4 LLC (the “FL4 Co-Issuer”), both wholly owned indirect subsidiaries of the Company, entered into an Indenture (the “FL4 Indenture”) with ACRC Lender LLC, a wholly owned subsidiary of the Company (the “Seller”), as advancing agent, Wells Fargo Bank, National Association, as note administrator, and Wilmington Trust, National Association, as trustee, which governs the issuance of approximately $603.0 million principal balance secured floating rate notes (the “FL4 Notes”) and $64.3 million of preferred equity in the FL4 Issuer (the “FL4 CLO Securitization”). For U.S. federal income tax purposes, the FL4 Issuer and FL4 Co-Issuer are disregarded entities. As of December 31, 2022, the FL4 Notes were collateralized by interests in a pool of 12 mortgage assets having a total principal balance of approximately $458.3 million (the “FL4 Mortgage Assets”) that were closed by a wholly-owned subsidiary of the Company and approximately $1.9 million of receivables related to repayments of outstanding principal on previous mortgage assets. As of December 31, 2021, the FL4 Notes were collateralized by interests in a pool of 17 mortgage assets having a total principal balance of approximately $522.8 million that were closed by a wholly-owned subsidiary of the Company and approximately $23.2 million of receivables related to repayments of outstanding principal on previous mortgage assets. During the period ending in April 2024 (the “Companion Participation Acquisition Period”), the FL4 Issuer may use certain principal proceeds from the FL4 Mortgage Assets to acquire additional funded pari-passu participations related to the FL4 Mortgage Assets that meet certain acquisition criteria. The sale of the FL4 Mortgage Assets to the FL4 Issuer is governed by a FL4 Mortgage Asset Purchase Agreement between the Seller and the FL4 Issuer, and acknowledged by the Company solely for purposes of confirming its status as a REIT, in which the Seller made certain customary representations, warranties and covenants. In connection with the FL4 CLO Securitization, the FL4 Issuer and FL4 Co-Issuer offered and issued the following classes of FL4 Notes to third party investors: Class A, Class A-S, Class B, Class C, Class D and Class E Notes (collectively, the “FL4 Offered Notes”). A wholly owned subsidiary of the Company retained approximately $62.5 million of the FL4 Notes and all of the $64.3 million of preferred equity in the FL4 Issuer, which totaled $126.8 million. The Company, as the holder of the subordinated FL4 Notes and all of the preferred equity in the FL4 Issuer, has the obligation to absorb losses of the FL4 CLO Securitization, since the Company has a first loss position in the capital structure of the FL4 CLO Securitization. During the year ended December 31, 2022, the Company paid down $85.9 million of the FL4 Offered Notes. The FL3 CLO Securitization and the FL4 CLO Securitization are collectively referred to as the “CLO Securitizations.” As the directing holder of the CLO Securitizations, the Company has the ability to direct activities that could significantly impact the CLO Securitizations’ economic performance. ACRES is designated as special servicer of the CLO Securitizations and has the power to direct activities during the loan workout process on defaulted and delinquent loans, which is the activity that most significantly impacts the CLO Securitizations’ economic performance. ACRES did not waive the special servicing fee, and the Company pays its overhead costs. If an unrelated third party had the right to unilaterally remove the special servicer, then the Company would not have the power to direct activities that most significantly impact the CLO Securitizations’ economic performance. In addition, there were no substantive kick-out rights of any unrelated third party to remove the special servicer without cause. The Company’s subsidiaries, as directing holders, have the ability to remove the special servicer without cause. Based on these factors, the Company is determined to be the primary beneficiary of each of the CLO Securitizations; thus, the CLO Securitizations are consolidated into the Company’s consolidated financial statements. The CLO Securitizations are consolidated in accordance with FASB ASC Topic 810 and are structured as pass through entities that receive principal and interest on the underlying collateral and distributes those payments to the note holders, as applicable. The assets and other instruments held by the CLO Securitizations are restricted and can only be used to fulfill the obligations of the respective CLO Securitizations. Additionally, the obligations of the CLO Securitizations do not have any recourse to the general credit of any other consolidated entities, nor to the Company as the primary beneficiary.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS The Company’s management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no subsequent events that occurred during such period that would require disclosure in this annual report on Form 10-K or would be required to be recognized in the consolidated financial statements as of and for the year ended December 31, 2022, except as disclosed below. In January 2023, the senior mortgage loan held by the Company on an office property located in Illinois was not repaid upon its contractual maturity, which triggered an event of default under the loan agreement. As of February 14, 2023, the outstanding principal balance of the senior Illinois loan is $27.2 million. In January 2023, the senior mortgage loan held by the Company on a mixed-use property located in California did not receive the January interest payment, which triggered an event of default under the loan agreement. As of February 14, 2023, the outstanding principal balance of the senior California loan is $37.9 million. In January 2023, the Company sold the senior loan collateralized by a residential property in California and was in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the maturity date. The Company sold the loan at an all-cash price of $10.0 million, with estimated net proceeds of $9.8 million. In February 2023, the senior mortgage loan held by the Company on a mixed-use property located in Florida was not repaid upon its contractual maturity, which triggered an event of default under the loan agreement. As of February 14, 2023, the outstanding principal balance of the senior Florida loan is $84.0 million. The Company’s Board of Directors declared a regular cash dividend of $0.33 per common share and a supplemental cash dividend of $0.02 per common share for the first quarter of 2023. The first quarter 2023 and supplemental cash dividends will be payable on April 18, 2023 to common stockholders of record as of March 31, 2023.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated.
Use of Estimates in the Preparation of Financial Statements	Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Global macroeconomic conditions, including heightened inflation, changes to fiscal and monetary policy, higher interest rates, currency fluctuations, labor shortages and challenges in the supply chain, have the potential to negatively impact the Company and its borrowers. These current macroeconomic conditions may continue or aggravate and could cause the United States economy or other global economies to experience an economic slowdown or recession. We anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States or other major global economy. The Company believes the estimates and assumptions underlying its consolidated financial statements are reasonable and supportable based on the information available as of December 31, 2022, however, uncertainty over the global economy and the Company’s business, makes any estimates and assumptions as of December 31, 2022 inherently less certain than they would be absent the current and potential impacts of current macroeconomic conditions. Actual results could differ from those estimates.
Variable Interest Entities	Variable Interest Entities The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation , defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE. To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE. To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company. For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements. The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change. See Note 16 included in these consolidated financial statements for further discussion of the Company’s VIEs.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short‑term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and statements of cash flows.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, loans held for investment, available-for-sale debt securities and interest receivable. The Company places its cash and cash equivalents with financial institutions and, at times, cash held may exceed the Federal Deposit Insurance Corporation insured limit. The Company has exposure to credit risk on its loans held for investment and available-for-sale debt securities. The Company and the Company’s Manager seek to manage credit risk by performing due diligence prior to origination or acquisition and through the use of non‑recourse financing, when and where available and appropriate.
Loans Held for Investment	Loans Held for Investment The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized loan fees and origination costs (the “carrying value”). Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors. Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.
Current Expected Credit Losses	Current Expected Credit Losses Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,
Real Estate Owned	Real Estate Owned Real estate assets are carried at their estimated fair value at acquisition and are presented net of accumulated depreciation and impairment charges. The Company allocates the purchase price of acquired real estate assets based on the fair value of the acquired land, building, furniture, fixtures and equipment. Real estate assets are depreciated using the straight-line method over estimated useful lives of up to 40 years for buildings and improvements and up to 15 years for furniture, fixtures and equipment. Renovations and/or replacements that improve or extend the life of the real estate asset are capitalized and depreciated over their estimated useful lives. The cost of ordinary repairs and maintenance are expensed as incurred. Real estate assets are evaluated for indicators of impairment on a quarterly basis. Factors that the Company may consider in its impairment analysis include, among others: (1) significant underperformance relative to historical or anticipated operating results; (2) significant negative industry or economic trends; (3) costs necessary to extend the life or improve the real estate asset; (4) significant increase in competition; and (5) ability to hold and dispose of the real estate asset in the ordinary course of business. A real estate asset is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate asset over the estimated remaining holding period is less than the carrying amount of such real estate asset. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate asset. An impairment charge is recorded equal to the excess of the carrying value of the real estate asset over the fair value. When determining the fair value of a real estate asset, the Company makes certain assumptions including, but not limited to, consideration of projected operating cash flows, comparable selling prices and projected cash flows from the eventual disposition of the real estate asset based upon the Company’s estimate of a capitalization rate and discount rate. The Company reviews its real estate assets, from time to time, in order to determine whether to sell such assets. Real estate assets are classified as held for sale when the Company commits to a plan to sell the asset, when the asset is being actively marketed for sale at a reasonable price and the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year. Real estate assets that are held for sale are carried at the lower of the asset’s carrying amount or its fair value less costs to sell.
Available-for-Sale Debt Securities	Available-for-Sale Debt Securities The Company acquires debt securities that are collateralized by mortgages on CRE properties primarily for short-term cash management and investment purposes. On the acquisition date, the Company designates investments in CRE debt securities as available-for-sale. Investments in CRE debt securities that are classified as available-for-sale are carried at fair value. Unrealized holding gains and losses for available-for-sale debt securities are recorded each period in other comprehensive income (“OCI”). The Company uses a specific identification method when determining the cost of a debt security sold and the amount of unrealized gain or loss reclassified from accumulated other comprehensive income (loss) into earnings. Available-for-sale debt securities that are in an unrealized loss position are evaluated on a quarterly basis to determine whether declines in the fair value below the amortized cost basis qualify as other than temporary impairment (“OTTI”). The OTTI assessment is performed at the individual security level. In assessing whether the entire amortized cost basis of each security will be recovered, the Company will compare the present value of cash flows expected to be collected from the security with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the entire amortized cost basis of the security will not be recovered and an OTTI shall be considered to have occurred.
Debt Issuance Costs	Debt Issuance Costs Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on the (i) Secured Funding Agreements (each individually defined in Note 6 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable, the Secured Term Loan (each defined in Note 6 included in these consolidated financial statements) and secured borrowings (described in Note 7 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability in the Company’s consolidated balance sheets. Amortization of debt issuance costs for the note payable on the hotel property that was recognized as real estate owned in the Company’s consolidated balance sheets (see Note 6 included in these consolidated financial statements for additional information on the note payable) is included within expenses from real estate owned in the Company’s consolidated statements of operations.
Derivative Financial Instruments	Derivative Financial Instruments Derivative financial instruments are classified as either other assets (gain positions) or other liabilities (loss positions) in the Company’s consolidated balance sheets at fair value. These amounts may be offset to the extent that there is a legal right to offset and if elected by management. On the date the Company enters into a derivative contract, the Company designates each contract as a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability, or cash flow hedge, or as a derivative instrument not to be designated as a hedging derivative, or non-designated hedge. For all derivatives other than those designated as non-designated hedges, the Company formally documents the hedge relationships and designation at the contract’s inception. This documentation includes the identification of the hedging instruments and the hedged items, its risk management objectives, strategy for undertaking the hedge transaction and an evaluation of the effectiveness of its hedged transaction. The Company performs a formal assessment on a quarterly basis on whether the derivative designated in each hedging relationship is expected to be, and has been, highly effective in offsetting changes in the value or cash flows of the hedged items. Changes in the fair value of derivative contracts are recorded each period in either current earnings or OCI, depending on whether the derivative is designated as part of a hedge transaction and, if so, the type of hedge transaction. For derivatives that are designated as cash flow hedges, the effective portion of the unrealized gains or losses on these contracts is recorded in OCI. If it is determined that a derivative is not highly effective at hedging the designated exposure, hedge accounting is discontinued and the changes in fair value of the instrument are included in current earnings prospectively. The Company does not enter into derivatives for trading or speculative purposes.
Revenue Recognition	Revenue Recognition Interest income is accrued based on the outstanding principal amount and the contractual terms of each loan or debt security. For loans held for investment, the origination fees, contractual exit fees and direct loan origination costs are also recognized in interest income over the initial loan term as a yield adjustment using the effective interest method. For available-for-sale debt securities, premiums or discounts are amortized or accreted into interest income as a yield adjustment using the effective interest method. Revenue from real estate owned represents revenue associated with the operations of a hotel property classified as real estate owned that was sold in March 2022. Revenue from the operation of the hotel property was recognized when guestrooms were occupied, services had been rendered or fees had been earned. Revenues were recorded net of any discounts and sales and other taxes collected from customers. Revenues consisted of room sales, food and beverage sales and other hotel revenues.
Net Interest Margin and Interest Expense	Net Interest Margin and Interest Expense    Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans and debt securities as compared to its use of debt leverage. The Company includes interest income from its loans and debt securities and interest expense related to its Secured Funding Agreements, Notes Payable, securitization debt, the Secured Term Loan (each individually defined in Note 6 included in these consolidated financial statements) and secured borrowings (described in Note 7 included in these consolidated financial statements) in net interest margin.
Income Taxes	Income Taxes The Company has elected and qualified for taxation as a REIT commencing with its taxable year ended December 31, 2012. As a result of the Company’s REIT qualification and its distribution policy, the Company does not generally pay United States federal corporate level income taxes. Many of the REIT requirements, however, are highly technical and complex. To continue to qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement that the Company distributes annually to its stockholders at least 90% of the Company’s REIT taxable income prior to the deduction for dividends paid. To the extent that the Company distributes less than 100% of its REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), the Company will pay tax at regular corporate rates on that undistributed portion. Furthermore, if the Company distributes less than the sum of 1) 85% of its ordinary income for the calendar year, 2) 95% of its capital gain net income for the calendar year, and 3) any undistributed shortfall from its prior calendar year (the “Required Distribution”) to its stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then it is required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if the Company elects to retain any of its net capital gain for any tax year, it must notify its stockholders and pay tax at regular corporate rates on the retained net capital gain. The stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If it is determined that the Company’s estimated current year taxable income will be in excess of estimated dividend distributions (including capital gain dividend) for the current year from such income, the Company accrues excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations. Excise tax expense is included in the line item income tax expense, including excise tax in the consolidated statements of operations included in this annual report on Form 10-K. The Company formed a wholly-owned subsidiary, ACRC Lender W TRS LLC (“ACRC W TRS”), in December 2013 in order to issue and hold certain loans intended for sale. The Company also formed a wholly-owned subsidiary, ACRC 2017-FL3 TRS LLC (“FL3 TRS”), in March 2017 in order to hold a portion of the CLO Securitizations (as defined below), including the portion that generates excess inclusion income. Additionally, the Company also formed a wholly-owned subsidiary, ACRC WM Tenant LLC (“ACRC WM”), in March 2019 in order to lease the hotel property classified as real estate owned, which was acquired on March 8, 2019. Entity classification elections to be taxed as a corporation and taxable REIT subsidiary (“TRS”) elections were made with respect to ACRC W TRS, FL3 TRS and ACRC WM. A TRS is an entity taxed as a corporation that has not elected to be taxed as a REIT, in which a REIT directly or indirectly holds equity, and that has made a joint election with such REIT to be treated as a TRS. A TRS generally may engage in any business, including investing in assets and engaging in activities that could not be held or conducted directly by the Company without jeopardizing its qualification as a REIT. A TRS is subject to applicable United States federal, state and local income tax on its taxable income. In addition, as a REIT, the Company also may be subject to a 100% excise tax on certain transactions between it and its TRS that are not conducted on an arm’s-length basis. For financial reporting purposes, a provision for current and deferred taxes has been established for the portion of the Company’s GAAP consolidated earnings recognized by ACRC W TRS, FL3 TRS and ACRC WM. The income tax provision is included in the line item income tax expense, including excise tax in the consolidated statements of operations included in this annual report on Form 10-K. FASB ASC Topic 740, Income Taxes (“ASC 740”), prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has analyzed its various federal and state filing positions and believes that its income tax filing positions and deductions are well documented and supported. As of December 31, 2022 and 2021, based on the Company’s evaluation, there is no reserve for any uncertain income tax positions. ACRC W TRS, FL3 TRS and ACRC WM recognize interest and penalties, if any, related to unrecognized tax benefits within income tax expense in the consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the consolidated balance sheets.
Comprehensive Income	Comprehensive Income Comprehensive income consists of net income and OCI that are excluded from net income.
Stock-based Compensation	Stock-Based Compensation The Company recognizes the cost of stock‑based compensation, which is included within general and administrative expenses in the Company’s consolidated statements of operations. The fair value of the time vested restricted stock or restricted stock units (“RSUs”) granted is recorded to expense on a straight‑line basis over the vesting period for the award, with an offsetting increase in stockholders’ equity. For grants to directors and officers and employees of the Manager, the fair value is determined based upon the market price of the stock on the grant date.
Earnings per Share	Earnings per Share The Company calculates basic earnings (loss) per share by dividing net income (loss) allocable to common stockholders for the period by the weighted average shares of common stock outstanding for that period after consideration of the earnings (loss) allocated to the Company’s restricted stock, which are participating securities as defined in GAAP. Diluted earnings (loss) per share takes into effect any dilutive instruments, such as restricted stock, RSUs and convertible debt, except when doing so would be anti‑dilutive. See Note 11 included in these consolidated financial statements for the earnings per share calculations.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848), to clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. ASU No. 2020-04 and ASU No. 2021-01 are effective for all entities and may be adopted retrospectively as of any date from the beginning of any interim period that includes or is subsequent to March 12, 2020. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848) to defer the sunset date of Topic 848 from December 31, 2022 to December 31, 2024. The Company elected to adopt the new guidance and, for the modifications that have occurred to date, the adoption of the guidance has not had a material impact on the Company’s consolidated financial statements. In March 2022, the FASB issued ASU 2022-02, Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of interest expense	For the years ended December 31, 2022, 2021 and 2020, interest expense is comprised of the following ($ in thousands): For the years ended December 31, 2022 2021 2020 Secured funding agreements $ 33,602 $ 16,403 $ 28,003 Notes payable (1) 3,410 2,275 1,317 Securitization debt 29,341 20,104 12,384 Secured term loan 7,028 4,353 7,114 Secured borrowings 845 6,145 3,131 Other (2) (8,232) 800 — Interest expense $ 65,994 $ 50,080 $ 51,949 ____________________________

LOANS HELD FOR INVESTMENT (Tabl

LOANS HELD FOR INVESTMENT (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of loans held for investments	The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of December 31, 2022 and 2021 ($ in thousands): As of December 31, 2022 Carrying Amount (1) Outstanding Principal (1) Weighted Average Unleveraged Effective Yield Weighted Average Remaining Life (Years) Senior mortgage loans $ 2,225,725 $ 2,243,818 8.4 % (2) 8.8 % (3) 1.3 Subordinated debt and preferred equity investments 38,283 39,003 14.0 % (2) 14.0 % (3) 2.8 Total loans held for investment portfolio $ 2,264,008 $ 2,282,821 8.5 % (2) 8.9 % (3) 1.4 As of December 31, 2021 Carrying Amount (1) Outstanding Principal (1) Weighted Average Unleveraged Effective Yield Weighted Average Remaining Life (Years) Senior mortgage loans $ 2,397,655 $ 2,411,718 5.3 % (2) 5.4 % (3) 1.5 Subordinated debt and preferred equity investments 16,728 17,394 13.7 % (2) 13.7 % (3) 4.0 Total loans held for investment portfolio $ 2,414,383 $ 2,429,112 5.4 % (2) 5.5 % (3) 1.6 ______________________________ (1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. (2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of December 31, 2022 and 2021 as weighted by the outstanding principal balance of each loan.
Schedule of current investment portfolio	A more detailed listing of the Company’s loans held for investment portfolio based on information available as of December 31, 2022 is as follows ($ in millions, except percentages): Loan Type Location Outstanding Principal (1) Carrying Amount (1) Interest Rate Unleveraged Effective Yield (2) Maturity Date (3) Payment Terms (4) Senior Mortgage Loans: Office IL $151.5 $151.4 L+3.60% 8.3% Mar 2023 I/O Multifamily NY 130.6 129.3 S+3.90% 8.7% Jun 2025 I/O Office Diversified 118.0 117.7 S+3.75% 8.5% Jan 2024 (5) I/O Multifamily TX 100.0 99.2 S+3.50% 8.2% Jul 2025 I/O Industrial IL 98.2 97.8 L+4.55% 9.4% May 2024 I/O Mixed-use FL 84.0 84.0 L+4.25% 8.6% Feb 2023 I/O Office AZ 77.4 76.8 L+3.50% 8.3% Oct 2024 I/O Mixed-use NY 75.0 74.6 L+3.65% 8.4% Jul 2024 I/O Residential Condominium FL 72.5 72.3 L+5.25% 10.2% Jul 2023 I/O Residential Condominium NY 72.2 71.7 S+8.95% 15.3% Oct 2023 (6) I/O Office NC 69.1 69.0 L+4.25% 9.0% Mar 2023 (7) P/I (8) Office NY 68.2 67.6 L+3.85% 8.6% Aug 2025 I/O Multifamily TX 67.9 67.4 L+2.85% 7.6% Dec 2024 I/O Multifamily/Office SC 67.0 66.8 L+2.90% 7.6% Nov 2024 I/O Office NC 66.5 66.0 S+3.65% 8.5% Aug 2024 I/O Office IL 56.9 55.0 S+3.95% —% Jun 2023 (9) I/O Office IL 56.0 55.5 S+4.25% 9.1% Jan 2025 I/O Office GA 48.7 48.6 S+3.15% 7.8% Dec 2023 (10) I/O Hotel CA 40.0 40.0 L+4.12% 9.0% Jan 2023 I/O Hotel CA 39.5 39.1 S+4.20% 9.0% Mar 2025 I/O Mixed-use CA 37.9 37.9 L+4.10% 9.1% Mar 2023 I/O Mixed-use TX 35.3 35.2 S+3.85% (11) 8.5% Sep 2024 (11) I/O Hotel IL 35.0 29.8 S+4.00% —% (12) May 2024 (12) I/O Student Housing CA 34.5 34.5 S+3.95% 8.3% Jul 2023 (13) I/O Hotel NY 34.0 33.5 S+4.40% 9.2% Mar 2026 I/O Office CA 33.2 33.1 L+3.35% 8.5% Mar 2023 (14) I/O Multifamily CA 31.7 31.5 L+2.90% 7.6% Dec 2025 I/O Office IL 30.2 30.2 L+3.80% 8.8% Jan 2023 I/O Multifamily PA 29.3 29.3 S+4.00% (15) 8.6% Dec 2023 (15) I/O Industrial FL 25.5 25.4 L+2.90% 7.6% Dec 2025 I/O Industrial CO 24.5 24.5 (16) 12.2% Feb 2023 I/O Office MA 23.7 23.0 S+3.75% 9.6% Apr 2025 I/O Industrial NJ 23.3 23.1 L+3.75% 8.9% May 2024 I/O Multifamily WA 23.1 23.0 L+2.90% 7.5% Nov 2025 I/O Office CA 22.8 22.8 S+3.50% 8.1% Nov 2023 I/O Multifamily TX 22.2 22.1 L+2.50% 7.3% Oct 2024 I/O Industrial CA 19.6 19.6 L+3.75% 8.7% Mar 2023 I/O Student Housing AL 19.5 19.4 L+3.85% 8.6% May 2024 I/O Multifamily WA 18.8 18.7 L+3.00% 7.8% Mar 2023 I/O Self Storage PA 17.9 17.7 L+2.90% 7.6% Dec 2025 I/O Self Storage NJ 17.6 17.3 S+2.90% 8.0% Apr 2025 I/O Residential CA 14.3 14.3 13.00% —% (17) May 2021 (17) I/O Self Storage WA 11.5 11.3 S+2.90% 8.0% Mar 2025 I/O Industrial TX 10.4 10.3 L+5.25% 10.0% Dec 2024 I/O Industrial FL 9.5 9.4 L+4.75% 10.7% Nov 2024 I/O Self Storage MA 8.5 8.5 L+2.90% 7.5% Dec 2024 I/O Industrial PA 8.0 8.0 L+5.50% 10.3% Sep 2024 I/O Self Storage TX 8.0 8.0 L+2.90% 7.5% Aug 2024 I/O Self Storage MA 7.7 7.7 L+2.90% 7.5% Nov 2024 I/O Industrial PA 7.0 6.9 L+5.90% 10.7% Nov 2024 I/O Industrial TN 6.7 6.6 L+5.50% 10.3% Nov 2024 I/O Self Storage MA 6.5 6.5 L+2.90% 7.5% Oct 2024 I/O Self Storage MO 6.5 6.5 L+3.00% 7.5% Dec 2023 I/O Self Storage NJ 5.9 5.9 L+2.90% 7.7% Jul 2024 I/O Self Storage IL 5.6 5.6 L+3.00% 7.7% Dec 2023 I/O Industrial FL 4.7 4.6 S+5.75% 10.5% Mar 2025 I/O Self Storage TX 2.9 2.9 L+2.90% 7.4% Sep 2024 I/O Industrial GA 1.3 1.3 L+5.25% 10.0% Sep 2024 I/O Subordinated Debt and Preferred Multifamily SC 20.6 20.4 S+9.53% 14.3% Sep 2025 I/O Office NJ 18.4 17.9 12.00% 13.6% Jan 2026 I/O Total/Weighted Average $2,282.8 $2,264.0 8.5% _________________________ (1) The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 14 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected. (2) Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR or SOFR as of December 31, 2022 or the LIBOR or SOFR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of December 31, 2022 as weighted by the outstanding principal balance of each loan. (3) Certain loans are subject to contractual extension options that generally vary between one and two 12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications. (4) I/O = interest only, P/I = principal and interest. (5) In December 2022, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior diversified loan to January 2024. (6) This senior mortgage loan refinanced the previously existing $53.3 million senior mortgage loan that was held by the Company. The senior New York loan is currently in default due to the failure of the borrower to reach certain construction milestones. (7) In March 2022, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior North Carolina loan to March 2023. (8) In April 2022, amortization began on the senior North Carolina loan, which had an outstanding principal balance of $69.1 million as of December 31, 2022. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms. (9) Loan was on non-accrual status as of December 31, 2022 and the Unleveraged Effective Yield is not applicable. In May 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, amend the interest rate from L + 3.95% to S + 3.95% and extend the maturity date on the senior Illinois loan from June 2022 to June 2023. For the year ended December 31, 2022, the Company received $3.5 million of interest payments in cash on the senior Illinois loan that was recognized either as interest income or as a reduction to the carrying value of the loan and the borrower is current on all contractual interest payments. (10) In October 2022, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Georgia loan to December 2023. (11) In September 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, amend the interest rate from L + 3.75% to S + 3.85% and extend the maturity date on the senior Texas loan from September 2022 to September 2024. (12) Loan was on non-accrual status as of December 31, 2022 and the Unleveraged Effective Yield is not applicable. In March 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, amend the interest rate from L + 4.40% to S + 4.00% and extend the maturity date on the senior Illinois loan from May 2022 to May 2024. For the year ended December 31, 2022, the Company received $1.8 million of interest payments in cash on the senior Illinois loan that was recognized either as interest income or as a reduction to the carrying value of the loan and the borrower is current on all contractual interest payments. However, the senior Illinois loan is currently in default due to the failure of the borrower to make certain contractual reserve deposits by the May 2022 due date. (13) In May 2022, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior California loan to July 2023. (14) In November 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the senior California loan from November 2022 to March 2023. (15) In December 2022, the Company and the borrower entered into a modification and extension agreement to, among other things, amend the interest rate from L + 3.00% to S + 4.00% and extend the maturity date on the senior Pennsylvania loan from December 2022 to December 2023. (16) At origination, the Colorado loan was structured as a senior loan and in January 2022, the Company also originated the mezzanine loan. The senior loan, which had an outstanding principal balance of $20.8 million as of December 31, 2022, accrues interest at a per annum rate of L + 6.75% and the mezzanine loan, which had an outstanding principal balance of $3.8 million as of December 31, 2022, accrues interest at a per annum rate of S + 8.50%. (17) Loan was on non-accrual status as of December 31, 2022 and the Unleveraged Effective Yield is not applicable. As of December 31, 2022, the senior California loan, which is collateralized by a residential property, is in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the May 2021 maturity date. As of December 31, 2022, the Company has elected to assign a specific CECL reserve on the senior California loan. See Note 4 included in these consolidated financial statements for more information. See Note 17 included in these consolidated financial statements for a subsequent event related to the senior California loan.
Schedule of activity in loan portfolio	For the years ended December 31, 2022 and 2021, the activity in the Company’s loan portfolio was as follows ($ in thousands): Balance at December 31, 2020 $ 1,815,219 Initial funding 1,166,100 Origination fees and discounts, net of costs (12,192) Additional funding 93,973 Amortizing payments (2,586) Loan payoffs (654,564) Origination fee and discount accretion 8,433 Balance at December 31, 2021 $ 2,414,383 Initial funding 578,652 Origination fees and discounts, net of costs (9,577) Additional funding 96,057 Amortizing payments (4,333) Loan payoffs (821,513) Origination fee and discount accretion 10,339 Balance at December 31, 2022 $ 2,264,008

CURRENT EXPECTED CREDIT LOSSES

CURRENT EXPECTED CREDIT LOSSES (Tables)	12 Months Ended
	Dec. 31, 2022
Credit Loss [Abstract]
Financing receivable, allowance for credit loss	Activity related to the CECL Reserve for outstanding balances on the Company’s loans held for investment as of and for the years ended December 31, 2022 and 2021 was as follows ($ in thousands): Balance at December 31, 2020 (1) $ 23,604 Provision for current expected credit losses 335 Write-offs — Recoveries — Balance at December 31, 2021 (1) $ 23,939 Provision for current expected credit losses 42,030 Write-offs — Recoveries — Balance at December 31, 2022 (1) $ 65,969 __________________________ (1) The CECL Reserve related to outstanding balances on loans held for investment is recorded within current expected credit loss reserve in the Company's consolidated balance sheets. Current Expected Credit Loss Reserve for Unfunded Loan Commitments Activity related to the CECL Reserve for unfunded commitments on the Company’s loans held for investment as of and for the years ended December 31, 2022 and 2021 was as follows ($ in thousands): Balance at December 31, 2020 (1) $ 1,633 Provision for current expected credit losses (325) Write-offs — Recoveries — Balance at December 31, 2021 (1) $ 1,308 Provision for current expected credit losses 4,031 Write-offs — Recoveries — Balance at December 31, 2022 (1) $ 5,339 __________________________ (1) The CECL Reserve related to unfunded commitments on loans held for investment is recorded within other liabilities in the Company's consolidated balance sheets.
Schedule of company loan risk definitions	Based on a 5-point scale, the Company’s loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows: Ratings Definition 1 Very Low Risk 2 Low Risk 3 Medium Risk 4 High Risk/Potential for Loss: Asset performance is trailing underwritten expectations. Loan at risk of impairment without material improvement to performance 5 Impaired/Loss Likely: A loan that has a significantly increased probability of default and principal loss
Financing receivable credit quality indicators	As of December 31, 2022, the carrying value, excluding the CECL Reserve, of the Company’s loans held for investment within each risk rating by year of origination is as follows ($ in thousands): 2022 2021 2020 2019 2018 Prior Total Risk rating: 1 $ 13,536 $ 27,684 $ — $ — $ — $ — $ 41,220 2 34,706 323,544 — — 22,802 34,460 415,512 3 442,153 461,706 136,456 256,359 29,280 40,000 1,365,954 4 71,709 — 189,348 63,289 84,807 17,845 426,998 5 — — — — 14,324 — 14,324 Total $ 562,104 $ 812,934 $ 325,804 $ 319,648 $ 151,213 $ 92,305 $ 2,264,008

REAL ESTATE OWNED (Tables)

REAL ESTATE OWNED (Tables)	12 Months Ended
	Dec. 31, 2022
Real Estate Owned [Abstract]
Schedule of real estate properties	The following table summarizes the Company’s real estate owned as of December 31, 2021 ($ in thousands): Land $ 10,200 Buildings and improvements 24,281 Furniture, fixtures and equipment 4,506 38,987 Less: Accumulated depreciation (2,385) Real estate owned, net $ 36,602

DEBT (Tables)

DEBT (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Schedule of outstanding balances and total commitments under financing agreements	As of December 31, 2022 and 2021, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands): As of December 31, 2022 2021 Outstanding Balance Total Outstanding Balance Total Secured Funding Agreements: Wells Fargo Facility $ 270,798 $ 450,000 (1) $ 399,528 $ 450,000 (1) Citibank Facility 236,240 325,000 192,970 325,000 CNB Facility — 75,000 — 75,000 MetLife Facility — 180,000 20,648 180,000 Morgan Stanley Facility 198,193 250,000 226,901 250,000 Subtotal $ 705,231 $ 1,280,000 $ 840,047 $ 1,280,000 Notes Payable $ 105,000 $ 105,000 $ 51,110 $ 51,755 Secured Term Loan $ 150,000 $ 150,000 $ 150,000 $ 150,000 Total $ 960,231 $ 1,535,000 $ 1,041,157 $ 1,481,755 ______________________________ (1) The maximum commitment for the Wells Fargo Facility (as defined below) may be increased to up to $500.0 million at the Company’s option, subject to the satisfaction of certain conditions, including payment of an upsize fee.
Schedule of maturities of long-term debt	At December 31, 2022, approximate principal maturities of the Company’s Financing Agreements are as follows ($ in thousands): Wells Fargo Citibank CNB Facility MetLife Facility Morgan Stanley Facility Notes Payable Secured Term Loan Total 2023 $ — $ — $ — $ — $ — $ — $ — $ — 2024 — — — — 198,193 — — 198,193 2025 270,798 236,240 — — 105,000 — 612,038 2026 — — — — 150,000 150,000 2027 — — — — — — — — Thereafter — — — — — — — — $ 270,798 $ 236,240 $ — $ — $ 198,193 $ 105,000 $ 150,000 $ 960,231

DERIVATIVE FINANCIAL INSTRUME_2

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of interest rate derivatives	The following tables detail our outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk as of December 31, 2022 and 2021 (notional amount in thousands): As of December 31, 2022 December 31, 2021 Interest Rate Derivatives Number of Instruments Notional Amount Rate (1) Index Weighted Average Maturity (Years) Number of Instruments Notional Amount Rate (1) Index Weighted Average Maturity (Years) Interest rate swaps 1 $410,000 0.2075% LIBOR (2) 0.4 1 $700,000 0.2075% LIBOR (2) 1.0 Interest rate caps 0 (3) $— — — — 1 $220,000 0.5000% LIBOR 1.0 _______________________________ (1) Represents fixed rate for interest rate swaps and strike rate for interest rate caps. (2) Subject to a 0.00% floor. (3) In March 2022, the Company re-calibrated its net exposure to interest rate changes by terminating its interest rate cap derivative, which had a notional amount of $170.0 million on the termination date and a strike rate of 0.50%. For the year ended December 31, 2022, the Company recognized a $2.0 million realized gain within OCI in conjunction with the termination of the interest rate cap. In accordance with ASC 815, the realized gain will be recognized within current earnings over the remaining original term of the interest rate cap derivative as it was designated as an effective hedge. For the year ended December 31, 2022, the Company recognized a realized gain of $1.0 million through a reduction in interest expense, on the termination of the interest rate cap within current earnings.
Schedule of derivative assets at fair value	The following table summarizes the fair value of our derivative financial instruments ($ in thousands): Fair Value of Derivatives in an Asset Position (1) as of Fair Value of Derivatives in a Liability Position (2) as of December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Derivatives designated as hedging instruments: Interest rate derivatives $ 6,565 $ 2,979 $ — $ — ____________________________ (1) Included in other assets in the Company’s consolidated balance sheets. (2) Included in other liabilities in the Company’s consolidated balance sheets.

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of loan commitments	As of December 31, 2022 and 2021, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands): As of December 31, 2022 2021 Total commitments $ 2,510,308 $ 2,662,853 Less: funded commitments (2,282,821) (2,429,112) Total unfunded commitments $ 227,487 $ 233,741

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of restricted stock award activity	The following tables summarize the (i) non-vested shares of restricted stock and RSUs and (ii) vesting schedule of shares of restricted stock and RSUs for the Company’s directors and officers and employees of the Manager as of December 31, 2022: Schedule of Non-Vested Share and Share Equivalents Restricted Stock Grants—Directors Restricted Stock Grants—Officers and Employees of the Manager RSUs—Officers and Employees of the Manager Total Balance at December 31, 2021 16,640 25,373 497,161 539,174 Granted 24,780 — 434,150 458,930 Vested (25,283) (25,373) (84,776) (135,432) Forfeited — — (14,063) (14,063) Balance at December 31, 2022 16,137 — 832,472 848,609
Future anticipated vesting schedule of restricted stock awards	Future Anticipated Vesting Schedule Restricted Stock Grants—Directors Restricted Stock Grants—Officers and Employees of the Manager RSUs—Officers and Employees of the Manager Total 2023 14,052 — 168,274 182,326 2024 1,668 — 285,405 287,073 2025 417 — 234,097 234,514 2026 — — 144,696 144,696 2027 — — — — Total 16,137 — 832,472 848,609
Schedule of restricted stock and restricted stock unit, activity	The following table summarizes the restricted stock and RSU compensation expense included within general and administrative expenses in the Company’s consolidated statements of operations, the total fair value of shares vested and the weighted average grant date fair value of the restricted stock and RSUs granted to the Company’s directors and officers and employees of the Manager for the years ended December 31, 2022, 2021 and 2020 ($ in thousands): For the years ended December 31, 2022 2021 2020 Restricted Stock and RSU Grants Restricted Stock and RSU Grants Restricted Stock and RSU Grants Directors Officers and Employees of the Manager Total Directors Officers and Employees of the Manager Total Directors Officers and Employees of the Manager Total Compensation expense $ 399 $ 2,477 $ 2,876 $ 329 $ 1,611 $ 1,940 $ 319 $ 1,020 $ 1,339 Total fair value of shares vested (1) 338 1,623 1,961 460 1,009 1,469 315 849 1,164 Weighted average grant date fair value 390 4,654 5,044 403 4,255 4,658 292 2,898 3,190 ___________________________ (1) Based on the closing price of the Company’s common stock on the NYSE on each vesting date.

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of computations of basic and diluted earnings per share	The following information sets forth the computations of basic and diluted earnings per common share for the years ended December 31, 2022, 2021 and 2020 ($ in thousands, except share and per share data): For the years ended December 31, 2022 2021 2020 Net income attributable to common stockholders $ 29,785 $ 60,460 $ 21,840 Divided by: Basic weighted average shares of common stock outstanding: 51,679,744 42,399,613 32,977,462 Weighted average non-vested restricted stock and RSUs 446,512 281,892 219,046 Diluted weighted average shares of common stock outstanding: 52,126,256 42,681,505 33,196,508 Basic earnings per common share $ 0.58 $ 1.43 $ 0.66 Diluted earnings per common share $ 0.57 $ 1.42 $ 0.66

INCOME TAX (Tables)

INCOME TAX (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of components of the TRS's income tax provision	The income tax provision for the Company and the TRSs consisted of the following for the years ended December 31, 2022, 2021 and 2020 ($ in thousands): For the years ended December 31, 2022 2021 2020 Current $ 42 $ 450 $ 82 Deferred — — (99) Excise tax 430 272 369 Total income tax expense, including excise tax $ 472 $ 722 $ 352

FAIR VALUE (Tables)

FAIR VALUE (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Debt Securities, Available-for-Sale	The following table summarizes the Company’s investments in available-for-sale debt securities as of December 31, 2022 ($ in thousands): Face Amount Amortized Cost Unamortized Discount Unrealized Gain (Loss), Net Available-for-sale debt securities $ 28,000 $ 27,881 $ 119 $ 55
Fair value, assets measured on recurring basis	The following tables summarize the financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 and 2021 ($ in thousands): As of December 31, 2022 Level 1 Level 2 Level 3 Total Financial assets: Interest rate derivatives $ — $ 6,565 $ — $ 6,565 Available-for-sale debt securities $ — $ 27,936 $ — $ 27,936 Financial liabilities: Interest rate derivatives $ — $ — $ — $ — As of December 31, 2021 Level 1 Level 2 Level 3 Total Financial assets: Interest rate derivatives $ — $ 2,979 $ — $ 2,979 Financial liabilities: Interest rate derivatives $ — $ — $ — $ —
Fair value, liabilities measured on recurring basis	The following tables summarize the financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 and 2021 ($ in thousands): As of December 31, 2022 Level 1 Level 2 Level 3 Total Financial assets: Interest rate derivatives $ — $ 6,565 $ — $ 6,565 Available-for-sale debt securities $ — $ 27,936 $ — $ 27,936 Financial liabilities: Interest rate derivatives $ — $ — $ — $ — As of December 31, 2021 Level 1 Level 2 Level 3 Total Financial assets: Interest rate derivatives $ — $ 2,979 $ — $ 2,979 Financial liabilities: Interest rate derivatives $ — $ — $ — $ —
Schedule of carrying value and estimated fair value of the Company's financial instruments not carried at fair value on the consolidated balance sheet	As of December 31, 2022 and 2021, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands): As of December 31, 2022 2021 Level in Fair Value Hierarchy Carrying Value Fair Carrying Value Fair Financial assets: Loans held for investment 3 $ 2,264,008 $ 2,233,319 $ 2,414,383 $ 2,408,463 Financial liabilities: Secured funding agreements 2 $ 705,231 $ 705,231 $ 840,047 $ 840,047 Notes payable 3 104,460 103,635 50,358 51,110 Secured term loan 3 149,200 137,571 149,016 150,000 Collateralized loan obligation securitization debt (consolidated VIEs) 3 777,675 749,242 861,188 863,403 Secured borrowings 3 — — 22,589 22,715

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Summary of related-party costs incurred by the company and amounts payable to the Manager	The following table summarizes the related party costs incurred by the Company for the years ended December 31, 2022, 2021 and 2020 and amounts payable to the Company’s Manager as of December 31, 2022 and 2021 ($ in thousands): Incurred Payable For the years ended December 31, As of December 31, 2022 2021 2020 2022 2021 Affiliate Payments Management fees $ 11,456 $ 9,384 $ 7,323 $ 3,026 $ 2,613 Incentive fees 3,442 2,752 836 1,264 830 General and administrative expenses 3,777 3,016 3,653 1,232 703 Direct costs(1) 165 9 100 58 10 Total $ 18,840 $ 15,161 $ 11,912 $ 5,580 $ 4,156 _______________________________

DIVIDENDS AND DISTRIBUTIONS (Ta

DIVIDENDS AND DISTRIBUTIONS (Tables)	12 Months Ended
	Dec. 31, 2022
DIVIDENDS AND DISTRIBUTIONS
Summary of the company's dividends declared	The following table summarizes the Company’s dividends declared during the years ended December 31, 2022, 2021 and 2020 ($ in thousands, except per share data): Date Declared Record Date Payment Date Per Share Amount Total Amount November 2, 2022 December 30, 2022 January 18, 2023 $ 0.35 (1) $ 19,347 July 29, 2022 September 30, 2022 October 17, 2022 0.35 (1) 19,196 May 3, 2022 June 30, 2022 July 15, 2022 0.35 (1) 19,198 February 15, 2022 March 31, 2022 April 14, 2022 0.35 (1) 16,740 Total cash dividends declared for the year ended December 31, 2022 $ 1.40 $ 74,481 November 3, 2021 December 31, 2021 January 19, 2022 $ 0.35 (1) $ 16,674 July 30, 2021 September 30, 2021 October 15, 2021 0.35 (1) 16,524 May 4, 2021 June 30, 2021 July 15, 2021 0.35 (1) 16,528 February 17, 2021 March 31, 2021 April 15, 2021 0.35 (1) 14,248 Total cash dividends declared for the year ended December 31, 2021 $ 1.40 $ 63,974 December 15, 2020 December 30, 2020 January 15, 2021 $ 0.33 $ 11,124 September 16, 2020 September 30, 2020 October 15, 2020 0.33 11,072 June 19, 2020 June 30, 2020 July 15, 2020 0.33 11,072 February 20, 2020 March 31, 2020 April 15, 2020 0.33 11,057 Total cash dividends declared for the year ended December 31, 2020 $ 1.32 $ 44,325

ORGANIZATION (Details)

ORGANIZATION (Details)	12 Months Ended
	Dec. 31, 2022 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	1

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Reserve for uncertain tax positions	$ 0	$ 0
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Useful life (in years)	15 years
Maximum | Buildings and improvements
Property, Plant and Equipment [Line Items]
Useful life (in years)	40 years

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Interest expense		$ 65,994	$ 50,080	$ 51,949
Secured funding agreements
Debt Instrument [Line Items]
Interest expense		33,602	16,403	28,003
Notes Payable
Debt Instrument [Line Items]
Interest expense		3,410	2,275	1,317
Securitization debt
Debt Instrument [Line Items]
Interest expense		29,341	20,104	12,384
Secured term loan
Debt Instrument [Line Items]
Interest expense		7,028	4,353	7,114
Secured borrowings
Debt Instrument [Line Items]
Interest expense		845	6,145	3,131
Other
Debt Instrument [Line Items]
Other		$ (8,232)	$ 800	$ 0
Notes Payable, Due June 10, 2024 | Notes Payable | NEW YORK
Debt Instrument [Line Items]
Interest expense from real estate owned	$ 28,300

LOANS HELD FOR INVESTMENT - Nar

LOANS HELD FOR INVESTMENT - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) loan	Dec. 31, 2021 USD ($) loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of loans originated or co-originated | loan	60
Number of loans repaid or sold, since inception | loan	150
Total commitment	$ 2,600
Loans held for investment	2,300
Amount funded	676.9
Amount of repayments	$ 823.2
Percentage of loans held for investment having LIBOR floors	90.20%
Weighted average floor (as a percent)	0.95%
Impact of COVID-19
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of loans in non-accrual status | loan	3	2
Financing receivable, nonaccrual	$ 99.1	$ 45

LOANS HELD FOR INVESTMENT - Loa

LOANS HELD FOR INVESTMENT - Loans held for Investments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Loans held for investment	$ 2,264,008	$ 2,414,383
Outstanding Principal	$ 2,282,821	$ 2,429,112
Weighted Average Unleveraged Effective Yield, Including Non-accrual Loans	8.50%	5.40%
Weighted Average Unleveraged Effective Yield, Excluding Non-accrual Loans	8.90%	5.50%
Weighted Average Remaining Life (Years)	1 year 4 months 24 days	1 year 7 months 6 days
Senior mortgage loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Loans held for investment	$ 2,225,725	$ 2,397,655
Outstanding Principal	$ 2,243,818	$ 2,411,718
Weighted Average Unleveraged Effective Yield, Including Non-accrual Loans	8.40%	5.30%
Weighted Average Unleveraged Effective Yield, Excluding Non-accrual Loans	8.80%	5.40%
Weighted Average Remaining Life (Years)	1 year 3 months 18 days	1 year 6 months
Subordinated debt and preferred equity investments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Loans held for investment	$ 38,283	$ 16,728
Outstanding Principal	$ 39,003	$ 17,394
Weighted Average Unleveraged Effective Yield, Including Non-accrual Loans	14%	13.70%
Weighted Average Unleveraged Effective Yield, Excluding Non-accrual Loans	14%	13.70%
Weighted Average Remaining Life (Years)	2 years 9 months 18 days	4 years

LOANS HELD FOR INVESTMENT - Inv

LOANS HELD FOR INVESTMENT - Investment Portfolio (Details) $ in Thousands	1 Months Ended		12 Months Ended
	May 31, 2022	Mar. 31, 2022	Dec. 31, 2022 USD ($) option	Sep. 30, 2022	Jul. 31, 2022	Dec. 31, 2021 USD ($)	Mar. 08, 2019 USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 2,282,821			$ 2,429,112
Loans held for investment			$ 2,264,008			2,414,383
Unleveraged effective yield			8.50%
Minimum
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of extension options | option			1
Maximum
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of extension options | option			2
Extension period of maturity date			12 months
SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate					2%
Office | Senior Mortgage Loans | IL | LIBOR Plus 3.60% Due Mar 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 151,500
Loans held for investment			$ 151,400
Unleveraged effective yield			8.30%
Office | Senior Mortgage Loans | IL | LIBOR Plus 3.60% Due Mar 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.60%
Office | Senior Mortgage Loans | IL | SOFR Plus 3.95% Due Jun 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 56,900
Loans held for investment			$ 55,000
Unleveraged effective yield			0%
Office | Senior Mortgage Loans | IL | SOFR Plus 3.95% Due Jun 2023 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.95%
Interest income			$ 3,500
Office | Senior Mortgage Loans | IL | SOFR Plus 4.25%, Due Jan 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			56,000
Loans held for investment			$ 55,500
Basis spread on variable rate			4.25%
Unleveraged effective yield			9.10%
Office | Senior Mortgage Loans | IL | LIBOR Plus 3.80% Due Jan 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 30,200
Loans held for investment			$ 30,200
Basis spread on variable rate			3.80%
Unleveraged effective yield			8.80%
Office | Senior Mortgage Loans | IL | LIBOR Plus 3.95%, Due Jun 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	395%
Office | Senior Mortgage Loans | NY | LIBOR Plus 3.85% Due Aug 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 68,200
Loans held for investment			$ 67,600
Unleveraged effective yield			8.60%
Office | Senior Mortgage Loans | NY | LIBOR Plus 3.85% Due Aug 2025 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.85%
Office | Senior Mortgage Loans | Diversified | SOFR Plus 3.75% Due Jan 2024 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 118,000
Loans held for investment			$ 117,700
Basis spread on variable rate			3.75%
Unleveraged effective yield			8.50%
Office | Senior Mortgage Loans | AZ | LIBOR Plus 3.50% Due Oct 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 77,400
Loans held for investment			$ 76,800
Unleveraged effective yield			8.30%
Office | Senior Mortgage Loans | AZ | LIBOR Plus 3.50% Due Oct 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.50%
Office | Senior Mortgage Loans | NC | LIBOR Plus 4.25% Due Mar2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Extension option period exercised (in years)		1 year
Office | Senior Mortgage Loans | NC | LIBOR Plus 4.25% Due Mar2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 69,100
Loans held for investment			$ 69,000
Basis spread on variable rate			4.25%
Unleveraged effective yield			9%
Office | Senior Mortgage Loans | NC | SOFR Plus 3.65% Due Aug 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 66,500
Loans held for investment			$ 66,000
Unleveraged effective yield			8.50%
Office | Senior Mortgage Loans | NC | SOFR Plus 3.65% Due Aug 2024 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.65%
Office | Senior Mortgage Loans | GA | SOFR Plus 3.15%, Due Dec 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 48,700
Loans held for investment			$ 48,600
Unleveraged effective yield			7.80%
Office | Senior Mortgage Loans | GA | SOFR Plus 3.15%, Due Dec 2023 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.15%
Office | Senior Mortgage Loans | CA | LIBOR Plus 3.35% Due Mar 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 33,200
Loans held for investment			$ 33,100
Unleveraged effective yield			8.50%
Office | Senior Mortgage Loans | CA | LIBOR Plus 3.35% Due Mar 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.35%
Office | Senior Mortgage Loans | CA | SOFR Plus 3.50% Due Nov 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 22,800
Loans held for investment			$ 22,800
Unleveraged effective yield			8.10%
Office | Senior Mortgage Loans | CA | SOFR Plus 3.50% Due Nov 2023 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.50%
Office | Senior Mortgage Loans | MA | SOFR Plus 3.75% Due Apr 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 23,700
Loans held for investment			$ 23,000
Unleveraged effective yield			9.60%
Office | Senior Mortgage Loans | MA | SOFR Plus 3.75% Due Apr 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.75%
Office | Subordinated debt and preferred equity investments | NJ
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 18,400
Loans held for investment			$ 17,900
Fixed interest rate			12%
Unleveraged effective yield			13.60%
Multifamily | Senior Mortgage Loans | NY | SOFR Plus 3.90%, Due Jun 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 130,600
Loans held for investment			$ 129,300
Basis spread on variable rate			3.90%
Unleveraged effective yield			8.70%
Multifamily | Senior Mortgage Loans | TX | SOFR Plus 3.50% Due Jul 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 100,000
Loans held for investment			$ 99,200
Basis spread on variable rate			3.50%
Unleveraged effective yield			8.20%
Multifamily | Senior Mortgage Loans | TX | LIBOR Plus 2.85% Due Dec 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 67,900
Loans held for investment			$ 67,400
Unleveraged effective yield			7.60%
Multifamily | Senior Mortgage Loans | TX | LIBOR Plus 2.85% Due Dec 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.85%
Multifamily | Senior Mortgage Loans | TX | LIBOR Plus 2.50% Due Oct 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 22,200
Loans held for investment			$ 22,100
Unleveraged effective yield			7.30%
Multifamily | Senior Mortgage Loans | TX | LIBOR Plus 2.50% Due Oct 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.50%
Multifamily | Senior Mortgage Loans | CA | LIBOR Plus 2.90% Due Dec 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 31,700
Loans held for investment			$ 31,500
Unleveraged effective yield			7.60%
Multifamily | Senior Mortgage Loans | CA | LIBOR Plus 2.90% Due Dec 2025 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Multifamily | Senior Mortgage Loans | PA | SOFR Plus 4.00% Due Dec 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 29,300
Loans held for investment			$ 29,300
Unleveraged effective yield			8.60%
Multifamily | Senior Mortgage Loans | PA | SOFR Plus 4.00% Due Dec 2023 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate		4%	4%
Multifamily | Senior Mortgage Loans | PA | LIBOR Plus 3 .00% Due Dec 2022 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3%
Multifamily | Senior Mortgage Loans | WA | LIBOR Plus 2 .90% Due Nov 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 23,100
Loans held for investment			$ 23,000
Unleveraged effective yield			7.50%
Multifamily | Senior Mortgage Loans | WA | LIBOR Plus 2 .90% Due Nov 2025 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Multifamily | Senior Mortgage Loans | WA | LIBOR Plus 3.00% Due Mar 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 18,800
Loans held for investment			$ 18,700
Unleveraged effective yield			7.80%
Multifamily | Senior Mortgage Loans | WA | LIBOR Plus 3.00% Due Mar 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3%
Multifamily | Subordinated debt and preferred equity investments | SC | SOFR Plus 9.53%, Due Sep 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 20,600
Loans held for investment			$ 20,400
Unleveraged effective yield			14.30%
Multifamily | Subordinated debt and preferred equity investments | SC | SOFR Plus 9.53%, Due Sep 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Fixed interest rate			9.53%
Industrial | Senior Mortgage Loans | IL | LIBOR Plus 4.55% Due May 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 98,200
Loans held for investment			$ 97,800
Unleveraged effective yield			9.40%
Industrial | Senior Mortgage Loans | IL | LIBOR Plus 4.55% Due May 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			4.55%
Industrial | Senior Mortgage Loans | IL | LIBOR Plus 3.00% Due Dec 2023, Instrument 1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 5,600
Loans held for investment			$ 5,600
Unleveraged effective yield			7.70%
Industrial | Senior Mortgage Loans | IL | LIBOR Plus 3.00% Due Dec 2023, Instrument 1 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3%
Industrial | Senior Mortgage Loans | TX | LIBOR Plus 5.25% Due Dec 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 10,400
Loans held for investment			$ 10,300
Unleveraged effective yield			10%
Industrial | Senior Mortgage Loans | TX | LIBOR Plus 5.25% Due Dec 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Fixed interest rate			5.25%
Industrial | Senior Mortgage Loans | FL | LIBOR Plus 2.90% Due Dec 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 25,500
Loans held for investment			$ 25,400
Unleveraged effective yield			7.60%
Industrial | Senior Mortgage Loans | FL | LIBOR Plus 2.90% Due Dec 2025 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Industrial | Senior Mortgage Loans | FL | LIBOR Plus 4 .75% Due Nov 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 9,500
Loans held for investment			$ 9,400
Unleveraged effective yield			10.70%
Industrial | Senior Mortgage Loans | FL | LIBOR Plus 4 .75% Due Nov 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			4.75%
Industrial | Senior Mortgage Loans | FL | SOFR Plus 5.75% Due Mar 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 4,700
Loans held for investment			$ 4,600
Unleveraged effective yield			10.50%
Industrial | Senior Mortgage Loans | FL | SOFR Plus 5.75% Due Mar 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			5.75%
Industrial | Senior Mortgage Loans | GA | LIBOR Plus 5.25% Due Sep 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 1,300
Loans held for investment			$ 1,300
Unleveraged effective yield			10%
Industrial | Senior Mortgage Loans | GA | LIBOR Plus 5.25% Due Sep 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			5.25%
Industrial | Senior Mortgage Loans | CA | LIBOR Plus 3.75% Due Mar 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 19,600
Loans held for investment			$ 19,600
Unleveraged effective yield			8.70%
Industrial | Senior Mortgage Loans | CA | LIBOR Plus 3.75% Due Mar 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.75%
Industrial | Senior Mortgage Loans | PA | LIBOR Plus 5.50% Due Sep 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 8,000
Loans held for investment			$ 8,000
Unleveraged effective yield			10.30%
Industrial | Senior Mortgage Loans | PA | LIBOR Plus 5.50% Due Sep 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			5.50%
Industrial | Senior Mortgage Loans | CO
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 24,500
Loans held for investment			$ 24,500
Unleveraged effective yield			12.20%
Industrial | Senior Mortgage Loans | CO | LIBOR Plus 6.75% Due Feb 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Loans held for investment			$ 20,800
Industrial | Senior Mortgage Loans | CO | LIBOR Plus 6.75% Due Feb 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			6.75%
Industrial | Senior Mortgage Loans | CO | SOFR Plus 8.50% Due Feb 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Loans held for investment			$ 3,800
Industrial | Senior Mortgage Loans | CO | SOFR Plus 8.50% Due Feb 2023 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			8.50%
Industrial | Senior Mortgage Loans | MA | LIBOR Plus 2.90% Due Nov 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 7,700
Loans held for investment			$ 7,700
Unleveraged effective yield			7.50%
Industrial | Senior Mortgage Loans | MA | LIBOR Plus 2.90% Due Nov 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Industrial | Senior Mortgage Loans | NJ | LIBOR Plus 3.75%, Due May 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 23,300
Loans held for investment			$ 23,100
Unleveraged effective yield			8.90%
Industrial | Senior Mortgage Loans | NJ | LIBOR Plus 3.75%, Due May 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.75%
Industrial | Senior Mortgage Loans | TN | LIBOR Plus 5.50% Due Nov 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 6,700
Loans held for investment			$ 6,600
Unleveraged effective yield			10.30%
Industrial | Senior Mortgage Loans | TN | LIBOR Plus 5.50% Due Nov 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			5.50%
Mixed-use | Senior Mortgage Loans | NY | LIBOR Plus 3.65% Due Jul 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 75,000
Loans held for investment			$ 74,600
Unleveraged effective yield			8.40%
Mixed-use | Senior Mortgage Loans | NY | LIBOR Plus 3.65% Due Jul 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.65%
Mixed-use | Senior Mortgage Loans | TX | SOFR Plus 3.85%, Due Sep 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 35,300
Loans held for investment			$ 35,200
Unleveraged effective yield			8.50%
Mixed-use | Senior Mortgage Loans | TX | SOFR Plus 3.85%, Due Sep 2024 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.85%	3.85%
Mixed-use | Senior Mortgage Loans | TX | LIBOR Plus 3.75% Due Sep 2022 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate	375%
Mixed-use | Senior Mortgage Loans | FL | LIBOR Plus 4.25% Due Feb 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 84,000
Loans held for investment			$ 84,000
Unleveraged effective yield			8.60%
Mixed-use | Senior Mortgage Loans | FL | LIBOR Plus 4.25% Due Feb 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			4.25%
Mixed-use | Senior Mortgage Loans | CA | LIBOR Plus 4.10% Due Mar 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 37,900
Loans held for investment			$ 37,900
Basis spread on variable rate			4.10%
Unleveraged effective yield			9.10%
Residential Condominium | Senior Mortgage Loans | NY | SOFR Plus 8.95% Due Oct 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 72,200
Loans held for investment			$ 71,700
Unleveraged effective yield			15.30%
Residential Condominium | Senior Mortgage Loans | NY | SOFR Plus 8.95% Due Oct 2023 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal						$ 53,300
Basis spread on variable rate			8.95%
Residential Condominium | Senior Mortgage Loans | FL | LIBOR Plus 5.25% Due Jul 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 72,500
Loans held for investment			$ 72,300
Unleveraged effective yield			10.20%
Residential Condominium | Senior Mortgage Loans | FL | LIBOR Plus 5.25% Due Jul 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			5.25%
Multifamily/Office | Senior Mortgage Loans | SC | LIBOR Plus 2.90% Due Nov 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 67,000
Loans held for investment			$ 66,800
Basis spread on variable rate			2.90%
Unleveraged effective yield			7.60%
Hotel | Senior Mortgage Loans | IL
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest income			$ 1,800
Hotel | Senior Mortgage Loans | IL | SOFR Plus 4.00% Due May 2024 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			35,000
Loans held for investment			$ 29,800
Basis spread on variable rate		4%	4%
Unleveraged effective yield			0%
Hotel | Senior Mortgage Loans | IL | LIBOR Plus 4.40%, Due May 2022 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate		4.40%
Hotel | Senior Mortgage Loans | NY
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal							$ 38,600
Hotel | Senior Mortgage Loans | NY | LIBOR Plus 4 .40% Due Mar 2026 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 34,000
Loans held for investment			$ 33,500
Basis spread on variable rate			4.40%
Unleveraged effective yield			9.20%
Hotel | Senior Mortgage Loans | CA | LIBOR Plus 4.12% Due Jan 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 40,000
Loans held for investment			$ 40,000
Unleveraged effective yield			9%
Hotel | Senior Mortgage Loans | CA | LIBOR Plus 4.12% Due Jan 2023 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			4.12%
Hotel | Senior Mortgage Loans | CA | SOFR Plus 4.20% Due Mar 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 39,500
Loans held for investment			$ 39,100
Unleveraged effective yield			9%
Hotel | Senior Mortgage Loans | CA | SOFR Plus 4.20% Due Mar 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			4.20%
Student Housing | Senior Mortgage Loans | CA | SOFR Plus 3.95% Due July 2023 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 34,500
Loans held for investment			$ 34,500
Basis spread on variable rate			3.95%
Unleveraged effective yield			8.30%
Extension option period exercised (in years)	1 year
Student Housing | Senior Mortgage Loans | AL | LIBOR Plus 3.85% Due May 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 19,500
Loans held for investment			$ 19,400
Unleveraged effective yield			8.60%
Student Housing | Senior Mortgage Loans | AL | LIBOR Plus 3.85% Due May 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3.85%
Self Storage | Senior Mortgage Loans | TX | LIBOR Plus 2.90% Due Aug 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 8,000
Loans held for investment			$ 8,000
Unleveraged effective yield			7.50%
Self Storage | Senior Mortgage Loans | TX | LIBOR Plus 2.90% Due Aug 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Self Storage | Senior Mortgage Loans | TX | LIBOR Plus 2.90% Due Sep 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 2,900
Loans held for investment			$ 2,900
Unleveraged effective yield			7.40%
Self Storage | Senior Mortgage Loans | TX | LIBOR Plus 2.90% Due Sep 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Self Storage | Senior Mortgage Loans | PA | LIBOR Plus 2.90% Due Dec 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 17,900
Loans held for investment			$ 17,700
Unleveraged effective yield			7.60%
Self Storage | Senior Mortgage Loans | PA | LIBOR Plus 2.90% Due Dec 2025 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Self Storage | Senior Mortgage Loans | PA | LIBOR Plus 5.90% Due Nov 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 7,000
Loans held for investment			$ 6,900
Unleveraged effective yield			10.70%
Self Storage | Senior Mortgage Loans | PA | LIBOR Plus 5.90% Due Nov 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			5.90%
Self Storage | Senior Mortgage Loans | MA | LIBOR Plus 2.90% Due Dec 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 8,500
Loans held for investment			$ 8,500
Unleveraged effective yield			7.50%
Self Storage | Senior Mortgage Loans | MA | LIBOR Plus 2.90% Due Dec 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Self Storage | Senior Mortgage Loans | MA | LIBOR Plus 2.90% Due Oct 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 6,500
Loans held for investment			$ 6,500
Unleveraged effective yield			7.50%
Self Storage | Senior Mortgage Loans | MA | LIBOR Plus 2.90% Due Oct 2024 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Self Storage | Senior Mortgage Loans | NJ | SOFR Plus 2.90% Due April 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 17,600
Loans held for investment			$ 17,300
Unleveraged effective yield			8%
Self Storage | Senior Mortgage Loans | NJ | SOFR Plus 2.90% Due April 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Self Storage | Senior Mortgage Loans | NJ | LIBOR Plus 2.90% Due Dec 2023, Instrument 4
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 5,900
Loans held for investment			$ 5,900
Unleveraged effective yield			7.70%
Self Storage | Senior Mortgage Loans | NJ | LIBOR Plus 2.90% Due Dec 2023, Instrument 4 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			2.90%
Self Storage | Senior Mortgage Loans | WA | SOFR Plus 2.90%, Due March 2025 | SOFR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 11,500
Loans held for investment			$ 11,300
Fixed interest rate			2.90%
Unleveraged effective yield			8%
Self Storage | Senior Mortgage Loans | MO | LIBOR Plus 3.00% Due Dec 2023, Instrument 1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 6,500
Loans held for investment			$ 6,500
Unleveraged effective yield			7.50%
Self Storage | Senior Mortgage Loans | MO | LIBOR Plus 3.00% Due Dec 2023, Instrument 1 | LIBOR
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Basis spread on variable rate			3%
Residential | Senior Mortgage Loans | CA
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding Principal			$ 14,300
Loans held for investment			$ 14,300
Basis spread on variable rate			13%
Unleveraged effective yield			0%

LOANS HELD FOR INVESTMENT - Por

LOANS HELD FOR INVESTMENT - Portfolio Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Change in the activity of loan portfolio
Balance at the beginning of the period	$ 2,414,383	$ 1,815,219
Initial funding	578,652	1,166,100
Origination fees and discounts, net of costs	(9,577)	(12,192)
Additional funding	96,057	93,973
Amortizing payments	(4,333)	(2,586)
Loan payoffs	(821,513)	(654,564)
Origination fee and discount accretion	10,339	8,433
Balance at the end of the period	$ 2,264,008	$ 2,414,383

CURRENT EXPECTED CREDIT LOSSE_2

CURRENT EXPECTED CREDIT LOSSES - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, allowance for credit loss, excluding accrued interest	$ 71,300
Allowance for credit loss, basis points	28,400%
Commitments	$ 2,510,308	$ 2,662,853
Outstanding Principal	2,282,821	2,429,112
Senior Mortgage Loans | Residential | CA
Financing Receivable, Allowance for Credit Loss [Line Items]
Outstanding Principal	14,300
Senior Mortgage Loans | Residential | CA | 5 - Impaired/Loss Likely: A loan that has significantly increased probability of default or principal loss
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, allowance for credit loss, excluding accrued interest	5,600
Outstanding Principal	14,300
Other Assets
Financing Receivable, Allowance for Credit Loss [Line Items]
Interest receivable	14,000	17,100
Loans Held for Investment
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, allowance for credit loss, excluding accrued interest	65,969	23,939	$ 23,604
Unfunded Loan Commitment
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, allowance for credit loss, excluding accrued interest	$ 5,339	$ 1,308	$ 1,633

CURRENT EXPECTED CREDIT LOSSE_3

CURRENT EXPECTED CREDIT LOSSES - Allowance for Credit Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision for current expected credit losses	$ 46,061	$ 10	$ 20,185
Balance at the end of the period	71,300
Loans Held for Investment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at the beginning of the period	23,939	23,604
Provision for current expected credit losses	42,030	335
Write-offs	0	0
Recoveries	0	0
Balance at the end of the period	65,969	23,939	23,604
Unfunded Loan Commitment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at the beginning of the period	1,308	1,633
Provision for current expected credit losses	4,031	(325)
Write-offs	0	0
Recoveries	0	0
Balance at the end of the period	$ 5,339	$ 1,308	$ 1,633

CURRENT EXPECTED CREDIT LOSSE_4

CURRENT EXPECTED CREDIT LOSSES - Internal Credit Risk Rating (Details) - Loans Held for Investment $ in Thousands	Dec. 31, 2022 USD ($)
Financing Receivable, Credit Quality Indicator [Line Items]
2022	$ 562,104
2021	812,934
2020	325,804
2019	319,648
2018	151,213
Prior	92,305
Total	2,264,008
1 - Very Low Risk
Financing Receivable, Credit Quality Indicator [Line Items]
2022	13,536
2021	27,684
2020	0
2019	0
2018	0
Prior	0
Total	41,220
2 - Low Risk
Financing Receivable, Credit Quality Indicator [Line Items]
2022	34,706
2021	323,544
2020	0
2019	0
2018	22,802
Prior	34,460
Total	415,512
3 - Medium Risk
Financing Receivable, Credit Quality Indicator [Line Items]
2022	442,153
2021	461,706
2020	136,456
2019	256,359
2018	29,280
Prior	40,000
Total	1,365,954
4 - High Risk/Potential for Loss: Asset performance is trailing underwritten expectations. Loan at risk of impairment without material improvement to performance
Financing Receivable, Credit Quality Indicator [Line Items]
2022	71,709
2021	0
2020	189,348
2019	63,289
2018	84,807
Prior	17,845
Total	426,998
5 - Impaired/Loss Likely: A loan that has significantly increased probability of default or principal loss
Financing Receivable, Credit Quality Indicator [Line Items]
2022	0
2021	0
2020	0
2019	0
2018	14,324
Prior	0
Total	$ 14,324

REAL ESTATE OWNED - Narrative (

REAL ESTATE OWNED - Narrative (Details) - USD ($) $ in Thousands			3 Months Ended	12 Months Ended
	Mar. 01, 2022	Nov. 08, 2021	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Mar. 08, 2019
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding principal				$ 2,282,821	$ 2,429,112
Real estate owned held for sale, net				0	36,602
Gain on sale of real estate owned				2,197	0	$ 0
Depreciation of real estate owned				0	825	$ 892
NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Real estate owned held for sale, net					36,602
Repossessed hotel property					38,987
Depreciation of real estate owned				0	$ 825
Senior Mortgage Loans | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Outstanding principal							$ 38,600
Debt derecognized							38,600
Real estate owned held for sale, net							36,900
Other repossessed hotel assets							1,700
Repossessed hotel property							$ 38,600
Proceeds from sale of hotel property		$ 40,000
Gain on sale of real estate owned			$ 2,200
Senior Mortgage Loans | NEW YORK | Hotel | Third Party Buyer of the Hotel Property
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Initial funding of loan receivable				30,700
Senior Mortgage Loans | NEW YORK | Hotel | Third Party Buyer of the Hotel Property | Unfunded Loan Commitment
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Additional loan proceeds to be available to fund future advances				$ 25,000
Contributed equity into purchase	$ 12,900
Additional equity associated with planned renovation costs	$ 8,700

REAL ESTATE OWNED - Schedule of

REAL ESTATE OWNED - Schedule of Real Estate Owned, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Real estate owned held for sale, net	$ 0	$ 36,602
NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repossessed hotel property		38,987
Less: Accumulated depreciation		(2,385)
Real estate owned held for sale, net		36,602
Land | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repossessed hotel property		10,200
Buildings and improvements | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repossessed hotel property		24,281
Furniture, fixtures and equipment | NEW YORK | Hotel
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repossessed hotel property		$ 4,506

DEBT - Schedule of outstanding

DEBT - Schedule of outstanding balances and total commitments under Financing Agreements (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Outstanding Balance	$ 960,231,000	$ 1,041,157,000
Total Commitment	1,535,000,000	1,481,755,000
Secured term loan
Debt Instrument [Line Items]
Outstanding Balance	150,000,000	150,000,000
Total Commitment	150,000,000	150,000,000
Wells Fargo Facility | Revolving credit facility, optional commitment amount
Debt Instrument [Line Items]
Total Commitment	500,000,000
Secured funding facility
Debt Instrument [Line Items]
Outstanding Balance	705,231,000	840,047,000
Total Commitment	1,280,000,000	1,280,000,000
Secured funding facility | Wells Fargo Facility
Debt Instrument [Line Items]
Outstanding Balance	270,798,000	399,528,000
Total Commitment	450,000,000	450,000,000
Secured funding facility | Citibank Facility
Debt Instrument [Line Items]
Outstanding Balance	236,240,000	192,970,000
Total Commitment	325,000,000	325,000,000
Secured funding facility | CNB Facility
Debt Instrument [Line Items]
Outstanding Balance	0	0
Total Commitment	75,000,000	75,000,000
Secured funding facility | MetLife Facility
Debt Instrument [Line Items]
Outstanding Balance	0	20,648,000
Total Commitment	180,000,000	180,000,000
Secured funding facility | Morgan Stanley Facility
Debt Instrument [Line Items]
Outstanding Balance	198,193,000	226,901,000
Total Commitment	250,000,000	250,000,000
Notes Payable
Debt Instrument [Line Items]
Outstanding Balance	105,000,000	51,110,000
Total Commitment	$ 105,000,000	$ 51,755,000

DEBT - Disclosures (Details)

DEBT - Disclosures (Details)

1 Months Ended

3 Months Ended

6 Months Ended

10 Months Ended

12 Months Ended

18 Months Ended

Nov. 30, 2019 USD ($) loan extension

Jul. 31, 2022 USD ($) loan

Nov. 30, 2021 USD ($)

Jun. 30, 2019 USD ($)

Jun. 30, 2023

Mar. 31, 2023

Dec. 31, 2022 USD ($) extension

Nov. 12, 2025

Oct. 31, 2021

Nov. 12, 2026

Dec. 31, 2022 USD ($) extension option

Dec. 31, 2021 USD ($)

Dec. 31, 2020 USD ($)

Nov. 12, 2026

Funding agreements

Line of credit facility, maximum borrowing capacity

$ 1,535,000,000

$ 1,535,000,000

$ 1,481,755,000

Number of non-recourse notes | loan

2

Outstanding Balance

960,231,000

960,231,000

1,041,157,000

Outstanding principal

2,282,821,000

$ 2,282,821,000

2,429,112,000

SOFR

Funding agreements

Basis spread on variable rate

2%

Minimum

Funding agreements

Number of extension options | option

1

Maximum

Funding agreements

Extension period of maturity date

12 months

Number of extension options | option

2

Notes Payable, Due June 10, 2024 | NEW YORK

Funding agreements

Interest rate margin (as a percent)

3%

Notes Payable

Funding agreements

Number of extension periods available for maturity date | extension

2

Extension period of maturity date

12 months

Interest rate margin (as a percent)

3.75%

Outstanding Balance

$ 23,500,000

Notes Payable | SOUTH CAROLINA

Funding agreements

Outstanding Balance

$ 34,600,000

Secured term loan

Funding agreements

Line of credit facility, maximum borrowing capacity

150,000,000

$ 150,000,000

150,000,000

Outstanding Balance

150,000,000

150,000,000

$ 150,000,000

Aggregate principal amount

$ 150,000,000

$ 150,000,000

$ 150,000,000

Debt discount on initial draw down (as a percent)

4.60%

520%

640%

Secured term loan | Forecast

Funding agreements

Interest rate during period

4.50%

Interest rate, increase (decrease)

0.125%

Interest rate, quarterly increase

0.25%

Secured term loan | LIBOR

Funding agreements

Interest rate margin (as a percent)

0.50%

5%

Interest rate, increase (decrease)

0.125%

Secured term loan | LIBOR | Forecast

Funding agreements

Interest rate, increase (decrease)

0.75%

0.375%

Secured term loan | Minimum

Funding agreements

Covenant ratio of EBITDA to fixed charges

1.10

Covenant percentage of net proceeds raised in future equity issuances, used for computing tangible net worth to be maintained

80%

Covenant percentage of tangible net worth at specified date used for computing tangible net worth to be maintained

80%

Asset coverage ratio

115%

Unencumbered asset ratio

125%

Covenant percentage of tangible net worth required to be maintained

65%

Secured term loan | Maximum

Funding agreements

Covenant ratio of debt to tangible net worth

4.50

Wells Fargo Facility | Secured revolving funding facility

Funding agreements

Line of credit facility, maximum borrowing capacity

$ 450,000,000

$ 450,000,000

Number of extension periods available for maturity date | extension

2

2

Extension period of maturity date

12 months

Non-utilization fee on average available balance (basis points)

0.25%

Facility used on average (at least) (as a percent)

75%

Non-utilization fee

$ 19,000

Covenant liquidity to be maintained as percentage of recourse indebtedness

5%

Wells Fargo Facility | Secured revolving funding facility | Minimum

Funding agreements

Covenant percentage of net proceeds raised in future equity issuances, used for computing tangible net worth to be maintained

80%

Covenant amount of liquidity to be maintained

$ 5,000,000

Wells Fargo Facility | Secured revolving funding facility | Minimum | 30 day LIBOR

Funding agreements

Interest rate margin (as a percent)

1.50%

Wells Fargo Facility | Secured revolving funding facility | Minimum | One-month LIBOR

Funding agreements

Interest rate margin (as a percent)

1.50%

Wells Fargo Facility | Secured revolving funding facility | Maximum

Funding agreements

Covenant ratio of debt to tangible net worth

4.50

Covenant ratio of recourse debt to tangible net worth

3,000

Covenant ratio of EBITDA to fixed charges

1.25

Covenant specified amount for computing tangible net worth to be maintained

$ 135,500,000

Covenant amount of liquidity to be maintained

$ 10,000,000

Wells Fargo Facility | Secured revolving funding facility | Maximum | 30 day LIBOR

Funding agreements

Interest rate margin (as a percent)

2.75%

Wells Fargo Facility | Secured revolving funding facility | Maximum | One-month LIBOR

Funding agreements

Interest rate margin (as a percent)

3.75%

Wells Fargo Facility | Revolving credit facility, optional commitment amount

Funding agreements

Line of credit facility, maximum borrowing capacity

$ 500,000,000

$ 500,000,000

Citibank Facility | Secured revolving funding facility

Funding agreements

Line of credit facility, maximum borrowing capacity

$ 325,000,000

$ 325,000,000

Number of extension periods available for maturity date | extension

2

2

Extension period of maturity date

12 months

Non-utilization fee on average available balance (basis points)

0.25%

Facility used on average (at least) (as a percent)

75%

Non-utilization fee

$ 11,000

$ 598,000

516,000

Covenant liquidity to be maintained as percentage of recourse indebtedness

5%

Citibank Facility | Secured revolving funding facility | Minimum

Funding agreements

Covenant percentage of net proceeds raised in future equity issuances, used for computing tangible net worth to be maintained

80%

Covenant percentage of tangible net worth at specified date used for computing tangible net worth to be maintained

80%

Covenant amount of liquidity to be maintained

$ 5,000,000

Citibank Facility | Secured revolving funding facility | Minimum | 30 day LIBOR

Funding agreements

Interest rate margin (as a percent)

1.50%

Citibank Facility | Secured revolving funding facility | Maximum

Funding agreements

Covenant ratio of debt to tangible net worth

4.50

Covenant ratio of recourse debt to tangible net worth

3

Covenant ratio of EBITDA to fixed charges

1.25

Covenant amount of liquidity to be maintained

$ 10,000,000

Citibank Facility | Secured revolving funding facility | Maximum | 30 day LIBOR

Funding agreements

Interest rate margin (as a percent)

2.10%

CNB Facility | CNB Facility

Funding agreements

Line of credit facility, maximum borrowing capacity

$ 75,000,000

$ 75,000,000

Non-utilization fee

$ 284,000

146,000

38,000

CNB Facility | CNB Facility | LIBOR

Funding agreements

Interest rate margin (as a percent)

2.65%

CNB Facility | CNB Facility | One-month LIBOR

Funding agreements

Interest rate margin (as a percent)

1%

CNB Facility | CNB Facility | SOFR

Funding agreements

Interest rate margin (as a percent)

1%

CNB Facility | CNB Facility | Federal funds rate

Funding agreements

Interest rate margin (as a percent)

0.50%

Non-utilization fee on average available balance (basis points)

0.375%

Facility used on average (at least) (as a percent)

75%

CNB Facility | CNB Facility | Minimum

Funding agreements

Covenant percentage of net proceeds raised in future equity issuances, used for computing tangible net worth to be maintained

80%

Covenant percentage of tangible net worth at specified date used for computing tangible net worth to be maintained

80%

CNB Facility | CNB Facility | Minimum | SOFR

Funding agreements

Interest rate margin (as a percent)

0.35%

CNB Facility | CNB Facility | Maximum

Funding agreements

Covenant ratio of debt to tangible net worth

4.50

Covenant ratio of EBITDA to fixed charges

1.25

CNB Facility | CNB Facility | Maximum | SOFR

Funding agreements

Interest rate margin (as a percent)

2.65%

CNB Facility | Revolving Credit Facility - Optional Funding Period

Funding agreements

Extension period of maturity date

12 months

MetLife Facility | Secured revolving funding facility

Funding agreements

Non-utilization fee on average available balance (basis points)

0.25%

Non-utilization threshold percentage (less than) (as a percent)

65%

65%

MetLife Facility | CNB Facility

Funding agreements

Non-utilization fee

$ 247,000

$ 162,000

$ 7,000

MetLife Facility | Revolving master repurchase facility

Funding agreements

Line of credit facility, maximum borrowing capacity

$ 180,000,000

$ 180,000,000

Number of extension periods available for maturity date | extension

1

1

Extension period of maturity date

12 months

MetLife Facility | Revolving master repurchase facility | 30 day LIBOR

Funding agreements

Interest rate margin (as a percent)

2.50%

MetLife Facility | Revolving master repurchase facility | Maximum

Funding agreements

Covenant ratio of debt to tangible net worth

4.50

Covenant ratio of recourse debt to tangible net worth

3

Covenant ratio of EBITDA to fixed charges

1.25

MetLife Facility | Revolving credit facility, optional commitment amount | Minimum

Funding agreements

Covenant percentage of tangible net worth at specified date used for computing tangible net worth to be maintained

80%

Morgan Stanley Facility | Revolving master repurchase facility

Funding agreements

Line of credit facility, maximum borrowing capacity

$ 250,000,000

$ 250,000,000

Number of extension periods available for maturity date | extension

1

1

Extension period of maturity date

12 months

Morgan Stanley Facility | Revolving master repurchase facility | 30 day LIBOR

Funding agreements

Interest rate margin (as a percent)

2.25%

Morgan Stanley Facility | Revolving master repurchase facility | Minimum | 30 day LIBOR

Funding agreements

Interest rate margin (as a percent)

1.75%

Morgan Stanley Facility | Revolving credit facility, optional commitment amount

Funding agreements

Covenant liquidity to be maintained as percentage of recourse indebtedness

5%

Morgan Stanley Facility | Revolving credit facility, optional commitment amount | Minimum

Funding agreements

Covenant percentage of tangible net worth at specified date used for computing tangible net worth to be maintained

80%

Covenant amount of liquidity to be maintained

$ 5,000,000

Morgan Stanley Facility | Revolving credit facility, optional commitment amount | Maximum

Funding agreements

Covenant ratio of EBITDA to fixed charges

1.25

Covenant amount of liquidity to be maintained

$ 10,000,000

Notes Payable | Secured revolving funding facility

Funding agreements

Covenant liquidity to be maintained as percentage of recourse indebtedness

5%

Notes Payable | Secured revolving funding facility | Minimum

Funding agreements

Covenant percentage of net proceeds raised in future equity issuances, used for computing tangible net worth to be maintained

80%

Covenant percentage of tangible net worth at specified date used for computing tangible net worth to be maintained

80%

Covenant amount of liquidity to be maintained

$ 5,000,000

Notes Payable | Secured revolving funding facility | Maximum

Funding agreements

Covenant amount of liquidity to be maintained

$ 10,000,000

Notes Payable | Notes Payable, Due June 10, 2024 | NEW YORK

Funding agreements

Number of extension periods available for maturity date | extension

1

1

Extension period of maturity date

6 months

Interest expense from real estate owned

$ 28,300,000

ACRC Lender CO LLC

Funding agreements

Outstanding Balance

$ 105,000,000

ACRC Lender CO LLC | NEW YORK | Multifamily | Senior Mortgage Loans

Funding agreements

Outstanding Balance

105,000,000

Outstanding principal

$ 133,000,000

ACRC Lender CO LLC | Notes Payable

Funding agreements

Extension period of maturity date

12 months

Number of extension options | loan

2

DEBT - Schedule of Maturity (De

DEBT - Schedule of Maturity (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
2023	$ 0
2024	198,193
2025	612,038
2026	150,000
2027	0
Thereafter	0
Long-term debt	960,231
Wells Fargo Facility
Debt Instrument [Line Items]
2023	0
2024	0
2025	270,798
2026
2027	0
Thereafter	0
Long-term debt	270,798
Citibank Facility
Debt Instrument [Line Items]
2023	0
2024	0
2025	236,240
2026	0
2027	0
Thereafter	0
Long-term debt	236,240
CNB Facility
Debt Instrument [Line Items]
2023	0
2024	0
2025	0
2026	0
2027	0
Thereafter	0
Long-term debt	0
MetLife Facility
Debt Instrument [Line Items]
2023	0
2024	0
2025	0
2026	0
2027	0
Thereafter	0
Long-term debt	0
Morgan Stanley Facility
Debt Instrument [Line Items]
2023	0
2024	198,193
2025
2026	0
2027	0
Thereafter	0
Long-term debt	198,193
Notes Payable
Debt Instrument [Line Items]
2023	0
2024	0
2025	105,000
2026
2027	0
Thereafter	0
Long-term debt	105,000
Secured term loan
Debt Instrument [Line Items]
2023	0
2024	0
2025	0
2026	150,000
2027	0
Thereafter	0
Long-term debt	$ 150,000

SECURED BORROWINGS (Details)

SECURED BORROWINGS (Details) - USD ($)		1 Months Ended		12 Months Ended
	Nov. 30, 2019	Jul. 31, 2022	Apr. 30, 2019	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Outstanding Balance				$ 960,231,000	$ 1,041,157,000
Notes Payable
Debt Instrument [Line Items]
Outstanding Balance	$ 23,500,000
Extension period of maturity date	12 months
Interest rate margin (as a percent)				3.75%
NORTH CAROLINA | Multifamily
Debt Instrument [Line Items]
Repayments of debt		$ 30,500,000
NORTH CAROLINA | Notes Payable
Debt Instrument [Line Items]
Aggregate principal amount			$ 30,500,000
Outstanding Balance			24,400,000
NORTH CAROLINA | Notes Payable | Multifamily
Debt Instrument [Line Items]
Outstanding Balance			$ 6,100,000
NORTH CAROLINA | Notes Payable | Multifamily | Senior Mortgage Loan Purchased
Debt Instrument [Line Items]
Outstanding Balance		$ 24,400,000
NORTH CAROLINA | Senior Mortgage Loans
Debt Instrument [Line Items]
Extension period of maturity date			12 months
NORTH CAROLINA | Senior Mortgage Loan, Due May 5, 2023 | Office
Debt Instrument [Line Items]
Interest rate margin (as a percent)			2.50%

DERIVATIVE FINANCIAL INSTRUME_3

DERIVATIVE FINANCIAL INSTRUMENTS - Schedule of Interest Rate Derivatives (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) derivative	Dec. 31, 2021 USD ($) derivative
Derivative [Line Items]
Floor rate (percent)	0
Other comprehensive income	$ 4,697	$ 2,844
Interest rate caps | LIBOR
Derivative [Line Items]
Notional Amount	170,000
Other comprehensive income	2,000
Gain on derivative	$ 1,000
Designated as Hedging Instrument | Interest rate swaps | LIBOR
Derivative [Line Items]
Number of Instruments | derivative	1	1
Notional Amount	$ 410,000	$ 700,000
Interest rate swaps, fixed rate (percent)	0.2075%	0.2075%
Weighted Average Maturity (Years)	4 months 24 days	1 year
Designated as Hedging Instrument | Interest rate caps | LIBOR
Derivative [Line Items]
Number of Instruments | derivative	0	1
Notional Amount	$ 0	$ 220
Interest rate caps, fixed rate (percent)	0.50%	0.50%
Weighted Average Maturity (Years)		1 year

DERIVATIVE FINANCIAL INSTRUME_4

DERIVATIVE FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Instruments (Details) - Designated as Hedging Instrument - Interest rate derivatives - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Other Assets
Derivatives, Fair Value [Line Items]
Fair Value of Derivatives in an Asset Position	$ 6,565	$ 2,979
Other Liabilities
Derivatives, Fair Value [Line Items]
Fair Value of Derivatives in an Liability Position	$ 0	$ 0

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Commitments to Fund (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Total commitments	$ 2,510,308	$ 2,662,853
Less: funded commitments	(2,282,821)	(2,429,112)
Total unfunded commitments	$ 227,487	$ 233,741

STOCKHOLDERS' EQUITY - Narrativ

STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions				12 Months Ended
	May 20, 2022	May 17, 2022	Nov. 22, 2019	Dec. 31, 2022	Dec. 31, 2021	Jul. 26, 2022	Dec. 31, 2020	Jun. 30, 2018
Class of Stock [Line Items]
Share repurchase program, authorized amount.						$ 50
Cost not yet recognized, amount				$ 8	$ 6		$ 3.7
Period for recognition				2 years 3 months 18 days
Restricted stock | Amended and Restated 2012 Equity Incentive Plan
Class of Stock [Line Items]
Shares available for grant (in shares)								2,490,000
Restricted Stock and Restricted Stock Units | Amended and Restated 2012 Equity Incentive Plan | Minimum
Class of Stock [Line Items]
Award vesting period (in years)				1 year
Restricted Stock and Restricted Stock Units | Amended and Restated 2012 Equity Incentive Plan | Maximum
Class of Stock [Line Items]
Award vesting period (in years)				3 years
Common Stock | At the Market Stock Offering Program
Class of Stock [Line Items]
Sale of stock, consideration received on transaction				$ 2.9	$ 2.1
Sale of stock, shares issued in transaction (in shares)				190,369	137,237
Sale of stock, share price (in dollars per share)				$ 15.33	$ 15.68
Common Stock | At the Market Stock Offering Program | Maximum
Class of Stock [Line Items]
Sale of stock, consideration received on transaction			$ 100
Common Stock | Equity Offerings
Class of Stock [Line Items]
Sale of stock, consideration received on transaction	$ 103.2
Sale of stock, shares issued in transaction (in shares)		7,000,000

STOCKHOLDERS' EQUITY - Disclosu

STOCKHOLDERS' EQUITY - Disclosures (Details)	12 Months Ended
	Dec. 31, 2022 shares
Restricted stock activity
Balance at the beginning of the period (in shares)	539,174
Granted (in shares)	458,930
Vested (in shares)	(135,432)
Forfeited (in shares)	(14,063)
Balance at the end of the period (in shares)	848,609
Future Anticipated Vesting Schedule
2023 (in shares)	182,326
2024 (in shares)	287,073
2025 (in shares)	234,514
2026 (in shares)	144,696
2027 (in shares)	0
Total (in shares)	848,609
Restricted stock | Restricted Stock Grants—Directors
Restricted stock activity
Balance at the beginning of the period (in shares)	16,640
Granted (in shares)	24,780
Vested (in shares)	(25,283)
Forfeited (in shares)	0
Balance at the end of the period (in shares)	16,137
Future Anticipated Vesting Schedule
2023 (in shares)	14,052
2024 (in shares)	1,668
2025 (in shares)	417
2026 (in shares)	0
2027 (in shares)	0
Total (in shares)	16,137
Restricted stock | Officers and Employees of the Manager
Restricted stock activity
Balance at the beginning of the period (in shares)	25,373
Granted (in shares)	0
Vested (in shares)	(25,373)
Forfeited (in shares)	0
Balance at the end of the period (in shares)	0
Future Anticipated Vesting Schedule
2023 (in shares)	0
2024 (in shares)	0
2025 (in shares)	0
2026 (in shares)	0
2027 (in shares)	0
Total (in shares)	0
Restricted Stock Units (RSUs) | Officers and Employees of the Manager
Restricted stock activity
Balance at the beginning of the period (in shares)	497,161
Granted (in shares)	434,150
Vested (in shares)	(84,776)
Forfeited (in shares)	(14,063)
Balance at the end of the period (in shares)	832,472
Future Anticipated Vesting Schedule
2023 (in shares)	168,274
2024 (in shares)	285,405
2025 (in shares)	234,097
2026 (in shares)	144,696
2027 (in shares)	0
Total (in shares)	832,472

STOCKHOLDERS' EQUITY - Disclo_2

STOCKHOLDERS' EQUITY - Disclosures (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restricted Stock and Restricted Stock Units
Equity Incentive Plan
Compensation expense	$ 2,876,000	$ 1,940,000
Total fair value of shares vested	1,961,000	1,469,000
Weighted average grant date fair value	5,044,000	4,658,000
Restricted stock
Equity Incentive Plan
Compensation expense			$ 1,339,000
Total fair value of shares vested			1,164,000
Weighted average grant date fair value			3,190,000
Restricted Stock Grants—Directors | Restricted Stock and Restricted Stock Units
Equity Incentive Plan
Compensation expense	399,000	329,000
Total fair value of shares vested	338,000	460,000
Weighted average grant date fair value	390,000	403,000
Restricted Stock Grants—Directors | Restricted stock
Equity Incentive Plan
Compensation expense			319,000
Total fair value of shares vested			315,000
Weighted average grant date fair value			292,000
Officers and Employees of the Manager | Restricted Stock and Restricted Stock Units
Equity Incentive Plan
Compensation expense	2,477,000	1,611,000
Total fair value of shares vested	1,623,000	1,009,000
Weighted average grant date fair value	$ 4,654,000	$ 4,255,000
Officers and Employees of the Manager | Restricted stock
Equity Incentive Plan
Compensation expense			1,020,000
Total fair value of shares vested			849,000
Weighted average grant date fair value			$ 2,898,000

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Net income attributable to common stockholders, basic	$ 29,785	$ 60,460	$ 21,840
Net income attributable to common stockholders, diluted	$ 29,785	$ 60,460	$ 21,840
Divided by:
Basic weighted average shares of common stock outstanding (in shares)	51,679,744	42,399,613	32,977,462
Weighted average non-vested restricted stock and RSUs (in shares)	446,512	281,892	219,046
Diluted weighted average shares of common stock outstanding (in shares)	52,126,256	42,681,505	33,196,508
Basic earnings per common share (in dollars per share)	$ 0.58	$ 1.43	$ 0.66
Diluted earnings per common share (in dollars per share)	$ 0.57	$ 1.42	$ 0.66

INCOME TAX - Schedule of Compon

INCOME TAX - Schedule of Components of Income Tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Components of the company's income tax provision
Total income tax expense, including excise tax	$ 472	$ 722	$ 352
Excise tax rate	4%
ACRE Capital Sale
Components of the company's income tax provision
Current	$ 42	450	82
Deferred	0	0	(99)
Excise tax	430	272	369
Total income tax expense, including excise tax	$ 472	$ 722	$ 352

FAIR VALUE - Available-For-Sale

FAIR VALUE - Available-For-Sale Debt Securities - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) investment loan	Dec. 31, 2021 investment
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Number of debt securities for an aggregate purchase price | loan	3
Debt securities for an aggregate purchase price | $	$ 27.9
Debt securities, available-for-sale, term	10 years
Number of debt security investments | investment	3	0
SOFR
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Debt securities floating Rate, investment grade rated	247%

FAIR VALUE - Available-For-Sa_2

FAIR VALUE - Available-For-Sale Debt Securities (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Fair Value Disclosures [Abstract]
Face Amount	$ 28,000
Amortized Cost	27,881
Unamortized Discount	119
Unrealized Gain (Loss), Net	$ 55

FAIR VALUE - Derivative Assets

FAIR VALUE - Derivative Assets and Liabilities, Recurring (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Interest rate derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets:	$ 6,565	$ 2,979
Financial liabilities:	0	0
Interest rate derivatives | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets:	0	0
Financial liabilities:	0	0
Interest rate derivatives | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets:	6,565	2,979
Financial liabilities:	0	0
Interest rate derivatives | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets:	0	0
Financial liabilities:	0	$ 0
Available-for-sale debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets:	27,936
Available-for-sale debt securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets:	0
Available-for-sale debt securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets:	27,936
Available-for-sale debt securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets:	$ 0

FAIR VALUE - Carrying Value and

FAIR VALUE - Carrying Value and Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financial assets:
Loans held for investment	$ 2,264,008	$ 2,414,383
Financial liabilities:
Collateralized loan obligation securitization debt (consolidated VIEs)	777,675	861,188
Carrying Value
Financial assets:
Loans held for investment	2,264,008	2,414,383
Financial liabilities:
Secured funding agreements	705,231	840,047
Notes payable	104,460	50,358
Secured term loan	149,200	149,016
Collateralized loan obligation securitization debt (consolidated VIEs)	777,675	861,188
Secured borrowings	0	22,589
Fair Value | Level 3
Financial assets:
Loans held for investment	2,233,319	2,408,463
Financial liabilities:
Notes payable	103,635	51,110
Secured term loan	137,571	150,000
Collateralized loan obligation securitization debt (consolidated VIEs)	749,242	863,403
Secured borrowings	0	22,715
Fair Value | Level 2
Financial liabilities:
Secured funding agreements	$ 705,231	$ 840,047

RELATED PARTY TRANSACTIONS - Na

RELATED PARTY TRANSACTIONS - Narrative (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) quarter	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Related Party Transaction [Line Items]
Amended agreement to exclude real estate revenues from net income	$ 2,400,000
Amended agreement to include gain on termination of interest rate cap derivative	$ 2,000,000
Incentive fees incurred		$ 3,400,000	$ 2,800,000	$ 800,000
Management fee renewal term (in years)		1 year
Management agreement termination, termination fee times average annual base management free and incentive fees received		300%
Management fee look back period		24 months
Loans held for investment		$ 2,264,008,000	2,414,383,000
Outstanding principal		2,282,821,000	2,429,112,000
Residential
Related Party Transaction [Line Items]
Loans held for investment		213,700,000	$ 158,300,000
Senior Mortgage Loans | Industrial | Loan Purchase Commitments
Related Party Transaction [Line Items]
Outstanding principal		$ 200,000,000
ACREM
Related Party Transaction [Line Items]
Base management fees as a percentage of stockholders' equity per annum		1.50%
Incentive fee payable (not less than)		$ 0
Percentage multiplied to arrive at first value affecting calculation of incentive fees		20%
Previous period for which core earnings are considered to arrive at first value affecting calculation of incentive fees		12 months
Previous period for product of weighted average price per share and weighted average number of shares of common stock and other shares		12 months
Percentage multiplied to arrive at difference of first value affecting calculation of incentive fees		8%
Period whose fiscal quarters are considered to arrive at first value affecting calculation of incentive fees		12 months
Minimum cumulative core earnings, number of quarters | quarter		12
Minimum cumulative core earnings for calculation of incentive fee		$ 0

RELATED PARTY TRANSACTIONS - Re

RELATED PARTY TRANSACTIONS - Related Party Costs Incurred (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Payable	$ 5,580	$ 4,156
ACREM | Continuing Operations
Related Party Transaction [Line Items]
Incurred	18,840	15,161	$ 11,912
Payable	5,580	4,156
ACREM | Continuing Operations | Management fees
Related Party Transaction [Line Items]
Incurred	11,456	9,384	7,323
Payable	3,026	2,613
ACREM | Continuing Operations | Incentive fees
Related Party Transaction [Line Items]
Incurred	3,442	2,752	836
Payable	1,264	830
ACREM | Continuing Operations | General and administrative expenses
Related Party Transaction [Line Items]
Incurred	3,777	3,016	3,653
Payable	1,232	703
ACREM | Continuing Operations | Direct costs
Related Party Transaction [Line Items]
Incurred	165	9	$ 100
Payable	$ 58	$ 10

DIVIDENDS AND DISTRIBUTIONS (De

DIVIDENDS AND DISTRIBUTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands													12 Months Ended
	Nov. 02, 2022	Jul. 29, 2022	May 03, 2022	Feb. 15, 2022	Nov. 03, 2021	Jul. 30, 2021	May 04, 2021	Feb. 17, 2021	Dec. 15, 2020	Sep. 16, 2020	Jun. 19, 2020	Feb. 20, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
DIVIDENDS AND DISTRIBUTIONS
Dividends per share amount declared (in dollars per share)	$ 0.35	$ 0.35	$ 0.35	$ 0.35	$ 0.35	$ 0.35	$ 0.35	$ 0.35	$ 0.33	$ 0.33	$ 0.33	$ 0.33	$ 1.40	$ 1.40	$ 1.32
Total cash dividends	$ 19,347	$ 19,196	$ 19,198	$ 16,740	$ 16,674	$ 16,524	$ 16,528	$ 14,248	$ 11,124	$ 11,072	$ 11,072	$ 11,057	$ 74,481	$ 63,974	$ 44,325
Cash dividends payable (in dollars per share)													$ 0.33
Supplemental cash dividend payable (in dollars per share)													$ 0.02

VARIABLE INTEREST ENTITIES - Na

VARIABLE INTEREST ENTITIES - Narrative (Details) $ in Thousands		12 Months Ended
	Jan. 28, 2021 USD ($)	Dec. 31, 2022 USD ($) loan	Dec. 31, 2021 USD ($) loan	Dec. 31, 2020 USD ($)	Jan. 11, 2019 USD ($)	Mar. 30, 2017 USD ($)
Variable Interest Entity [Line Items]
Debt commitment		$ 960,231
Financing receivable, unpaid principal balance		127,600	$ 105,400
Loans held for investment		2,264,008	2,414,383
Sale of common stock		106,267	$ 204,779	$ 73,232
Credit risk, financial instrument, maximum exposure		238,200
ACRE Commercial Mortgage 2021-FL4 Ltd. and ACRE Commercial Mortgage 2021-FL4 LLC | Preferred Stock
Variable Interest Entity [Line Items]
Sale of common stock	$ 64,300
ACRE Commercial Mortgage 2021-FL4 Ltd. and ACRE Commercial Mortgage 2021-FL4 LLC | Preferred Stock | Wholly Owned Subsidiary To Parent Company
Variable Interest Entity [Line Items]
Sale of common stock		$ 64,300
Floating Rate Notes, Weighted Average Coupon Rate, LIBOR Plus 1.85%
Variable Interest Entity [Line Items]
Number of properties collateralized for mortgage loan | loan		16	16
Receivables related to repayments of outstanding principal		$ 429,400	$ 451,600
Mortgaged Assets | Holdco
Variable Interest Entity [Line Items]
Principal amount of certificates retained by wholly owned subsidiary of the entity		58,500
Offered Certificates | Parent Company
Variable Interest Entity [Line Items]
Preferred equity fully funded amount		52,900
Secured funding agreements | Parent Company
Variable Interest Entity [Line Items]
Loans held for investment		111,400
Secured, Floating Rate Notes | ACRE Commercial Mortgage 2021-FL4 Ltd. and ACRE Commercial Mortgage 2021-FL4 LLC
Variable Interest Entity [Line Items]
Aggregate principal amount	$ 603,000
Secured, Floating Rate Notes | ACRE Commercial Mortgage 2021-FL4 Ltd. and ACRE Commercial Mortgage 2021-FL4 LLC | Wholly Owned Subsidiary To Parent Company
Variable Interest Entity [Line Items]
Aggregate principal amount		62,500
Collateral amount		126,800
Repayments of debt		$ 85,900
FL4 Mortgage Assets
Variable Interest Entity [Line Items]
Number of properties collateralized for mortgage loan | loan		12	17
Receivables related to repayments of outstanding principal		$ 458,300	$ 522,800
Financing Receivable, Excluding Accrued Interest, Receivables Related to Repayments of Outstanding Principal on Mortgage Assets		$ 1,900	$ 23,200
Wells Fargo Facility | Notes Payable
Variable Interest Entity [Line Items]
Debt commitment						$ 308,800
Wells Fargo Facility | Notes Payable | 2019 FL3 CLO Securitization
Variable Interest Entity [Line Items]
Debt commitment					$ 504,100
Wells Fargo Facility | Collateralized Loan Obligations
Variable Interest Entity [Line Items]
Debt commitment						$ 32,400
Wells Fargo Facility | Collateralized Loan Obligations | 2019 FL3 CLO Securitization
Variable Interest Entity [Line Items]
Debt commitment					$ 52,900

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Mar. 31, 2023	Feb. 14, 2023
Subsequent Event [Line Items]
Outstanding principal		$ 2,282,821,000	$ 2,429,112,000
Proceeds from sale of loans held for sale		$ 0	$ 0	$ 96,597,000
Cash dividends payable (in dollars per share)		$ 0.33
Supplemental cash dividend payable (in dollars per share)		$ 0.02
Senior Mortgage Loans | CA | Residential
Subsequent Event [Line Items]
Outstanding principal		$ 14,300,000
Subsequent Event
Subsequent Event [Line Items]
Cash dividends payable (in dollars per share)					$ 0.33
Supplemental cash dividend payable (in dollars per share)					$ 0.02
Subsequent Event | CA | Residential
Subsequent Event [Line Items]
Proceeds from sale of loans held for sale	$ 10,000,000
Proceeds from Loans	$ 9,800,000
Subsequent Event | Senior Mortgage Loans | IL | Office
Subsequent Event [Line Items]
Outstanding principal						$ 27,200,000
Subsequent Event | Senior Mortgage Loans | CA | Mixed-use
Subsequent Event [Line Items]
Outstanding principal						37,900,000
Subsequent Event | Senior Mortgage Loans | FL | Mixed-use
Subsequent Event [Line Items]
Outstanding principal						$ 84,000,000

Uncategorized Items - acre-2022

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2016-13 [Member]